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Abstract 
Toxoplasma gondii is a globally distributed protozoan parasite that infects humans and a wide 
variety of warm-blooded animals. Although there are many surveys for T. gondii infection in 
mammals, little is known about the detailed distribution in localised natural populations. In 
this study we investigated host genotype and spatial location in relation to T. gondii infection 
and genotypes. We collected wood mice (Apodemus sylvaticus) from 4 sampling sites within 
a localised peri-aquatic woodland ecosystem which is relatively free of cats. Mice were 
genotyped using standard A. sylvaticus microsatellite markers and T. gondii and its genotypes 
were detected using 5 specific PCR based markers: SAG1, SAG2, SAG3, B1 and GRA6 
directly from infected tissue. Of 126 wood mice collected, 44 samples gave positive reactions 
with T. gondii specific markers giving an infection rate of 34.92% (95% CI: 27.14%-
43.59%). A total of 24/76 (31.58%, 95% CI: 22.19%-42.74%) males and 20/50 (40%, 95% 
CI: 27.59%-53.84%) female mice were found to be positive for T. gondii with no significant 
difference (P = 0.353). Juvenile, young adults and adults were infected at similar prevalences, 
respectively, 7/17 (41.18%), 27/65 (41.54%) and 10/44 (22.72%) with no significant age-
prevalence effect (P = 0.23). Detailed analysis of the RFLP patterns and the DNA sequences 
for the SAG2, SAG3 and GRA6 loci showed a range of genotypes but, surprisingly, 
suggested that 30/44 (68.2%) infected mice had multiple genotypes (mixed infections) 
present. Results of genetic analysis of the mice showed that the collection consists of four 
genetically distinct populations. There was a significant difference in T. gondii infection in 
the different mouse genotypically derived populations (P=0.035) but not between 
geographically defined populations based on sampling location (P=0.29). In a parallel study, 
DNA was successfully collected from 88 human lung tissue samples. All samples showed 
successful amplification of the human α-tubulin gene and were used for T. gondii DNA 
detection. We used commonly used PCR markers (B1, SAG1, SAG2, SAG3, GRA6, APICO, 
L358, PK1, SAG1-Su, BTUB, alt.SAG2, c22-8 and c29-2), histological and 
immunohistochemical staining to confirm the presence of the parasite. All 88 tested samples 
were confirmed to be positive for T. gondii with markers B1, SAG1, SAG2 3’, SAG2 5’ and 
SAG3, giving a prevalence of 100% (95% CI: 95.82%-100%). From all successfully 
genotyped samples, 34 had single infection on all loci and 42 were of mixed infection on one 
or more loci with all three genotypes present. Type II genotype was the most predominant, 
followed by Type I and Type III. We detected 11 unusual genotypes. Immunohistochemistry 
XIII 
 
 
was performed on 76 of the 88 tissue sections using commercial polyclonal antibodies 
produced in rabbits. All 76 sections were confirmed to be positive for T. gondii. A 
surprisingly high number of patients (96.05%) showed evidence of an active form of 
infection, as defined by the presence of tachyzoites or infected alveolar macrophages (or 
other cell types). Only three subjects (3.95%) had the dormant cyst stage as the only stage 
present. All 76 tissue sections were successfully stained with haematoxylin and eosin and 
observed under the light microscope. The presence of structures consistent with infection by 
the parasite was confirmed in 67 samples. All these patients are at risk of reactivation of 
chronic infection, leading to toxoplasmic encephalitis or pulmonary toxoplasmosis; which 
can complicate and delay their treatment or lead to death. 
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Chapter 1: 
 
General Introduction 
  
2 
1. Introduction  
   
    Toxoplasma gondii is an obligate intracellular parasite capable of infecting any warm-
blooded animal including humans (Black et al. 2000, Dubey et al. 2001). Its distribution is 
global, ranging from Alaska to Australia and it infects up to a third of human world’s 
population (Jackson and Hutchinson, 1989). It is more prevalent in the temperate and moist 
tropical regions of the world than in the arctic zones or in the hot arid regions. It is unique in 
that it infects any type of nucleated cells (Dubey et al. 1988). It has been found in intestinal 
epithelium, hepatocytes, alveolar cells, macrophages, retinal cells, brain cells and in red 
blood cells of birds. This protozoan parasite was discovered in 1908 by Nicolle and 
Manceaux in Tunisia in rodents Ctenodactylus gundi. At about the same time Splendor 
(1909) found it in rabbits in Brazil. In 1923, Janků described the T. gondii cyst in the retina of 
hydrocephalic child, but the role of the parasite as a human pathogen was not known until 
Wolf and Cowen (1942) identified toxoplasmosis as a disease of humans. The name 
Toxoplasma (toxon = arc, plasma = form, Greek) is derived from its crescent shape.  
   Toxoplasma gondii is a protozoan parasite belonging to the Phylum Apicomplexa (which 
contains many human and veterinary disease agents (e.g. Plasmodium spp., Babesia spp., 
Eimeria spp., Sarcoscystis spp.). Class Conoidasida, Subclass Coccidiasina, Order 
Eucoccidiorida, Family Sarcocystidae, Subfamily Toxoplasmatinae.  
 
Figure 1.1 A maximum parsimony tree for the isosporoid coccidia (a single branch of the tree for the 
entire phylum Apicomplexa) that corresponds to the family Sarcocystidae. The current sub-families 
Sarcocystinae and Toxoplasmatinae are reasonably well-supported in this reconstruction based on the 
18S ribosomal RNA sequences (Barta et al. 2001).  
3 
The full life cycle was not known until 1970 when several groups independently discovered 
the oocyst stage in cat faeces (Hutchison et al. 1969, 1970, 1971; Frenkel et al. 1970; Dubey 
et al. 1970; Sheffield and Melton, 1970; Overdulve, 1970; Weiland and Kuhn, 1970; Witte 
and Piekarski, 1970). The discovery of T. gondii oocysts in cat faeces and its implications 
have been reviewed by Frenkel (1970, 1973). 
   Despite high prevalences in some areas, few studies have been conducted on natural 
populations of animals. Most of the tested samples were collected from domestic animals in 
farms, slaughterhouses, processed meat and human studies. The majority of epidemiological 
studies in wild animals have been based on serological diagnostic methods or isolation of the 
parasite. Only in few studies have the parasite bee investigated in an individual host 
population. For example, Dodd et al. (2014) used microsatellites to investigate the population 
of bats infected with T. gondii but to our knowledge no similar study has ever been conducted 
on wild rodents.  
 
1.1. Life cycle and morphology 
 
   The definitive hosts of T. gondii are domestic cats and a number of other members of the 
family Felidae.  It is only in these animals that the sexual stages of the parasite occur. There 
are three infectious stages of T. gondii: tachyzoites (in pseudocysts or clones), bradyzoites (in 
tissue cysts) and sporozoites (in oocysts).  These individual parasite stages possess the apical 
complex which is used for cell invasion. The apical complex consists of a set of spirally 
arranged microtubules (the conoid), a secretory body (the rhoptry) and one or more polar 
rings (Dubey et al. 1988). Additional slender electron dense secretory bodies (micronemes) 
surrounded by one or two polar rings may also be present.  
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Figure 1.2 Example of fluorescent protein labelling of subcellular organelles in T. gondii. 
(Joiner and Roos, 2002). 
 
    Tachyzoites (Greek. tachys, fast + zoon, animal) 
The tachyzoite is often crescent shaped and is approximately 2 x 6 µm. The nucleus is 
usually situated toward the posterior end or in the central area of the cell. This is the rapidly 
dividing stage that can multiply in any nucleated cells of the definitive and intermediate 
host. They have no cilia or pseudopodia but they are able to rotate, glide and undulate 
(Chiappino, et al. 1984). Tachyzoites actively penetrate the host cell wall or are internalised 
during phagocytosis (e.g. macrophages) and becomes surrounded by a parasitophorous 
vacuole, inside which endogeny occurs. During penetration parasites orientate themselves so 
that the apical end is facing the host cell. The micronemes are expelled first and expulsion 
occurs with initial contact between parasite and host cell. The rhoptries are discharged 
immediately after the micronemes, and dense granule contents are released last. Many dense 
granules are extruded after the parasite has completed its entry, and thus probably play a role 
in modifying the host cell (Baum et al. 2008). The tachyzoites multiply asexually by 
repeated division (endogeny, schizogony). Host cells containing numerous tachyzoites are 
called clones (terminal colony, pseudocysts). After a few divisions they finally rupture; 
releasing 5-32 tachyzoites (Dubey; Frenkel, 1972) with each tachyzoite of invading another 
host cell. Spread can be local, across serous cavities, by the blood stream or via the 
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lymphatic system. At least five generations of such propagative stages have been described 
(Dubey, 1972). Invasions and spread continue until the host dies or immunity is established.  
 
 
Figure 1.3 Toxoplasma gondii – the tachyzoite stage, Giemsa stain,  (x100) 
(http://www.studyblue.com/) 
 
 
 
   Bradyzoites (Greek. bradys, slow + zoon, animal) 
After a few divisions T. gondii forms tissue cysts that vary in size. The cyst wall is elastic, 
thin (˂0.5µm) and may enclose hundreds of crescent – shaped, slender T. gondii organisms 
known as bradyzoites. Young tissue cysts may be as small as 5 μm in diameter and contain 
only two bradyzoites, while older ones may contain hundreds of organisms. Tissue cysts in 
the brain are often spheroidal and rarely reach a diameter of 70 μm, whereas intramuscular 
cysts are elongated and may be 100 μm long (Dubey, 1977). Bradyzoites are 7 x 1.5 µm in 
size and differ only slightly in morphology from tachyzoites. They are smaller and the 
nucleus is situated towards the posterior end (Dubey, 1998). The cyst wall is ultimately lined 
by granular material which also fills the space between bradyzoites. It is likely that the host 
cells contribute to this deposition, because in electron photomicrographs of developing cysts 
a heavy concentration of mitochondria and host cell endoplasmatic reticulum lines the 
outside of the parasitophorous vacuole. Bradyzoites are less susceptible to destruction by 
proteolytic enzymes than tachyzoites.  Tissue cysts may occur in many organs, including 
liver and kidneys; they are more common in neural and muscular tissue, particularly the 
brain, eye and may persist for the life time of the host. Tissue cysts are more common in the 
latent stage of infection after the host has acquired immunity. The cyst form is well adapted 
to transmission to carnivores, because the bradyzoites released from the cyst when it is 
exposed to gastric juices are able to survive for at least 3 hours (Jacobs et al. 1960).  
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Figure 1.4 The tissue cyst with bradyzoites, Giemsa stain, (x100) 
(http://pathhsw5m54.ucsf.edu/overview/toxo.html) 
 
 
   Oocyst 
Oocysts are the environmentally resistant stage in the life cycle of coccidia. Oocysts of T. 
gondii are formed only in felids. After the ingestion of tissue cysts by cats, the tissue cyst 
wall is dissolved by proteolytic enzymes in the stomach and small intestine. The released 
bradyzoites penetrate the epithelial cells of the small intestine and initiate development of 
numerous generations of asexual and sexual cycles (Dubey and Frenkel, 1972). 
Microgametogony occurs in manner similar to schizogony. Fertilization of the macrogamete 
by the microgamete results in the formation of a zygote which measures 10 x 12 µm. The 
zygote is unsporulated when shed, but the sporulation takes place in outside environment 
and takes around 1- 5 days depending on aeration and temperature (Frenkel and Dubey, 
1972). The sporoblast gives rise to two sporocysts each containing four sporozoites. The 
sporozoites are 2 x 6(8) µm in size. The sporulated oocysts are highly infective and can 
remain viable in the environment for many months (Lass et al. 2009).  
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Figure 1.5 The life cycle of Toxoplasma gondii 
(http://clem.mscd.edu/~churchcy/BIO3270/Images/Protozoans/Toxoplasma_gondii.htm) 
 
The only known definitive hosts for T. gondii are members of family Felidae 
(domestic cats and their relatives), where the sexual stage occur within the intestinal 
epithelium. The domestic cat seems to be the true host of T. gondii. The jaguarondi and 
ocelot, bobcat, Asian leopard cat and mountain lion have been experimentally infected with 
tissue cysts and have shed oocysts (Jewel, Miller, 1972). The definitive host becomes 
infected by ingesting infected animals or sporulated oocysts. Prepatent periods to the 
shedding of oocysts vary with the stage of T. gondii ingested: 3 to 10 days after ingesting 
tissue cysts, 19 days or longer after ingesting tachyzoites, and 20 days or longer after 
ingesting oocysts (Wallace, 1973, Dubey, 1977). Unsporulated oocysts are shed in the cat’s 
faeces. Oocysts are usually shed only for 1-2 weeks but large numbers may be shed. Oocysts 
take 1-5 days to sporulate in the environment and become infective. Intermediate hosts in 
nature (mammals, birds) become infected after ingesting soil, water or plant material 
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contaminated with oocysts. Poikilothermic vertebrates can also be infected if their body 
temperature is raised high enough. Ingested oocysts release the sporozoites, and they 
transform into rapidly dividing tachyzoites. At this stage of the infection congenital 
transmission may occur as tachyzoites can cross the placenta. The tachyzoites localized in 
neural and muscle tissue usually develop into tissue cyst bradyzoites (Dubey et al. 1976). 
Cats become infected after consuming intermediate hosts harbouring tissue cysts. Cats may 
also become infected directly by ingestion of sporulated oocysts. The bradyzoites tissue 
cysts may be ingested by another intermediate host through carnivory.  
 
1.2.Transmission 
 
   Most apicomplexan genera consist of numerous species each of which interacts with a 
specific host. Toxoplasma gondii has successfully colonized a diverse range of host species 
from very different environments. The most general mode of spread of toxoplasmosis 
depends on the presence of the oocysts, which are produced only by the intestinal stages in 
the cat and the other members of the family Felidae. The proportion of cats excreting oocysts 
at any one moment is not high, being usually not more than 2% (Dubey, 1977). Oocysts are 
shed for only a short period of 1-2 weeks in the life of the cat; before the body's immune 
response stops oocyst production altogether, however the high numbers shed assure 
widespread contamination of the environment. It is rare for a cat to re-shed oocysts in faeces 
after their first infection, and when this does occur it usually results in a much smaller 
number of oocysts. Cats can also be infected by ingesting oocysts, but experiments have 
shown that these are much less potent sources of infection for cats than tissue cysts (Dubey, 
et al. 1976). Oocysts are highly infective to mice; however mice may not become infected 
following ingestion of up to 100 bradyzoites (Dubey, 2005). Depending on humidity, the 
oocysts in the soil persist for weeks or months to a year and a half (Frenkel, 1973). The feline 
habit of covering their faeces enhances the survival of oocysts since the humidity is greater 
underground than on the surface. Cold inhibits sporulation of oocysts and unsporulated 
oocysts are killed in from 1 to 7 days of constant freezing. Sporulated oocyst can survive 
constant freezing at -20˚C for 28 days (Hutchinson, 1967). Oocysts can be mechanically 
transferred by many animals on their surfaces, flies, cockroaches, earthworms and by weather 
conditions such as rain and snow (Chinchilla, 1976, Wallace 1972). Transmission by oocysts 
is the only mode of horizontal transmission to herbivores and one of the modes of 
transmission to omnivores and carnivores. Toxoplasmosis can be perpetuated among 
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carnivorous and omnivorous animals by cannibalism or by poor animal husbandry practices. 
In recent years, in many countries, a number of cases where toxoplasmosis has been 
contracted via a water source have been reported. In Panama in 1979 T. gondii infection was 
observed among soldiers stationed in the jungle. Epidemiological investigation showed that 
the source of infection was water from the stream contaminated with oocysts excreted by 
jungle cats (Benenson, 1982). Cases of toxoplasmosis were also confirmed among a group of 
vegetarians in India, which were related to the contamination of drinking water with the 
oocysts (Hall et al. 1999). 
  The infection in humans and carnivores is probably most often the result of ingestion of 
tissue cysts contained in undercooked meat (Dubey and Beattie, 1988; Roghmann et al. 1999; 
Lopez et al. 2000), though the exact contribution of food-borne toxoplasmosis versus oocyst-
induced toxoplasmosis to human infection is currently unknown. Viable tissue cysts have 
been found in tissues of naturally infected animals, particularly in pigs and sheep, and also in 
wild game. They are rare in cattle.  Some studies suggested that tissue cysts are killed by 
commercial procedures of curing with salt, sucrose, or low temperature smoking (Lundén et 
al. 1992). Therefore, it has previously been suggested that processed meat is an unlikely 
source of infection for humans.  
   Prevalence of infection varies considerably, both according to country and author. In the 
course of evolution, T. gondii has developed a broad range of potential routes of 
transmission. However, the elucidation of these routes during the past three decades has not 
elucidated which of these routes is more important epidemiologically.  
Over the last 30 years, the incidence of prenatal infection with T. gondii has been estimated to 
vary from 1 to 100 per 10 000 births in different countries. The risk of intrauterine infection 
of the foetus, the risk of manifestation of congenital toxoplasmosis, and the severity of the 
disease depend on the time of maternal infection during pregnancy, the immunological 
competence of the mother during parasitaemia, the number and virulence of the parasites 
transmitted to the foetus, and the age of the foetus at the time of transmission (Tenter et al. 
2000).  
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1.3 Human toxoplasmosis 
 
   Toxoplasma gondii infects all warm-blooded animals including humans (Black et al. 2000). 
It is estimated that 30 % of the human population is infected (Wong and Remington, 1993; 
Petersen and Dubey, 2001). The prevalence can be between 15 % up to 85% depending on 
geographical location (Dubey and Beattie, 1988). Toxoplasma gondii is the third most 
common food contracted disease in the United States, where approximately 225 000 cases are 
reported each year (Jones, 2001). Toxoplasmosis is more common in developing countries 
and in lower socioeconomic communities (Barry et al. 2013) but, for example around 50% of 
the adult population in Germany is infected and as many as 90% of adults in Paris are 
seropositive (Hökelek et al. 2013). High seroprevalence (59.8%) is documented in Inuit 
populations of Nunavik and other northern communities (Messier et al. 2009).  Humans 
usually get infected when they consume undercooked meat, through contaminated food 
(vegetables), water, in hospitals if they get infected transplants, congenitally or directly with 
oocysts from the cat faeces. Infection in immunocompetent individuals is usually 
asymptomatic but toxoplasmosis can establish itself as lifelong latent infection. In this form 
of disease cysts are formed and survive in various tissues of the body, including brain. 
Toxoplasma gondii infection can cause severe disease in immunocompromised patients 
(AIDS, transplant and oncological patients) and in the foetus of mothers who are infected 
during pregnancy (Dubey et al. 2008).  In these patients the disease transits into very acute 
phase and if left untreated the patients usually die of encephalitis. Other symptoms are 
myocarditis, toxoplasmic pneumonitis, fever, cough, dyspnoea and retinochoroiditis. In 
France, 37% of patients with AIDS have evidence of toxoplasmic encephalitis (Hökelek et al. 
2013). The reports show that most of the cases of toxoplasmosis in immunocompromised 
patients are a consequence of latent infection and reactivation (Porter et al. 1992).   
Ocular toxoplasmosis is usually a self-limiting condition in immunocompetent individuals. In 
previous reports, 7%-33% of all European patients and 27%-92% of American patients 
developed an ocular lesion (Freeman et al. 2008). Retinochoroiditis usually results from 
reactivation of congenital infection, although cases have been reported that were part of acute 
infection (Freeman et al. 2008).  Classic treatment of ocular toxoplasmosis has been with 
pyrimethamine, sulfadiazine and prednisone for 4 to 12 weeks (Rothova et al. 1993).  
Recent reports suggest that latent toxoplasmosis can play an important role in many 
psychiatric and neurological disorders such as bipolar disorder, personality disorder, 
Parkinson disease (Miman et al. 2010), Alzheimer disease (Kusbeci et al. 2011), epilepsy 
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(Yazar et al. 2003), schizophrenia (Torrey and Yolken, 2005; Niebuhr et al. 2008), autism 
and brain tumours (Vittecoq et al. 2012). The incidence of suicides in Europe correlates with 
prevalence of toxoplasmosis in particular country (Ling et al. 2011). Toxoplasma also 
increases the reaction time in infected subjects, which could possibly explain the increased 
probability of being involved in a traffic road accident (Flegr, 2002). All these behavioural 
changes are thought to be caused by bradyzoite cysts in the brain and their production of 
tyrosine hydroxylase, the enzyme necessary for the production of dopamine (Prandovzsky et 
al. 2011).  
 The most significant manifestation of toxoplasmosis in the foetus is encephalomyelitis. 
Toxoplasma gondii infection often leads to abortion or severe deformation of the foetus 
(hydrocephalus). Many infants develop clinical symptoms later during their lives. Multiple 
complications can occur in persons with congenital toxoplasmosis, including mental 
retardation, seizures, blindness and deafness. Women with latent toxoplasmosis have a higher 
probability to have a male offspring and there is an increased risk of giving birth to a child 
with Down syndrome (Hostomska et al. 1957).  Approximately 10-20 % of pregnant infected 
women become symptomatic (Montoya et al. 1996). Routine serological screening should be 
performed on all pregnant women considered to be at risk for primary T. gondii infection. 
Amniocentesis should be offered to identify infection in amniotic fluid by PCR.   
Immunoglobulin M (IgM) is the first antibody subclass to appear in the human immune 
response. Immunoglobulin G (IgG) is increased in the secondary response. One study found 
that IgM remained raised in patients for 12 to 18 months, while IgG activity stayed low for a 
maximum of 4 months (Kodym et al. 2007). If IgG and IgM are both negative, this can 
indicate the absence of infection or recent acute infection. If both are positive, this indicates 
either a recent infection or a false –positive test result. Interferon-γ (IFN-γ) secreted in 
response to T. gondii infection plays essential role in maintaining toxoplasmosis in latent 
form. IFN-γ is reduced in schizophrenia patients but elevated in the latent toxoplasmosis 
(Suzuki et al. 2005).  
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1.3.1 Diagnostics 
   Toxoplasmosis is generally benign and has little clinical relevance in immunocompetent 
patients. However it can be serious or fatal in children infected during their intra-uterine 
development and in immunocompromised patients. Parasitaemia occurs early and it is 
probable that all organs become infected. Histological changes can be found in many but not 
all organs in the majority of host species. They occur very rarely in kidneys of any species 
and very rarely in any organs of rats (Soulsby, 1978). Diagnosis is made by biological, 
serological, or histological methods, or by some combination of them. Clinical signs of 
toxoplasmosis are nonspecific and cannot be depended upon for a definitive diagnosis. 
Toxoplasma cysts do not provoke inflammatory reaction and only rarely are they found near 
one, even when they are, they still appear intact and unchanged by the inflammation unless 
there has been extensive necrosis. A rapid diagnosis may be made by microscopic 
examination of impression smears stained with Giemsa stain. Well – preserved tachyzoites 
are crescent shaped and stain well with any Romanowsky stain. Tissue sections stain well 
with haematoxylin and eosin (HE). Histological methods are relatively cheap and can 
confirm diagnosis within few hours but they have been proved insensitive by some studies 
(Garcia et al. 2006; Esteban-Redondo et al. 1999; da Silva and Langoni, 2001). The finding 
of tachyzoites indicates active infection and is diagnostic; finding of tissue cysts may indicate 
latent infection and is not necessarily diagnostic of disease.   
Titres of T. gondii antibody rise rapidly to a maximum in 4-6 weeks, are maintained at this 
level for a few weeks and then fall steadily. Many serologic tests have been used for the 
detection of IgG and IgM T. gondii antibodies.  
Dye Test (DT) 
The dye test requires human serum without antibody as accessory factor, but has an added 
disadvantage of requiring the use of live organisms. The tachyzoites are incubated with 
accessory factor and the test serum at 37˚C for 1hour and a dye (methylene blue) is added. 
Tachyzoites unaffected by antibody are stained uniformly with methylene blue. Specific 
antibody induces complement mediated cytolysis of tachyzoites and the cytoplasm leaks out 
(Endo, 1976; Schreiber, 1980). As a result tachyzoites affected by antibody do not 
incorporate methylene blue. This test is highly specific and sensitive with no evidence of 
false results in human. Although DT measures antibodies specific to T. gondii in many hosts, 
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ruminant sera have substances that give false results unless sera are inactivated at 60˚C for 30 
min (Berger et al. 1966).  
Indirect Haemaglutination Test (IHA) 
Soluble antigen from tachyzoites is coated on red blood cells which are then agglutinated by 
immune serum. The IHA test is frequently negative in congenital infections and does not 
become positive as early as DT. 
 
Complement Fixation Test (CF) 
It is generally believed that complement antibodies appear later than DT antibodies and the 
test is positive during acute infection, but this largely depends on the antigenic variation.  
 
Indirect Fluorescent Antibody Test (IFA) 
The IFA test is sensitive and specific, but requires the appropriate fluorescein labeled 
antispecies globulin free of antibody to T. gondii. In the conventional IFA test, whole killed 
tachyzoites are incubated with serum and antibody detection is enhanced by adding 
fluorescent-labeled antispecies IgG (or whole immunoglobulin) and viewing with a 
fluorescent microscope. A modification of IFA (IgM-IFA) was developed (Naot and 
Remington, 1980). The main disadvantage is the need of a fluorescent microscope and 
species specific conjugates and the presence of non-specific cross reaction with rheumatoid 
factor and antinuclear antibodies. Because IgM is not placentally transferred, the IgM-IFA 
test demonstrates the antibody developed by an infant, indicating infection rather than 
passively transferred antibody. Latent toxoplasmosis is typically accompanied by a stable low 
antibody titer; retinochoroiditis (Jacobs, 1954). In reactivated toxoplasmosis, the antibody 
titer tends to rise probably because antibody forming B-cells are less affected by 
immunosuppression than T-cells mediating cellular immunity.  
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Enzyme-Linked Immunoabsorbent Assay (ELISA) 
In the ELISA test, soluble antigen is absorbed on a plastic surface (microtiter plates or slides) 
and the antigen-antibody reaction is enhanced by the addition of a secondary enzyme-linked 
antibody–antigen system, and the reaction can be assessed objectively by quantitation of the 
colour that develops. Numerous modifications (Schaefer et al. 2011) of ELISA have been 
published (Immunoglobulin M Immunoabsorbent Agglutination Assay Test).  
More methods can be used for the detection of the parasite, but they are not commonly used 
in routine tests (Antigen-Specific Lymphocyte Transformation, Skin test, Immunoperoxidase 
staining, Detection of Circulating Antigens).  
Serological methods have often poor efficiency, especially in neonates and in 
immunodeficient patients. To improve these diagnoses there have been many studies with 
various immunological assays to detect the parasite or its components either in experimental 
infection or in human toxoplasmosis (Raizman, 1975; Hafid, 1995).  
 
Polymerase Chain Reaction detection (PCR) of T. gondii 
PCR assays for the detection of T. gondii DNA were developed and primers specific to 
different regions of the genome of the parasite have been used. These assays demonstrated 
high specificity and sensitivity in various human samples (blood, tissue and amniotic fluid).  
Hafid (2001) performed a study where PCR was compared with capture ELISA and 
immunoblotting for the detection of T. gondii in sera of acutely infected mice. PCR (B1 gene) 
was the most sensitive assay and detected the parasite from 18 h post infection, whereas the 
other assays detected it only after 24h.  However the sensitivity of the results depends on the 
strain of T. gondii, the load of the inoculum and the PCR protocols used. Nested PCRs 
followed by hybridization are the most sensitive; however they are not quantitative and are 
time-consuming. Using the marker for the B1 gene we can detect as little as 50fg of T. gondii 
DNA which is the equivalent of single tachyzoite (Jones et al. 2000). Other commonly used 
markers target the P30 gene, which encodes highly immunogenic major surface proteins -
SAGs (Rodriguez et al. 1985). Most of the Toxoplasma surface antigens belong to the 
developmentally regulated and distantly related SAG1 or SAG2 families. The genes encoding 
the surface antigens are distributed throughout the T. gondii genome, with remarkably little 
polymorphism being observed at each locus. The surfaces of tachyzoites and bradyzoites are 
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covered with glycosylphosphatidylinositol (GPI)-anchored antigens (Nagel et al. 1989) most 
of which are members of the surface antigen 1 (SAG1) or SAG2 families (Lekutis et al. 
2001). Collectively, these surface antigens are known as the SRS (SAG1-related sequences) 
superfamily of proteins. SAG1 antigen contains many cysteine residues which lead to 
disulphide bridge formation. Paralogous SRS sequences are 24-99% identical, are tandemly 
arrayed throughout the genome, and are present on most, if not all chromosomes. Genotypic 
differences among SRS sequences are present at several loci (e.g. the absence of SAG5B, the 
truncation of SAG2D in Me49 compared with RH (Jung et al. 2004). These molecules appear 
to play a role in host cell invasion, immune modulation and virulence attenuation, although 
they may also provide protection needed by the parasite to survive in the environment. It is 
possible that SAG1-related proteins provide a structural barrier required by the parasites to 
survive inside mammalian hosts. Alternatively, the major function of the SAG proteins may 
be as immune modulators or virulence factors, since the survival of the parasite is dependent 
upon the survival of the host. Thus, it could be argued that the high level of expression of 
SAG1, which is limited to the tachyzoite, could assist the host immune response in tachyzoite 
elimination (Lekutis et al. 2001).  
More than 50 different genetic markers are available for T. gondii isolate typing. Multilocus 
genotyping is used to reveal atypical or recombinant genotypes. Quantification of T. gondii 
by qPCR has been applied to the detection of the parasite in animal tissues, whole blood and 
amniotic fluid. Real-time PCR can detect low concentrations of target DNA and quantify 
starting copies of specific template. This PCR has been successfully used to detect T. gondii 
in human blood, cerebrospinal fluid, amniotic fluid and other samples. Toxoplasma gondii 
has a highly clonal population structure comprised of three widespread genotypes referred to 
as type I, type II and type III (Dardé, 1988; Howe, 1997). In humans, type II largely 
predominates in congenital toxoplasmosis, at least in Europe, but type I, atypical and 
recombinant genotypes are more frequently associated with severe forms of toxoplasmosis 
(Ajzenberg, 2002). In Europe, genotypes different from clonal type II were found in Spain, 
Poland, Portugal and Germany in chickens, pigs and pigeons (de Sousa et al. 2006; Waap et 
al. 2008; Berger-Schoch et al. 2011). All of the 3 lineages can be found in isolates from 
humans, however the majority fall into the type II genotype. Recently a fourth clonal type 
(haplogroup 12) has been discovered in North America (Khan et al. 2011).  The clonal 
lineages found in the T. gondii population structure are closely related to virulence in human 
and mice (Howe and Sibley, 1995). The three clonal lineages T. gondii system is based on the 
results of SAG2 typing and only recently after new multilocus typing was used more unusual 
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strains have started to emerge. Today, 11 T. gondii markers (SAG1, SAG2, SAG3, GRA6, 
APICO, L358, PK1, and BTUB, alt.SAG2, c22-8 and c29-2) are commonly used to identify 
the isolate (Su et al. 2010). Up to now 231 strains are known and their RFLP genotypes are 
available in the database (www.toxodb.org). Microsatellite typing is now considered one of 
the most powerful tools to study DNA polymorphism and is often used in combination with 
RFLP markers. A total of 15 microsatellite markers (TUB2, W35, TgM-A, B17, B18, M33, 
IV.1, XI.1, M48, M102, N60, N82, AA, N61 and N83) have been used to genotype T. gondii. 
Emerging new clonal types may show different levels of virulence in intermediate hosts. 
 
1.4 The ecology of the wood mouse (Apodemus sylvaticus) 
   Rodents are a very suitable intermediate hosts for T. gondii transmission as felids often prey 
on them. Experimental infections of mice with infective oocysts showed a high frequency of 
vertical transmission from one generation to the next (Owen and Trees, 1998; Marshall et al. 
2004) which suggests that mice could be a potential reservoir of T. gondii in natural 
populations. The wood mouse (A. sylvaticus) is a widespread wild rodent and is commonly 
found throughout Europe (except northern Scandinavia and Finland), British Isles and nearby 
islands (Nowak, 1991). It is an inhabitant of mainly woodland, grassy fields and cultivated 
areas, but is highly adaptable and is found in most habitats. Most wood mice build nests in 
underground burrows, tunnels, inside hollow logs or in dense vegetation. Males normally 
inhabit an area of approximately 109 m in diameter and females live in an area of 64 m in 
diameter. Most wood mice stay in the same area but can travel 400 m in one night (Nowak, 
1991). They are mainly active during the dark, and are very good climbers. The breeding 
season begins in March and continues through until early winter if it is mild and there is a 
good food supply. Breeding males range over larger areas occupied by a number of females 
which produce up to four litters annually, with four to seven young each litter. The maximum 
life span is approximately 18 - 20 months, but juvenile survival is negatively affected by the 
presence of adult males (Bengston, 1989). Adult males are aggressive to one another and are 
driven from the nest soon after weaning. Many wood mice do not live more than four months 
and the overall population has an annual variation, with the highest peak in autumn and 
lowest in the spring. Wood mice are primarily granivores and their diet consists of grains, 
seeds, nuts, roots, berries, fruits, small snails and insects (Nowak, 1991; Parker, 1990). 
During the winter they do not hibernate but group together when sleeping. During severe 
winter seasons they fall into a sort of torpor, with a decrease in physiological activity.  Wood 
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mice are seen as pests and are responsible for damage to seedlings in forests and crops 
(Nowak, 1991).  
 
Figure 1.6 The wood mouse (Apodemus sylvaticus) 
1.5 Malham Tarn  
   Malham Tarn is situated in the Yorkshire Dales, a National Park in the Yorkshire Pennines, 
approximately 25 miles (40 km) north-west of Bradford and about 2.5 miles (4.0 km) north of 
the nearest settlement, Malham. The glacial lake is 377 metres (1,237 ft.) above sea level, 
which makes it the highest lake in England. In 1992, the lake and its wetlands were 
designated as a National Nature Reserve. The estate was donated to the National Trust in 
1947, which leases part of the site to the Field Studies Council who offer residential and non-
residential field courses there. The area covered by the research was contained within the 
boundaries selected by C. A. Sinker for his study of the plant communities (Sinker, 1960). 
The major component are bog communities, woodlands on raised – bog peats and small fens, 
fen meadows and fen carrs. The four selected sampling sites used in this study were: Ha 
Mire, Tarn Woods, Tarn Fen and Spiggot Hill. 
Ha Mire   
   Ha Mire is an area of flat sloping mire in the eastern part of the Tarn covered by calcareous 
marshes. This area has a large plantation (10 acres) which was established during the 19
th
 
century (Seaward and Pentecost, 2001). It is a small, fenced wood of mature and young trees 
circled by a high dry-stone wall, designed to protect the trees from grazing sheep and cattle. 
The vegetation of Ha Mire is dependent on calcareous groundwater and rainfalls. Most of the 
plantation is covered by grass (Agrostis spp., Festuca spp.), bracken (Pteridium spp.) and 
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bramble (Rubus spp.). The woodland is dominated by sycamores (Acer pseudpolatanus), 
alders (Alnus spp.), larches (Larix spp.) and birches (Betula spp.). 
 
Figure 1.7 Ha Mire plantation, view from the distance and inside (Photos taken by J. Bajnok and K. 
Boyce) 
Tarn Woods 
Tarn Woods is the largest plantation (40 acres) situated on the north shore of the tarn and 
surrounding the Field Centre. It is mixed deciduous and coniferous woodland (Sinker, 1960) 
including larch (Larix spp.), spruce (Picea spp.), ash (Fraxinus excelsior), rowan tree (Sorbus 
aucuparia) and beech (Fagus spp.). The ground cover is dominated by dog’s mercury 
(Mercurialis perennis), large bryophytes, grasses (Poa trivialis), goosegrass (Gallium 
aparine) and red campion (Silene dioica).  
 
Figure 1.8 Tarn Woods (Photos taken by K. Boyce) 
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Tarn Fen  
Tarn Fen lying to the north of Tarn Moss is woodland amongst bog/marsh on the edge of the 
tarn and contains a diversity of wetlands sustained by springs and overbank flooding from the 
stream. This area covers an area of 26 acres and consists of three parts: West, Middle and 
East Fen.  The major components are bog communities dominated by Eriophorum vaginatum 
and Calluna vulgaris, Molinia caerulea vegetation and birch woodlands (Betula pubescens) 
with bushy willows (Salix spp.) and alders (Alnus spp.) on the raised bog peats. The rich fens 
and associated swamps contain some tall- herb vegetation (Potentilla palustris, Angelica 
sylvestris, menthe acquatica, Carex rostrata, Urtica dioica and Acrocladium nodum). Some 
areas of acidic peats are occupied by Carex echinata and Sphagnum recurvum (Sinker, 1960). 
It is only East Fen that has peats permanently kept wet with calcareous groundwater. Locally 
we can see some fallen trunks. The differences in vegetation structure in Tarn Fen reflect the 
differences in water levels. Almost the whole area shows substantial variations in water levels 
with the seasons and with changing weather. The variations are greatest near the stream 
inflows and around the margins of the fen.  
 
Figure 1.9 Tarn Fen (Photos taken by K. Boyce) 
Spiggot Hill 
Spiggot Hill is located at the southwest junction of the Tarn’s south and west shores. The 
vegetation is influenced by hydrological inputs, including streams that flood periodically. 
Several small peat pools are located to the northwest of Spiggot Hill. The area is covered by 
deciduous and coniferous woodland (Sinker, 1960) with larch (Larix spp.), birch (Betula 
spp.) and sycamore (Acer pseudoplatanus). The ground flora contains mainly grasses, dog’s 
mercury and meadowsweet (Filipendula ulmaria).   
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Figure 1.10 Traps set in Spiggot Hill (Photos taken by K. Boyce) 
 
 
Figure 1.11 Spiggot Hill in winter (Photos taken by K. Boyce) 
To date only few studies have been conducted on A. sylvaticus infections by T. gondii. 
Serological analysis of similar species, the striped field mice (Apodemus agrarius) detected 
prevalence of 1.49% in Korea (Jeon et al. 2000) and 7.4% in the Czech Republic (Hejlicek et 
al. 1998). Higher prevalences were reported after testing wood mice with PCR methods, with 
prevalences ranging from 14.3% (Kijlstra et al. 2008) up to 40.78% (Thomasson et al. 2011). 
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In this study we set out to analyse prevalence of T. gondii in populations of wood mice at the 
family level in relation to T. gondii infection and to use direct genotyping methods to identify 
the parasite strains circulating in wildlife in UK. This research is fully described in Chapter 3 
and Chapter 4. 
 
1.6 Lung cancer 
   Lung cancer (pulmonary carcinoma) is a malignant lung tumour characterized by 
uncontrolled cell growth in tissues of the lungs and the most common cancer in both men and 
woman in the world (Parkin et al. 2010). There were an estimated 1.2 million new cases and 
1.1 million deaths in 2000 (Parkin et al. 2010). The highest rates are in North America, 
Europe and East Asia, with over a third of new cases in 2012 in China (Spiro et al. 2010). In 
the European Union, there has been a decline in lung cancer mortality in men but the opposite 
situation was observed for women, in whom lung cancer rates increased from 9.0 to 11.4 
cases per 100 000, an increase of 27% (Rodriguez et al. 2012). In England and Wales the 
increase was 4% (La Vecchia et al. 2010). More than 90% of adults with lung cancer are 
asymptomatic when they are diagnosed. There are two main types of lung cancer: Small cell 
lung cancer (SCLC) and Non-small lung cancer (NSCLC). SCLC often starts in the bronchi 
near the centre of the chest and spreads widely trough the body. NSCLC includes about 85-
90% of all lung cancers (American Cancer Society, 2014). There are three main subtypes of 
NSCLC: squamous cell (epidermoid) carcinoma, adenocarcinoma and large cell carcinoma. 
Along with the two main types of lung cancer, other tumours can occur in the lungs: lung 
carcinoid tumours or cancer that has spread to the lungs. It has been observed that 10% of 
men and 20% of women that develop lung cancer are non-smokers (Sasco et al. 2004), so it 
has been suggested that the lung cancer in men can be considered a different disease from 
lung cancer in women (Sun et al. 2007).Women with lung cancer tend to be younger and 
have lower smoking histories than men, and are more likely to develop adenocarcinoma 
(Olak et al. 2004). Many observations suggest that hormones, especially oestrogens may be 
involved in lung carcinogenesis (Stabile et al. 2002). There are several risk factors that can 
increase the chance of getting lung cancer. Smoking is the leading risk factor. At least 80% of 
lung cancer deaths are thought to result from smoking with secondary smoking causing more 
than 7000 deaths from lung cancer each year (American Cancer Society, 2014). Exposure to 
radon, asbestos fibres, diesel exhausts, radioactive ores cadmium, and arsenic can increase 
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risk of getting lung cancer (American Cancer Society, 2014). Polymorphism on 
chromosomes 5, 6 and 15 are known to affect the risk of getting lung cancer (Kern et al. 
2008). Patients with lung cancer suffer from progressive shortness of breath, cough, and 
pneumonia, loss of voice and chest pain. The diagnosis is confirmed by biopsy which is 
usually performed by bronchoscopy. Common treatment includes surgery, chemotherapy and 
radiotherapy. In England between 2005 and 2009, the overall five year survival for lung 
cancer was less than 10% (Khemasuwan et al. 2015). 
1.7 Chronic obstructive pulmonary disease (COPD) 
   Chronic obstructive pulmonary disease is the most common respiratory condition and is 
characterized by decline in lung function over time. The main symptoms include shortness of 
breath, cough and sputum production (Vestbo et al. 2013). Acute exacerbations are 
associated with a rapid decline in lung function and are the major causes of morbidity and 
mortality in COPD (Beasley et al. 2012). The inflammation in the small airways often 
intensifies with disease progression and is characterized by infiltration of inflammatory and 
immune cells, CD4+, T-cells, B-cells, macrophages and neutrophils (Di Stefano et al. 1996). 
Currently the prevalence is estimated to be around 10% in the population aged over 40 years 
(Gagnon et al. 2014). Smoking is the leading factor, but only 15%-20% of the smokers 
develop the disease (Fletcher et al. 1977). In England around 0.84 million people have been 
diagnosed with COPD (WHO, January 2015). In many studies the incidence of COPD was 
greater in men than in women (de Marco et al. 2007). Most cases of COPD are preventable 
through decreasing exposure to smoke and improving air quality. Inhaled bronchodilators are 
the primary medication used. There are several short acting β-agonists (salbutamol, 
terbutaline) or long acting β-agonists (salmeterol, formoterol). Corticosteroids are usually 
used in inhaled form or tablets and prevent acute exacerbations. Patients with severe 
exacerbations often use antibiotics to improve the outcomes.  
   Patients with cancer may have deficient cellular immunity and are potentially susceptible to 
T. gondii infections (Montoya et al. 2004). Not much is known about toxoplasmosis in this 
group of patients and few reports are available. Serological measurement of infection rates 
(Yuan et al. 2007) showed high prevalences in nasopharyngeal carcinoma (46.15%) and 
rectal cancer (63.64%) but lower rates in the other cancer groups, for example, pulmonary 
carcinoma (4.55%), breast cancer (9.53%), gastric carcinoma (10.00%), hepatocellular 
carcinoma (14.29%) and uterine cervix carcinoma (12.50%). These studies have little 
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indication as to whether active infection is present, and they measure generic infection status 
rather than localised infection status in the cancer affected tissue. In this study specific DNA 
based and immunohistochemical detection systems were used to detect the presence of T. 
gondii, in lung biopsy samples taken from a well-characterised collection of patients with 
cancer. 
The spread and clinical manifestations of an infection in human populations depends on a 
variety of factors, among them host genetics. As humans migrated throughout the world, 
populations encountered distinct pathogens, and natural selection increased the prevalence of 
alleles that are advantageous in the new ecosystems in both host and pathogens. In this study 
we have used new approaches to study any possible links between T. gondii and a variety of 
lung diseases including lung cancer. Similar approaches to the way we studied T. gondii 
prevalence in natural mice populations were used. A combination of molecular and 
histological methods was used to investigate the prevalence of T. gondii in populations of 
humans with lung cancer.  Toxoplasmosis has been only recently recognized as significant 
cause of mortality at a population level for southern sea otters (Miller et al. 2008). Another 
study suggests that T. gondii has also a negative effect on the population dynamics of 
Hector’s dolphins (Roe et al. 2013). These studies show that T. gondii can be important agent 
in the population decline of endangered species, and highlights the need for further research 
into the route of transmission. As most of the published data is based on studies performed in 
laboratory or domestic animals, there is lack of information on prevalences and genotypes of 
T. gondii circulating in wild life and human populations. Procedures applicable to and 
knowledge acquired from studies related to these animals can be extrapolated to wild life and 
humans. Deeper analyses and understanding of mechanisms of transmission in the sylvatic 
cycles and natural populations are necessary to better understand the possible links between 
individual strains and disease symptoms.  
There is a need for development of generic approaches which can be used in studies of 
animals and humans. In this study we conducted a detailed analysis of the ecology of the 
wood mouse and investigated the prevalence, genotypes and transmission of T. gondii in this 
model system. In the second part, we selected a natural sub-population of humans (lung 
cancer patients) to further investigate these approaches. We analyzed collected sampled tissue 
using molecular methods and used them to investigate host genotype and spatial location in 
relation to T. gondii infection.  
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Objectives 
The aim of our study was to determine the prevalence and genotypes of T. gondii in natural 
rodent populations and in humans with a variety of lung diseases (cancer, asthma and 
COPD). Due to the usual diet of the wood mouse as granivores, testing for the presence of T. 
gondii in the area free of cats provides an opportunity to examine transmission routes that do 
not involve bradyzoite ingestion, and to confirm the presence of vertical transmission. In 
addition, vertical transmission of infection in mammals often ends with foetal abortion and is 
causing significant economic losses in the UK livestock industry. As rodents often serve as 
reservoir of T. gondii, it is important to know the actual prevalence of this parasite and its 
potential risk for the farm animals and humans. Cancer patients may have a compromised 
immune system and are potentially susceptible to T. gondii infections. Not much data are 
available on genotypes present in human populations as most of the studies were based on 
serological testing. Genetic analysis of T. gondii infecting humans is important to understand 
epidemiology, transmission patterns, and mechanisms of the disease. However, the difficulty 
in obtaining T. gondii strains from humans is a limiting factor. In order to identify the parasite 
genotypes; we have chosen to do direct PCR, sequencing and genotyping of the samples. 
Human samples were also tested with histological and immunohistochemical methods. We 
discuss the efficiency of individual sampling and detection methods, involvement of possible 
genotype pathogeny and potential sources of infection.   
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Chapter 2: 
Materials and Methods 
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2.1. Sampling of Apodemus sylvaticus 
 
     All samples were collected from surrounding area of Malham Tarn Research Field 
Centre as a part of an over 10 year ongoing study of parasites in this area. A total of 126 
A. sylvaticus were collected over a two year period   (October 2009- October 2011) using 
Longworth Traps and euthanased by anaesthetic inhalation, from four sites located within 
the boundaries of the Malham Tarn Nature Reserve, North Yorkshire, UK (Figure 2.1.) as 
described previously (Boyce et al. 2012; 2013). Collection points at these sites, labelled 
Tarn Woods (54
o06’03.3”N, 002o09’44.9”W), Tarn Fen (54o06’00.0”N, 002o10’43.4”W), 
Ha Mire (54
o05’72.9”N, 002o10’53.7”W) and Spiggot Hill (54o05’72.9”N, 
002
o10’43.1”W) were recorded using GPS position fixing (Datum: WGS84). Trapping 
was carried out over a period of four nights at each site. Four trap lines consisting of 15 
traps were set up with a 3m distance between two traps and when possible were placed 
strategically alongside and resting on top of natural objects such as fallen tree trunks and 
branches within shrubs and grass tussocks. All appropriate permissions were obtained 
(Boyce et al. 2012; 2013) and ethical approval was granted by the University of Salford 
Research Ethics and Governance Committee (CST 12/36). Mice were examined for a 
range of parameters including sex, weight and length. Mice weighing less than 14 g were 
considered juveniles (Higgs and Nowell, 2000). The brains were dissected out, using 
sterile technique, and transferred into sterile tubes containing 400 μl of lysis buffer (0.1 M 
Tris pH 8.0, 0.2 M NaCl, 5 mM EDTA, 0.4% SDS) and stored at −20 °C until DNA 
extraction (Terry et al. 2001). Neither serological analysis for T. gondii infection nor 
isolation of viable parasites was possible due to sampling logistics.  
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Figure 2.1 Location of Malham Tarn within the North Yorkshire 
(www.ciaofamiglia.com/frfletcher/fletchlinks.htm, accessed 6/6/2016) 
 
2.2. PCR detection of Toxoplasma gondii and RFLP genotyping  
   DNA was isolated, from A. sylvaticus brain tissue, using proteinase K lysis followed by 
phenol/chloroform extraction as previously described (Duncanson et al. 2001). Extracted 
DNA was tested by PCR for mammalian tubulin gene amplification to ensure the viability 
for subsequent PCR (Terry et al. 2001) and appropriate protocols to prevent cross 
contamination were followed (Williams et al. 2005; Hughes et al. 2006; Morley et al. 
2008). Detection of T. gondii was carried out using nested PCR amplification of the 
SAG1 genes (Savva et al. 1990) as modified by Morley et al. (2005). Positive 
amplification was confirmed by nested PCR amplification with three other sets of T. 
gondii specific primers (SAG2, SAG3 and GRA6) as described by Su et al. (2006) and 
Shwab et al. (2013). All samples were tested as positive three times with each of the four 
markers before the mouse brain was considered positive for T. gondii infection. In 
addition to being used for parasite detection, these three genes (SAG2, SAG3 and GRA6) 
were used as RFLP markers for direct genotyping of PCR positive brain tissues as 
described (Su et al. 2006; Shwab et al. 2013). Toxoplasma gondii infections were also 
tested by nested PCR amplification of the repetitive and conserved gene B1 (Jones et al. 
1999). Toxoplasma gondii DNA strains RH (Type I), SR (Type II) and C56 (Type III) 
were used as positive controls for diagnostic PCRs and genotyping and sterile water was 
used as a negative control. Negative controls were included at all stages to ensure that any 
contamination would be detectable All PCR reactions were performed using a Stratagene 
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ROBOCYCLER
TM
 (La Jolla, California, USA). PCR products were run on agarose TBE 
gels containing GelRed and visualized on a SYNGENE G: Box Gel Documentation and 
Analysis System (Cambridge, UK). To ensure the reliability of the genotyping PCRs, the 
following procedures were followed for all three markers. Each sample was successfully 
amplified, independently, for a minimum of 3 times before the final genotype result was 
accepted. 
2.2.1 Mammalian α-tubulin PCR  
   All 126 DNA samples were tested for mammalian tubulin to ensure the viability for 
PCR (Terry et al. 2001). Sheep DNA was used as a positive control. The PCR reaction 
mix contained 2.5 µl of HT PCR Buffer, 0 .5 µl of each primer (25pM), 0.25 µl dNTP 
mix (25mM each), 0.5 µl Taq DNA polymerase (5U/µl) and 19.75 µl of PCR water. 
Amplification was carried out using a Stratagene Robocycler as follows: an initial 
denaturation step of 5 min at 94 °C was followed by 40 cycles of PCR performed for 40 
sec at 94 °C, 40 sec at 60 °C and 1 min 30 sec at 72 °C, with a final extension step of 10 
min at 72 °C.  The PCR product was run on a 1% TBE gel using 1 kb marker (Bioline). 
The following primers were used TUBFOR: 5
/
CGTGAGTGCCATCTCCATCCAT-3
/
 and 
TUBREV: 5
/
GCCCTCACCCACATACCAGTG-3
/.
  
 
2.2.2 Amplification of the B1 Gene 
 
   Nested primers targeting the B1 gene (Jones et al. 2000) included outer primers for the 
first round of amplification, consisting of forward primer 5
/
GGAACTGCATCCGTT 
CATGAG-3
/
 and reverse primer 5
/ 
TCTTTAAAGCGTTCGTGGTC-3
/ 
which generates a 
193 bp product (nucleotides 694-887). The inner set of second round of primers 
consisting of forward primer 5
/ 
TGCATAGGTTGCAGTCACTG-3
/
 and reverse primer 
5
/
GGCGACCAATCTGCGAATACACC-3
/
 generates a 96 bp product after amplification 
by nPCR.  
PCRs for the first round contained 10mM TRIS-HCl, pH 8.3, 50mM KCl Buffer, 2mM 
MgCl2 (Bioline KCl buffer),  0.1µM each primer, 0.1mM each dNTP, 1.25 U Taq DNA 
polymerase and 2 µl of parasite DNA. Reactions were cycled 40 times with denaturation 
at 93˚C for 10 seconds followed by annealing at 57˚C for 10 seconds and finally an 
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extension step at 72˚C for 30 seconds. A final extension step of 10 min at 72 °C was 
added (not used in the original protocol).  
Second round reactions contained 1µ of the first-round product, 10mM Tris-HCl, pH 8.3, 
50mM KCl, 3mM MgCl2 , 0.5 µl each primer, 0.1mM each dNTP and 1U Taq DNA 
polymerase. Nested PCRs were cycled 40 times using a denaturation step of 93˚C for 10 
seconds, followed by annealing at 62˚C for 10 seconds and extension at 72˚C for 15 
seconds. Negative control samples from first-round amplification and were included in 
the nested reactions. A final extension step of 10 min at 72 °C was added. Ten µl of 
amplification products were visualized under UV illumination after electrophoresis on 
3.5% TBE gel using Hyperladder V (Bioline) as a marker. 
 
2.2.3 SAG1 PCR 
   The presence of T. gondii was detected using a nested PCR amplification of the Surface 
Antigen Gene 1 (SAG1) and resolved by gel electrophoresis as previously described by 
Williams et al. (2005). Each sample was tested at two dilutions of DNA (1/5 and 1/10 
dilution as the ratio of parasite to host DNA was unknown).  Four oligonucleotide 
primers were used. Their sequences were based on the published sequences for the 
toxoplasma P30 gene; two of these (DS29 and DS38) were of the same sense.  Oligo 
DS29 (5
/
TTGCCGCGCCCACACTGAG-3
/
) corresponds to nucleotides 405-424 of the 
P30 gene, oligo DS30 (5
/
CGCGACACAAGCTGCGATAG-3
/
) to nucleotides 1318-1299, 
oligo DS38 (5
/
GACAGCCGGCGGTCATTCTC-3
/
) to nucleotides 503-522 and oligo 
DS39 (5
/
GCAACCAGTCAGCGTCGTCC-3
/
) to nucleotides 1024-1005. When used in 
different combinations (DS29-DS30, DS29-DS-39, DS38-DS39, and DS30-DS38) these 
primers should result in the amplification of fragments of T. gondii of 914, 620, 522 and 
815 bp respectively (Savva et al. 1990). The PCR contained 2.5 µl Bioline PCR Buffer 
(excluding MgCl2), 2.5 µl β-mercaptoethanol (50mM), 1µl Bioline MgCl2 (50mM), 2.5 
µl of each primers  DS29 and DS30 (10pM each), 0.25 µl each dNTP (25mM each), 0.5 
µl  Taq DNA polymerase (5U) and 12.25 µl PCR water. Amplification was carried out 
using a Stratagene Robocycler as follows: an initial denaturation step of 5min at 95 °C 
was followed by 40 cycles of PCR performed for 40 sec at 95 °C, 40 sec at 63 °C and 
1min 10 sec at 72 °C, with a final extension step of 10 min at 72 °C. Second-round PCR 
was carried out using the same reaction and cycling conditions as the first round 
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(combination of primers DS38 and DS39 was used). A volume of 2 μl of first-round 
product was added to act as a template. Amplification products (10 μl) were visualized by 
agarose gel electrophoresis on a 1.5% TBE agarose gel containing GelRed. Hyperladder 
100 bp (Bioline) marker was used as size ladder. 522 bp products at the end of second 
round of amplification were considered PCR positive. 
 
2.2.4 SAG2 PCR 
   SAG2 locus has two polymorphic sites at 3
/
 and 5
/
 ends for Type II and Type III (Howe 
et al. 1997), so amplification of this locus was performed separately. Two nested PCRs, 
one targeting the 3
/
 end of the SAG2 gene and the other targeting the 5
/
 end of SAG 2 
gene were optimized as per the method of Fuentes et al. (2001). The nucleotide sequence 
of the outer and the inner set of primers targeting the 3
/
end and the 5
/
end of SAG2 gene 
are listed below. Amplification was carried out in a final volume of 20 μl containing 2.7 
µl of KCl Bioline buffer, 0.32 μl of dNTP mix (25mM each), 1 μl of (10 pM) forward 
primer and reverse primer and 0.4 µl of 5 unit Taq DNA polymerase (Bioline). Two µl of 
DNA were used as a template. First round amplification cycle was initiated with 4 minute 
denaturation at 95˚C, followed by 20 cycles amplification. Each cycle consisted of 
incubations at 94˚C for 30 s, 55˚C for 1 min and 72˚C for 2 min. At the end the reactions 
were incubated at 72˚C for 10 min. The resulting amplifications products were diluted 
1/10 in water and a second amplification of 35 cycles was performed, using 2 µl of the 
diluted product as template and inner primer sets as designated below. The annealing 
temperature for the second round was 60˚C.  
For the nPCR targeting the 3
/ 
end of SAG2 gene, detection of 222 bp products at the end 
of second round of amplification were considered PCR positive. For the nPCR targeting 
the 5
/
 end of SAG2 gene, detection of 242 bp products at the end of second round of 
amplification was considered PCR positive.  
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Table 2.1 Primer sequence of nPCR targeting the 5
/ 
and 3
/
 end of SAG2 gene (Howe 
et al. 1997; Su et al. 2006): 
 SAG2 5
/ 
 end SAG2 3
/ 
end 
External markers 5
/
 GACCTCGAACAGGAACAC3
/ 
5
/
TCTGTTCTCCGAAGTGACTCC3
/
 
 5
/
GACCTCGAACAGGAACAC3
/
 5
/
TCAAAGCGTGCATTATCGC3
/
 
Internal markers 5
/
GAAATGTTTCAGGTTGCTGC3
/
 5
/
ATTCTCATGCCTCCGCTTC3
/
 
 5
/
GCAAGAGCGAACTTGAACAC3
/
 5
/
AACGTTTCACGAAGGCACC3
/
 
 
Positive PCR reactions were further analysed by restriction enzyme digestion with the 
restriction enzymes MboI (5
/
-end products) and HhaI (3
/
-end products), 8.5 μl of PCR 
product, 1.5 μl of manufacturers recommended restriction enzyme buffer and 0.5 μl of 
enzyme (Fuentes et al. 2001). Reactions were incubated at 37 °C for a minimum of 2h or 
overnight. Products were visualized by gel electrophoresis on a 2.5% TBE agarose gel 
and Hyperladder II (Bioline) was used as a size marker.  
 
2.2.5 SAG3 PCR 
   A nested PCR was used to detect the SAG3 gene. This method has been modified from 
the method described by Grigg et al. (2001) and Su et al. (2006). Amplification was 
carried out in a final volume of 50 μl containing 5 μl of 10× HT PCR buffer (HT 
Biotechnologies) (100mM Tris HCl with pH 9.0, 15mM MgCl2, 500mM KCl, 1% 
TritonX-100, 0.1% (w/v) stabilizer), 0.5 μl of dNTP mix (100mM), 2.5 μl of (10 pM) 
forward primer (Fext:5
/
CAACTCTCACCATTCCACCC-3
/
) and reverse primer (Rext: 
5
/
GCGCGTTGTTAGACAAGACA-3
/
) and 2.5 units Taq DNA polymerase (Bioline). 
DNA-free water made the final volume to 50 μl. Amplification was carried out using a 
Stratagene Robocycler as follows: an initial denaturation step of 5 min at 94 °C was 
followed by 35 cycles of PCR performed for 40 sec at 94 °C, 40 sec at 60 °C and 60 sec 
at 72 °C, with a final extension step of 10 min at 72 °C. Second-round PCR was carried 
out using the same reaction and cycling conditions as the first round with the exception 
of the primers which were Fint: 5
/
TCTTGTCGGGTGTTCACTCA-3
/
 and Rint: 
5
/
CACAAGGAGACCGAGAAGGA-3
/. A volume of 2 μl of first-round product was 
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diluted into reaction mix (as above) to give a final volume of 50 µl. Amplification 
products (10 μl) were visualized by agarose gel electrophoresis on a 1.5% TBE agarose 
gel containing Gelred and Hyperladder I  size marker (Bioline). 
Positive PCR (226bp) reactions were further analysed by restriction enzyme digestion 
with each of the enzymes NciI and AlwNI, 13 μl of PCR product, 1.5 μl of buffer 4 
(NEB) and 0.5 μl of enzyme. Reactions were incubated at 37 °C for a minimum of 2 h or 
overnight. Products were visualized by gel electrophoresis on a 2.5% agarose gel using 
Bioline Hyperladdder V size marker (3.5µl). NciI cuts both Type I and Type III to 
generate distinct fragment patterns (Grigg et al. 2001; Su et al. 2006) while Type II 
remains uncut. To distinguish Type II pattern from undigested PCR products, AlwnI 
(which cuts only Type II) was used to confirm that uncut PCR products were indeed 
Type II).  
 
2.2.6 GRA6 PCR 
   GRA6 nested PCR was performed using published sequences: F1: 
5
/
ATTTGTGTTTCCGAGCAGG-3
/
, R1: 5
/
GCACCTTCGCTTGTGGT-3
/
 and F2:  
5
/
TTCCGAGCAGGTGACC-3
/
, R2: 5
/
GCCGAAGAGTTGACATAG-3
/
 (Su et al. 2006) and 
an optimized protocol The PCR reaction is carried out in a vol. of 25 µl containing 2.5µl of 
Bioline NH4Cl buffer (excluding MgCl2), 1µl of 50 mM MgCl2 buffer (Bioline), 0.32µl of the 
dNTP (25mM each), 1.5µl of the external forward primer and 1.5µl of reverse primer (10pM 
each) and 0.32 Taq DNA polymerase (5U, Bioline). DNA-free water made the final volume 
to 25μl. The reaction mixture is treated at 95˚C for 4 min, followed by 30 cycles of 94˚C for 
30 sec, 55˚C for 1.5 min and 72˚C for 2 min. A final extension step of 10 min at 72 °C was 
added (not used in the original protocol). The resulting amplifications products were diluted 
1/10 in water and a second amplification of 35 cycles was performed, using 1 µl of the 
diluted product as template in reaction mixture (as above) containing primers F2 and R2. The 
annealing temperature for the second round was 60˚C.  
A 344 bp product at the end of the second round was considered to be positive. For RFLP 
typing, 5 µl of PCR products were treated with MseI in total volume of 20 µl at 37˚C for 1 h 
and then digested samples were resolved on a 2.5% TBE agarose gel to reveal restriction 
fragment banding patterns (Khan et al. 2005).  
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2.3. Microsatellites analysis and host genotyping 
   A total of 126 DNA samples from A. sylvaticus were prepared for microsatellite 
genotyping. Nine A. sylvaticus loci were amplified and genotyped using fluorescent dye-
labelled DNA primers (Table 2.2.) and conditions previously described (Makova et al. 1998). 
One Mus domesticus microsatellite, which amplifies from A. sylvaticus was also used (MS19) 
The PCR reaction mixture (20 µl) consisted of 2 µl Bioline buffer (excluding MgCl2), 0.6 µl 
Bioline MgCl2 (50 mM), 2 µl of each primer (10 pM/µl), 0.2 µl dNTP mix (25 mM each), 0.2 
µl DNA Taq Polymerase (5U) and 12 µl PCR water.  
Thermal cycling conditions used were an initial 5 min denaturation at 95 °C followed by 35 
cycles at 95 °C for 40 sec (denaturation), 30–45 s at the annealing temperature (Table 2.3.), 
72 °C for 30–60 s (extension), concluding with a final 30 min extension at 72 °C (Makova et 
al. 1998, ). Amplification products (10 μl) were visualized by agarose gel electrophoresis on 
a 1.5% TBE agarose gel containing GelRed. 
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Table 2.2 Primer sequences (5
/
 to 3
/
), allele ranges and fluorescent dyes (green–Hex, blue-
FAM) used for 10 microsatellite loci in A. sylvaticus (Makova, 1998). 
 
Locus (Dye)                       Primer sequences                                                          Allele range (bp)          
GTTA1A              F: 5
/
 TTTGATGCCTTGACTTTGATTACC-3
/
                             168-209                
(HEX)                  R: 5
/
AATGCCAGTGGTGATTTTATTTGG-3
/
 
CAA2A                F: 5
/
AATTTGCCCTTAAGTGAGGAAG-3
/ 
                                94-118                   
(FAM)                  R: 5
/
GCAGTGACCCAGGAGAAATTACC-3
/
   
GACAB3A           F: 5
/
AGGGGAACCTCACAAATATAGGAAA-3                       361-622           
(HEX)                  R: 5
/
GGCTTCCAATTTTGAACTACAGAGC-3
/
 
GTTC4A              F: 5
/
GTAAATGGCTAGAAGGAGAGAAGGTTC-3
/ 
                 128-154               
(FAM)                 R: 5
/
TTCCCTGGAAACTATTTGGTAAATCC-3
/
 
GCATD7S           F: 5
/
CTGGGTCTTCTGCACTGTTCTTTACC-3
/ 
                         199-296           
(FAM)                 R: 5
/
GCAGATGCCCACCTTCTGTAACCAA-3
/
    
GTTD8S              F: 5
/
TCTGAACAGTGGTAGATAATTAGAGCTTA-3
/ 
              101-110              
(FAM)                 R: 5
/
GAAACCGTTTGGTAAGATACTACAAAA-3
/
 
 GTTD9A            F: 5
/
CCCAAAATTGCCTTCCTGTCAC-3
/ 
                                 202-216        
(HEX)                 R: 5
/
GGTCAGGATAGGCTGCATAGAAAG-3
/
 
 GACAE12          F: 5
/
GTTTTGTTTGGGTTTCTGAGACTGAA-3
/ 
                       252-268             
(HEX)                 R: 5
/
ACTCGGCTCTTACTTGGTAATCTTCC-3
/
 
 TNF                   F: 5
/
AGGAAATGGGTTTCAGTTCTCAGG-3
/ 
                           105-124               
(FAM)                 R: 5
/
GGTCCCCACCAGGATTCTGTG-3
/
 
MS19                  F: 5
/
CTGATTTGAGCCTGTGCA-3
/
                                             80-226                   
(HEX)                 R: 5
/
TGCTCAATAAATACAGAGCAAAGC-3
/
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Table 2.3 Core repeats and PCR conditions for 10 microsatellite loci in A. sylvaticus 
(Makova et al. 1998). 
Locus Cloned repeat Annealing 
temperature 
(°C) 
Annealing 
time (s) 
Extension 
time 
(s) 
CAA2A (CA)21 58 30 45 
GTTA1A (GTT) 7 GAA (GTT) 55 45 60 
GACAB3A (GATA) 2 (GACA) 5 (GATA) 55 45 60 
GTTC4A (GTT) T3 (GTT) 5 T3 (GTT) 2 55 45 60 
GCATD7S (CA)6 (GCAT) 3 (GCAC) 3 60 30 45 
GTTD8S (GTT)9 55 45 60 
GTTD9A (GTT) 14 60 30 45 
GACAE12A (GACA) 6 (CA) 6 (GA) 60 30 45 
TNF (CA) (CA) 17 60 30 45 
MS19 NA 58 40 60 
 
PCR products were then mixed with formamide and LIZ
TM 
standard marker and genotyped 
on the GENOTYPER (Applied Biosystems 3130 Genetic Analyser) according to the 
manufacturer to gain allele sizes relative to an internal size standard.  Each sample for each 
locus was scored with Peak Scanner 
TM
 v1.0 to identify peaks and fragment sizes for 
application-specific capillary electrophoresis assays (Dodd et al. 2014). The program 
STRUCTURE 2.3.3 (Pritchard et al. 2000; Evanno et al. 2005) was used to analyse multi-
locus microsatellite genotype data to investigate population structure. The parameters for the 
burnin period and the Markov Chain Monte Carlo (MCMC) were both set to 100 000 
replicates as recommended. The ancestry model was set to the admixture model as the mice 
were not expected to conform to the requirements for a fully discrete population. The allele 
frequency model was set to independent model as recommended (Pritchard et al. 2000). The 
sampling location was not used as prior information in the analysis. Replicate simulations 
were run for models with increasing numbers of assumed genetic clusters (K = 1-10) and 
average over 3 runs. The most likely K was inferred from graphical representations of K 
values plotted against the estimated log posterior probability following the recommendations 
(Evanno et al. 2005). Individuals were placed in clusters based on a proportion of greater 
than 50% of membership (q) being assigned to the cluster. In some cases, the program 
STRUCTURE cannot detect subgroups with weaker probabilities when all data is included. It 
36 
is common practice (e.g. Gelanew et al. 2010) to rerun each initial group separately through 
STRUCTURE to investigate substructuring. The program MICRO-CHECKER 2.2.3 (Van 
Oosterhout et al. 2004) was used to check for the presence of microsatellite null alleles and 
scoring errors.  
  The program COLONY v2.0.5.0 (Wang et al. 2004) was used to estimate the full- and half-
sib relationships of mice. COLONY is a computer program implementing a maximum 
likelihood method to assign/infer parentage and sibship among individuals using their multi-
locus genotypes. COLONY can be used, among others programmes, in estimating full- and 
half-sib relationships, assigning parentage, inferring mating systems 
(polygamous/monogamous,) and reproductive skew in both diploid and haplo-diploid 
species. It can also be used to simulate genotype data with a particular sibship and parentage 
structure. The new project wizard saved the data with a specific file name in the project 
folder (adding column headers if necessary), and assembled all of the data and parameters 
into a single file named “Colony2.dat” which is saved in the project folder on completion of 
the data input process. Empirical Data Analysis was selected in the first step. In most cases, 
the default values of the parameters were used. Longer runs consider more configurations in 
the simulated annealing process searching for the best assignment with the maximum 
likelihood, and thus are more likely to find the maximum likelihood configuration, but take 
more time to do so. Four methods (full likelihood, FL; pairwise-likelihood score, PLS; FL 
and PLS combined method, FPLS; pure pairwise likelihood, PPL) for sibship and parentage 
assignments are implemented in this program. We selected the FL method which is the most 
accurate one as verified by simulated and empirical data analyses (Wang et al. 2004). For the 
same dataset and parameters of a project, multiple runs can be conducted so that the best 
configuration with the maximum likelihood is more likely to be found and the uncertainties 
of the estimates are more reliably assessed.  
The program BOTTLENECK 1.2 (Piry et al. 1999) was used to test a possible recent 
population bottleneck. This program generates the expected HEQ (expected heterozygosity 
under mutation-drift equilibrium) from the number of alleles at a locus and the sample size 
using the SMM (stepwise mutation model), TPM (two-phase model) and IAM (infinite allele 
model) models. The HEQ values are then averaged across loci   and compared with the 
observed level of heterozygosity. The SMM counts new alleles along a stretch of DNA with 
respects to the addition or subtraction of particular subsets of DNA motifs, while the IAM 
considers any point mutation along a stretch of DNA within a locus to constitute a new allele. 
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The SMM and TPM are most appropriate for microsatellite data (Luikart et al. 1998). Five 
input data file formats (all are text files) are acceptable and automatically recognized by 
BOTTLENECK. One is GENEPOP (Raymond et al. 1995), the second is GENETIX (Belkhir 
et al. 1996) and the other three are described in the help file of the program. For our study the 
GENEPOP format was used. To achieve high statistical power at least 10 polymorphic loci 
(microsatellites or alloenzymes) and sampling at least 30 individuals is recommended. For 
fewer than 20 loci, the Wilcoxon’s test is the most powerful and appropriate while the 
standardized differences test is more suitable when using 20 or more loci (Cornuet et al. 
1996). This test relies on the assumption of allele neutrality and mutation-drift equilibrium. If 
a population has been subjected to a recent bottleneck, the mutation-drift equilibrium is 
temporarily disrupted and He will be significantly greater than HEQ calculated from the 
number of alleles (Nei et al. 1975). The Wilcoxon test allows the detection of the 
heterozygosity excess due to the faster loss of low frequency. In non-bottleneck population 
about 50% of the loci are expected to have a slight heterozygote excess and 50% slight 
heterozygote deficiency due to genetic drift or sampling error (Luikart et al. 1998).  The 
number of iterations influences the precision of the HEQ estimates. A minimum of 1000 
iterations is recommended. The distribution of the heterozygosity obtained through the 
simulation also enables the computation of P value for measured heterozygosity.  
The NEESTIMATOR V2.01 software was used to calculate genetic effective population sizes 
(Ne) from the allele frequency data using multi-locus diploid genotypes from population 
samples (Nomura et al. 2008). We used the genotypic data in GENEPOP format (FSTAT is 
also accepted). NeEstimator V2.01 included three single-sample estimators (updated versions 
of the linkage disequilibrium and heterozygote-excess methods, and a new method based on 
molecular coancestry), as well as the two-sample (moment-based temporal) method. One or 
multiple methods for calculating Ne can be performed simultaneously generally performed on 
a single data input file. For the single-sample method (linkage disequilibrium, heterozygote-
excess and molecular coancestry), each sample is treated as separate population.  
The analysis of the population history was run on the computer program DIYABC 2.1.0 
(Cornuet et al. 2014), which uses the approximate Bayesian computation (ABC). This 
Monte-Carlo algorithm is used to make model based interference on complex evolutionary 
scenarios that act on natural populations. The evaluation of evolutionary scenarios includes 
the comparison of competing scenarios and the quantification of their relative support, and 
the estimation of parameter posterior distribution under a given scenario. DIYABC allows 
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considering complex population histories involving any combination of population 
divergences, admixtures and population size changes, with population samples potentially 
collected at different times. The main limitation of the current version is the absence of 
migration among populations after they have diverged.  
Possible migrating individuals were detected with GENECLASS2 (Piry et al. 2004). Migrant 
detection needs a single data file that includes both the populations for which migrants will 
be searched and the potential source populations for migrants. 
 
Statistical analysis 
Statistical analysis was conducted using GRAPHPAD. P-values for expected and observed 
frequencies were calculated using the Chi-Squared test or using Chi-Squared analysis of 
contingency tables (r x c). Pairwise analyses were conducted using 2 x 2 contingency tables 
with P values calculated using the Fishers exact test (FET).  
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2.4. Processing and analysis of human lung tissue samples 
   The tissue samples were collected from 88 patients (provided by Helen Carlin as a part of 
her PhD study) with lung cancer at the Wythenshawe Hospital, Northwest Lung Centre in 
Manchester. For each sample, data was available on age, gender, lung conditions (COPD, 
asthma) if present and on smoking status of individuals. DNA from all 88 patients was used 
for molecular testing and only 76 tissue samples were of suitable quality to be used for 
immunohistochemical staining. The study received ethical approval from the South 
Manchester Local Research Ethics Committee (03/SM/396) and the University of Salford 
(CST 12/37). The lungs tissue was washed in sterile Phosphate Buffered Saline (PBS) and 
fixed in 10% formalin. After the fixation the tissue was embedded in paraffin. This was done 
on the Leica TP1020 automatic tissue processor. First, the tissue was dehydrated in range of 
alcohols, 50%, 70%, 90% and absolute ethanol for 1 hour each. After the dehydration step the 
tissue was left in two buckets of Histoclear, 1 hour each. In the final step the tissue was 
transferred into a paraffin bath (58˚C), 2 x 1.5h. Tissue blocks can be stored at room 
temperature for years. Tissues were sectioned using a microtome with the dial set to cut 5µm 
sections.  
  
2.4.1 Haematoxylin and Eosin staining 
 
  Haematoxylin is a basic dye and has an affinity for the nucleic acids of the cell nucleus. 
Eosin is an acidic dye with an affinity for cytoplasmic components of the cells. The slides 
were stained using an automated stainer. First, they were    dewaxed in Histoclear (2 x 5min) 
followed by rehydration in ethanol, 100% (5 minutes), 90% (3 minutes), 75%  (2minutes), 
50%  (1 minute) and rinsed in distilled water for 5 minutes. The next step was staining with 
haematoxylin (6 minutes). Stained slides were rinsed under the running tap water for 5 
minutes, decolorized in acid alcohol with one dip and rinsed again under the tap water. Tissue 
was counterstained with eosin (15 seconds). In final step, stained slides were dehydrated with 
alcohols, 50 % (1 minute), 75 % (2 minutes), 95 % (4 minutes), and 100 % (5 minutes), 
cleared in Histoclear (2 x 5 minutes) and mounted with cover slips in DPX.  
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2.4.2 Immunohistochemistry (IHC) for T. gondii in human lung sections 
  Immunohistochemistry was performed on paraffin embedded tissue using commercial 
polyclonal antibodies produced in rabbits (Thermo Fisher Scientific). The tissue sections 
were cut at 5 µm and mounted on positively charged glass slides. Slides were dewaxed in 
Histoclear (2 x 5min), rehydrated in alcohols (ethanol), 100% (5 minutes), 90% (3 minutes), 
75% (2 minutes), and 50% (1 minute). The rack was finally rinsed in tap water to remove the 
ethanol for 5 minutes. Antigen retrieval was performed in 1% trypsin/calcium chloride (pH 
7.8) at 37˚C, 30 minutes in a humidified chamber as recommended by Thermo Fisher. After 
the incubation the sections were left to cool down at room temperature for 10 minutes before 
they were washed in PBS Tween 20 for 2 x 2 minutes. Endogenous peroxidase activity was 
blocked by incubating slides in 0.3% hydrogen peroxide for 30 minutes at room temperature 
followed by washing in TBS. Nonspecific antibody was blocked using normal goat serum 
(Vectastain ABC Systems, Vector Laboratories, UK) for 30 minutes at room temperature and 
followed by incubation in diluted (1/100) polyclonal rabbit anti- T. gondii antibodies 
(Thermo Fisher Scientific, Catalogue number PA1-38789, Rockford, IL, USA) for 1 hour at 
room temperature. After the incubation, the slides were washed in TBS Tween for 3 x 3 
minutes and incubated in Vector biotinylated anti-goat secondary antibody (Vectastain ABC 
Systems, Vector Laboratories, UK) for 30 minutes at room temperature followed by another 
washing in TBS Tween (3 x 3 minutes).  The resulting complex was visualized using 3-3’-
diaminobenzidine (DAB) for maximum of 10 minutes (visualised under the light microscope 
and the reaction stopped with dH2O). Before the DAB visualization the slides were incubated 
in ABC-Px mix (Elite Px) mix for 30 minutes. Sections were then washed under the running 
water for 5 minutes, counterstained with haematoxylin for 45 seconds, washed under the 
water for another 5 minutes, dehydrated with alcohols, 50 % (1 minute), 75 % (2 minutes), 
95% (4 minutes), and 100 % (5 minutes), cleared in Histoclear (2 x 5 minutes) and mounted 
with cover slips in DPX. Two negative antibody controls were used, lung sections from T. 
gondii negative wood mouse and human lung sections omitted of primary antibodies. 
Immunostained slides were visualised using a light microscope (Leica) at x400 
magnification, slides were also assessed using quantitative criteria (ImageJ) to provide a 
percentage score which described the degree of infection. For each patient (slide) three 
randomly selected x400 magnification microscope fields were photographed. After 
calculation of the proportional staining area to whole fields with ImageJ (as percentage of 
stained pixels), the mean percentage of pixels in the stained areas was calculated for each 
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slide. According to the final mean (intensity), the patients were divided into three grades. 
Grade 1 had intensity below 10%, grade 2 between 10-20% and grade 3 contained all the 
patients with staining intensity greater than 20%. Data was analysed by logistic regression. 
All analyses were undertaken using R (R Core Team, 2013). 
 
2.5 PCR detection and genotypes of T. gondii in human samples 
   DNA from 88 patients was isolated from small blocks of frozen tissue, using proteinase K 
lysis followed by phenol/chloroform extraction as previously described (Duncanson et al. 
2001). Extracted DNA was tested for mammalian tubulin gene to ensure sample viability for 
PCR (Terry et al. 2001). The presence of the parasite was tested with standard T. gondii 
markers SAG1, SAG2 (3
/
 and 5
/
 were tested separately), SAG3 and B1. The protocols were 
the same as those used for testing A. sylvaticus and are fully described at the beginning of this 
chapter in section 2.2. Each sample was tested three times at its original DNA concentration. 
The sample was accepted as positive if the presence of the parasite DNA was confirmed in all 
three reactions. Additional strain typing with commonly used markers (Table 2.4) was 
performed (Su et al. 2006; Shwab et al. 2013). Samples were accepted as positive if at least 
one reaction gave positive results with listed markers. If samples were negative in all three 
reactions they were considered to be negative with that marker.  All markers were tested on 
human genomic DNA (Promega, Madison, WI, USA, product code G304A) as negative 
control. Type II strain from Slovakia and RH (Type I) strain were used as a positive controls. 
Two negative controls were used, sterile water and DNA from wood mouse negative for T. 
gondii. 
Selected tissue samples from two patients were sent to Salford Analytical Services (SAS) at 
the University of Salford for analysis with a Scanning electron microscope (SEM) and a 
Transmission electron microscope (TEM). 
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Table 2.4 Toxoplasma gondii PCR markers and RFLP conditions. The reaction mixture is treated at 95˚C for 4 min, followed by 35 cycles of 
94˚C for 30 sec, 60˚C for 1 min and 72˚C for 1.5 min (for marker Apico, the annealing temperature is at 58˚C instead of 60˚C). For RFLP 
typing, 6-10 µl of nested PCR products were treated with restriction enzymes  and digested samples were resolved in an agarose gel to reveal 
DNA banding patterns (Su et al. 2006), Grigg et al. 2001, Shwab et al. 2013) ). Buffers for the restriction enzymes were provided by supplier 
(New England BioLabs). F= forward primers, R= reverse primers.  
 
 
Markers External PCR markers Internal PCR markers Size 
(bp) 
Restriction enzymes, 
incubation temperature 
and time 
SAG1 F: GTTCTAACCACGCACCCTGAG 
R: AAGAGTGGGAGGCTCTGTGA 
F: CAATGTGCACCTGTAGGAAGC 
R: GTGGTTCTCCGTCGGTGTGAG 
390 Sau96I+HaeII (double 
digest).37˚C 1 h. 2.5% gel 
alt. SAG2 F: GGAACGCGAACAATGAGTTT 
R: GCACTGTTGTCCAGGGTTTT 
F: ACCCATCTGCGAAGAAAACG 
R: ATTTCGACCAGCGGGAGCAC 
546 HinfI+TaqI, 37˚C, 30min, 
65˚C 30 min. 2.5% gel. 
BTUB F: TCCAAAATGAGAGAAATCGT 
R: AAATTGAAATGACGGAAGAA 
F: GAGGTCATCTCGGACGAACA 
R: TTGTAGGAACACCCGGACGC 
411 BsiEI+TaqI  (double digest), 
, 60˚C 1 h. 2.5% gel 
C22-8 F: TGATGCATCCATGCGTTTAT 
R: CCTCCACTTCTTCGGTCTCA 
F: TCTCTCTACGTGGACGCC 
R:AGGTGCTTGGATATTCGC 
521 BsmAI+MboII (double 
digest), 37˚C 30 min, 55˚C 
30min. 2.5% gel. 
C29-2 F: ACCCACTGAGCGAAAAGAAA 
R: AGGGTCTCTTGCGCATACAT 
F: AGTTCTGCAGAGTGTCGC 
R:TGTCTAGGAAAGAGGCGC 
446 HpyCH4IV+RsaI (double 
digest), 37˚C 1 h. 2.5% gel. 
L358 F: TCTCTCGACTTCGCCTCTTC 
R: GCAATTTCCTCGAAGACAGG 
F: AGGAGGCGTAGCGCAAGT 
R: CCCTCTGGCTGCAGTGCT 
418 HaeIII+NlaIII  (double 
digest), 37˚C 1 h. 2.5% gel 
PK1 F: GAAAGCTGTCCACCCTGAAA 
R: AGAAAGCTCCGTGCAGTGAT 
F: CGCAAAGGGAGACAATCAGT 
R: TCATCGCTGAATCTCATTGC 
903 AvaI+RsaI  (double digest), 
37˚C 1 h. 2.5% gel. 
Apico F: TGGTTTTAACCCTAGATTGTG 
R: AAACGGAATTAATGAGATTTGAA 
F: GCAAATTCTTGAATTCTCAGTT 
R: GGGATTCGAACCCTTGATA 
640 AflII+DdeI (double digest), 
37˚C 1 h. 3% gel. 
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CHAPTER 3:  
 
Microsatellite-based genetic diversity and population structure of 
Apodemus sylvaticus in Malham Tarn Nature Reserve 
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3.1. Introduction 
    Mice from the genus Apodemus are the most common rodents of the Palaearctic region 
(Corbet et al. 1978) and have shown diverse adaptations throughout their wide distribution 
range. Wood mice (Apodemus sylvaticus) and yellow-necked mice (Apodemus flavicollis) 
have been used in several microsatellite studies (Makova et al. 1998, Harr et al. 2000, 
Sommer et al. 2010) but nobody has used this approach to investigate host – parasite 
interactions. In our study we applied combined analysis of the host genetic markers and data 
based on the population structure in relation to parasite prevalence and genotype.    
Theoretical and analytical tools of population genetics have been widely applied for 
addressing various questions in the fields of ecological genetics and conservation biology. By 
looking at the variation of microsatellite markers in populations, inferences can be made 
about population structures and differences, genetic drift, genetic bottlenecks and even the 
date of a last common ancestor.  Microsatellites are very good  markers in genetic studies  of 
populations because they have a high heterozygosity and so can be used to detect sudden 
changes in populations, effects of population fragmentation and interaction of different 
populations and they are useful in identification of new and incipient populations (Varilo et 
al. 2003). Microsatellites are short tandem repeats (STRs) or variable number tandem repeats 
(VNTR), which are made up of short repetitive sequences and they tend to occur in non-
coding DNA. The repeated sequence is often simple, consisting of two, three or four 
nucleotides (di-, tri-, and tetranucleotide repeats respectively), and can be repeated 3 to 100 
times, with the longer loci generally having more alleles due to the greater potential for 
slippage (Brinkmann et al. 1998). The repeat units are 1-13 nucleotides in length and are 
usually repeated 5-20 times. Dinucleotide repeats are the most frequently used loci, because 
they are the most common arrangement of microsatellite repeats (Li et al. 2002). Their 
density varies widely with species, peaking around one locus per 5kb.  The DNA from the 
animal kingdom is very rich in CA repeats, with a ubiquitous chromosomal distribution in 
humans and mice (Dib et al. 1996, Dietrich et al. 1996). Trinucleotide repeats are largely 
studied in connection with some human diseases and cancers (Sutherlands, 1992) and are 
often found within exons. Tetranucleotide repeats are often GATA/GACA repeats, which 
occur in many higher organisms though their density varies with species. In diploid 
organisms each individual animal will have two copies of any particular microsatellite 
segment (Berger-Wolf et al. 2007). Over time, as animals in a population breed, they will 
recombine their microsatellites during sexual reproduction and the population will maintain a 
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variety of microsatellites that is characteristic for that population and distinct from other 
populations which do not interbreed. Alleles at a specific location (locus) can differ in the number 
of repeats. The number of repeats at a locus can be determined by carrying out a PCR using 
primers that anneal either side  of the STR, and then examining the size of the product by 
agarose, polyacrylamide gel electrophoresis or capillary electrophoresis. If you flank a 
microsatellite with fluorescent PCR primers then amplification will give a pair of fluorescent 
allelic products which will vary in size according to their repeat length (Jouquand et al. 
1999). A population might possess alleles which vary in size like this.                                                                                                                                                                   
  The variability of microsatellites is due to a higher rate of mutation compared to other 
neutral regions of DNA. These high rates of mutation can be explained most frequently by 
slipped strand mispairing (slippage) during DNA replication on a single DNA strand. The 
primary mutational mechanism is believed to be replication slippage (Ellegren et al. 2000): 
during replication of microsatellite region the strands may be displaced and then realign 
incorrectly, leading to insertion or deletion of a number of repeat units. Mutation may also 
occur during recombination during meiosis. Interruption of microsatellites, perhaps due to 
mutation, can result in reduced polymorphism. Variation in flanking regions is also 
important. First point mutation in primer annealing sites may cause the occurrence of null 
alleles. Frequencies up to 15% have been reported, and they are found in up to 25% of loci 
(Callen et al. 1993). Null alleles may affect the estimation of population differentiation, for 
instance, by reducing the genetic diversity within populations. Null alleles may be detected in 
population studies by careful testing against frequencies that are expected under the Hardy-
Weinberg equilibrium, provided that heterozygote deficiencies have no other origin, such as 
the mating system (Viard et al. 1996). 
  Microsatellites are considered to be neutral markers because unlike other parts of the 
genome, they do not code for proteins and thus we can assume they are not under selection. 
Microsatellites developed for particular species can often be applied to closely related 
species, but the percentage of loci that successfully amplify may decrease with increasing 
genetic distance (Abdul-Muneer et al. 2014).  
  There is no up to date data on wood mouse populations in pastoral areas of northern and 
western England, Scotland or Wales. A study was carried out in Northern Ireland in a habitat, 
where there was 1.9 farms and 9.2 km of field boundaries per km
2
, and they found a density 
of A. sylvaticus of 3.0 per ha in summer and 2.5 per ha in winter, with 99% of these in field 
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boundaries and only 1% in buildings (Montgomery and Dowie 1993). A study on sand dunes 
in Scotland suggested that densities range from less than 0.5 per ha in spring to around 12 per 
ha in the autumn (Gorman and Zubaid, 1993). In urban areas, densities can be very high in 
isolated habitat patches due to restricted dispersal (Dickman and Doncaster 1987), although 
suitable habitat patches are scattered and overall densities in urban areas are much lower. 
Montgomery (1989) suggested that the average April-June density for wood mice in mixed 
deciduous woodland is about 7 per ha. In arable areas of Britain, seasonal variation in density 
is from 0.5 per ha in the summer to 17.5 per ha in winter, with winter peaks as low as 8.4 per 
ha (Green 1979; Wolton 1985; Attuquayefio, Gorman & Wolton 1986; Wilson, Montgomery 
& Elwood 1993; Tew & Macdonald 1993; Tew 1994). In mixed farmland on the Moray 
coast, Grampian, wood mouse numbers varied from 2 to 30 per ha (M.L. Gorman pers. 
comm.). These low spring densities in arable fields may simply reflect the large size of fields. 
A total pre-breeding population is estimated to be about 38,000,000; 19,500,000 in England, 
15,000,000 in Scotland and 3,500,000 in Wales. The autumn population would be about 
114,000,000 (Harris et al. 1995). In this study we aim to investigate the structure of natural 
population of the wood mice (A. sylvaticus) in Malham Tarn area using genetic analysis and 
statistical analysis.  
Objectives 
1) Microsatellite genotyping of 126 Apodemus sylvaticus DNA samples. 
2) Analysis of genotypes to determine population structure and family units. 
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3.2. Materials and Methods 
 
  A total of 126 DNA samples from A. sylvaticus were prepared for microsatellite genotyping. 
Nine A. sylvaticus loci were amplified and genotyped using primers and conditions 
previously described (Makova et al. 1998). One Mus domesticus microsatellite, which 
amplifies from A. sylvaticus was also used (MS19). PCR products were then mixed with 
formamide and LIZTM standard marker and genotyped on the Applied Biosystems 3130 
Genetic Analyser according to the manufacturer to gain allele sizes relative to an internal size 
standard (full protocol is described in Chapter 2).  Each sample for each locus was scored 
with PEAK SCANNER TM v1.0 to identify peaks and fragment sizes for application-specific 
capillary electrophoresis assays (Dodd et al. 2014). Quantification of allele frequencies and 
analyses of linkage disequilibrium were conducted using GENEPOP 3.4 (Raymond and 
Rousset, 1995) and GEMALEX 6.502 (Peakall et al. 2012), a cross-platform package for 
population genetic analyses that runs within Microsoft Excel. The program STRUCTURE 
2.3.3 (Pritchard et al. 2000; Evanno et al. 2005) was used to analyse multi-locus 
microsatellite genotype data to investigate population structure. The program MICRO-
CHECKER 2.2.3 (Van Oosterhout et al. 2004) was used to check for the absence of 
microsatellite null alleles and scoring errors. The program BOTTLENECK (Piry et al. 1999) 
was used to determine if the population displayed a genetic signature of having gone through 
a bottleneck during the study period.  Program COLONY v2.0.5.0 (Wang, 2004) was used to 
estimate the full- and half-sib relationships of mice. The analysis of the population history 
was run on the computer program DIYABC 2.1.0 (Cornuet et al. 2014), which uses 
approximate Bayesian computation (ABC). Contemporary effective population size was 
estimated with NEESTIMATOR V2.01 (Do et al. 2014) using linkage disequilibrium 
method. Possible migrating individuals were detected with GENECLASS2 (Piry et al. 2004).  
 
 
 
 
 
48 
3.3. Results 
 
  The aim of this study was to identify and optimise a sufficiently large set of microsatellites 
to use with wood mice to investigate population genetics and family units. In total, 126 wood 
mice A. sylvaticus were genotyped using 10 polymorphic microsatellite loci identified by 
Makova (1998). Examples of successful PCR microsatellite amplification are presented in 
Figure 3.1. All tested loci showed significantly higher level of polymorphism, with a 
maximum of 33 alleles present with MS19 and a minimum of 13 alleles for locus 8S. The 
average number of alleles per locus was 23.6 (SD 6.47) which is significantly higher than 
reported in the previous study. The allelic richness as well as observed and expected 
heterozygosity for each locus is shown in Table 3.1. Mean expected heterozygosity (He) was 
high, averaging from 0.359 (8S) to 0.927 (MS19), but six loci showed heterozygote 
deficiency. Significant departures (P<0.001) from Hardy –Weinberg equilibrium were 
observed on all ten loci when genotypes from all sites were pooled. Since most of the loci 
showed an excess of homozygotes, these deviations could be linked to family structure 
(Wahlund effect). No locus pairs were consistently in linkage disequilibrium and the program 
MICRO-CHECKER 2.2.3 (Van Oosterhout et al. 2004) found no evidence of null alleles so 
all loci were considered independent for further analyses.  
 
 
Figure 3.1 Example of a microsatellite PCR amplification of A. sylvaticus loci from sample 
number 12: Lane 1 = 1kb marker (Bioline), Lane 2 = 1A, Lane 3 = 2A, Lane 4 = 3A, Lane 5 
= 4A, Lane 6 = 7S, Lane 7 = 8S, Lane 8 = 9A, Lane 9= 12A, Lane 10 = TNF, Lane 11 = 
MS19 
 
  1         2         3         4         5        6         7        8         9        10      11 
100 bp 
200 bp 
300 bp 
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Table 3.1 Microsatellite loci diversity for Apodemus sylvaticus sampled from Malham Tarn 
Nature Reserve. Microsatellites and expected allele range were originally defined by Makova 
et al. (1998).  
 
 
 Locus 
 
n 
 
Na 
 
 
Ho 
 
He 
 
FST 
 
Allele range  
8S 122 13 0.364 0.359 0.071 101 – 110 
TNF 118 28 0.924 0.919 0.043 105 – 124 
4A 105 20 0.886 0.921 0.040 128 – 154 
3A 107 27 0.935 0.903 0.039 361 – 622 
1A 115 18 0.774 0.741 0.033 168 – 209 
2A 116 25 0.491 0.795 0.241 94 – 118 
7S 117 21 0.727 0.879 0.039 199 – 296 
9A 111 19 0.478 0.745 0.047 202 – 216 
12A 99 31 0.755 0.911 0.031 252 – 268 
MS19 120 33 0.793 0.927 0.091 82-226 
Mean 113 23.6 0.713 0.81 0.068 NA 
n = number of individuals, out of 126, successfully genotyped, Na = number of detected 
alleles, He = frequency of expected heterozygotes, Ho= observed heterozygotes, FST = fixation 
index 
 
      
The Bayesian analysis using STRUCTURE indicated the presence of multiple unique 
evolutionary clusters (R1, R2, B and G) of wood mice in Malham Tarn Nature Reserve.  The 
highest probability of the data Pr (X/K), was calculated using STRUCTURE for K= 4 (Table 
3.2, Figures 3.2. and 3.3.). The sampling location was not used as prior information in the 
analysis so as not to bias any genetic interpretation. As the generation of groups by 
STRUCTURE is based on probability of an individual belonging to a group, sometimes 
groups with weaker probabilities can be masked during the first analysis. It is common 
practice (e.g. Gelanew et al. 2010) to re-examine genetically defined STRUCTURE groups 
by re-running each group (i.e. R1, R2, G and B) separately through STRUCTURE. Following 
this more detailed analysis, STRUCTURE was unable to divide the individuals from all four 
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populations into subpopulations so they were considered as individual populations. These 
genetic populations, identified by STRUCTURE, were examined to see if there was any 
association between microsatellite derived populations and the trapping location of the mice. 
Interestingly, the evidence of admixture showed that most of the sampling sites did not 
consist of one population, but that each location contains individuals from two or four generic 
clusters with different proportions (Figure 3.5).  
 
Table 3.2 Inference of genetic clusters (K) from A. sylvaticus. The log-likehood values based 
on the STRUCTURE algorithm for each number of clusters are shown. The change in the 
value for K=4 is suggesting that most likely four evolutionary clusters are present.  
K 1 2 3 4 5 6 7 8 
-Log-likelihood -5207 -5088 -5065 -5055 -5092 -5126 -5163 -5194 
 
 
 
 
Figure 3.2 Four evolutionary clusters (K=4) inferred from STRUCTURE software (Pritchard 
et al. 2000; Evanno et al. 2005) analysis of 126 mice from four sampling sites.  Each 
individual is represented by a vertical line broken into segments of different colours, with 
lengths proportional to its membership to each of the clusters.  
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Figure 3.3 Evaluation of the robustness of the grouping by STRUCTURE. Summary 
structure diagrams are shown for K= 4 (Image A), when four clear populations were formed 
and can be compared with diagram generated when K= 5 (Image B), when the populations 
are not well defined.   
 
 
 The Principal Component Analysis (PCA) method (GENETIX) based on individual 
microsatellite genotypes revealed no substructure among individual groups and large overlap 
between individuals from the different populations (Figure 3.4). All four populations 
exhibited a high degree of allele frequency differentiation. FST values ranged from -0.297 to 
0.704 for individual loci. Mean value for all population was 0.05 (Table 3.3). Only 
population R2 had an excess of heterozygotes, the other three populations had heterozygote 
deficiency. FST values were very low between and within the populations, with highest figure 
observed in population R1, which means that most of the genetic variance is contained within 
the populations themselves and also there is a high gene flow between the genetic clusters. 
The pairwise FST analysis showed genetic distance between the populations R2 and B, R1 and 
B but confirmed a close connection of R1 and R2; and R1 and G. This data was further 
confirmed with a pairwise population matrix of Nei genetic distance and Nei genetic identity 
(Table 3.4). 
 
A 
B 
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Figure 3.4 Principal Component Analysis (PCA) of four A. sylvaticus populations done by 
GENETIX 4.05 (Belkhir, 2004) 
 
Table 3.3 Results of the genetic differentiation among populations. FST values were estimated 
using GENALEX (AMOVA). Na = number of alleles, Np = number of private alleles. Only 
the R2 population had a slight excess of heterozygotes, other populations were heterozygote 
deficient.  
Population Na Np He Ho FST 
R1 11.4 2.5 0.745 0.652 0.154 
R2 10.8 2 0.678 0.684 0.003 
B 11.4 2.9 0.81 0.784 0.026 
G 13.7 3.7 0.794 0.757 0.049 
Mean 11.83 2.3 0.757 0.719 0.058 
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Table 3.4 Pairwise Population Matrix of Nei genetic distance (Nei D), identity (Nei I) and    
FST. The values suggest that all four populations are closely related and probably originated 
from one source population.  
Population Nei D Nei I FST 
B G 0.313 0.731 0.044 
B R1 0.510 0.6 0.061 
G R1 0.266 0.766 0.04 
B R2 0.439 0.645 0.072 
G R2 0.250 0.779 0.047 
R1 R2 0.145 0.865 0.034 
 
Two different software programs (GENEPOP 3.4, GENALEX 6.502) confirmed that 12 
migrants are present in three analyzed populations (P < 0.01). Three were from population G, 
five from R1 and four originated in R2, four of them were adult males, four young female 
adults, three juvenile females and one juvenile male.   
An excess of heterozygotes can suggest that some populations are going through the 
expansion or early stage of bottleneck. To test this hypothesis the program BOTTLENECK 
1.2 (Piry et al. 1999) was used. The software compares excess of heterozygosity and 
heterozygosity expected under drift-mutation equilibrium (Nei et al. 1975). In a population at 
mutation-drift equilibrium (i.e. the effective size of which has remained constant in the past), 
there is approximately an equal probability that a locus shows a heterozygosity excess or a 
heterozygosity deficit. A population in mutation-drift equilibrium will have a large proportion 
of alleles at low frequency (<0.1), and alleles at a low frequency are expected to be more 
common than alleles present at an intermediate frequency, regardless of the mutation rate 
(Nei et al. 1976, Luikart et al. 1998). After a bottleneck there is often a shift in allele 
frequency distribution towards more alleles being present at an intermediate frequency than at 
a low frequency. The software calculated the distribution through simulating the coalescent 
process of n genes under two possible mutation models, the Infinite Allele Model (IAM) and 
the stricter Stepwise Mutation Model (SMM).  The allelic diversity is reduced faster than the 
heterozygosity, i.e. the observed heterozygosity is larger than the heterozygosity expected 
from the observed allele number were the locus at mutation-drift equilibrium, only if is 
evolving under IAM (Maruyama and Fuerst 1985). Under the SMM model there can be 
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situations where this heterozygosity excess is not observed (Cornuet and Luikart 1996). 
However, few loci follow the strict SMM, and as soon as they depart slightly from this 
mutation model towards the IAM, they will exhibit a heterozygosity excess as a consequence 
of a genetic bottleneck. The program BOTTLENECK computes for each population sample 
and for each locus the distribution of the heterozygosity expected from the observed number 
of alleles (k), given the sample size (n) under the assumption of mutation-drift equilibrium. 
Wilcoxon signed rank test showed highly significant heterozygote deficiency in all four 
tested population under the SMM model (Table 3.5). These results suggest that all four 
populations experienced a recent demographic expansion instead of bottleneck. Such a 
deviation can also arise in the earliest stages of a bottleneck, when a transient excess of 
alleles may exists (Cornuet and Luikart 1996). The mode shift model indicated that the 
distribution of allele frequencies fitted the normal L-shaped distribution.  
Table 3.5 BOTTLENECK 1.2 results (Piry et al. 1999) for four tested wood mouse 
populations in Malham Tarn under the SMM model (Wilcoxon test). He = expected number 
of loci with heterozygote deficiency, Ho = observed number of loci with heterozygote 
deficiency 
Population P  He Ho 
R1 0.005 5.84 1 
R2 0.002 5.87 1 
G 0.0001 5.9 1 
B 0.0015 5.94 1 
 
Approximate Bayesian Computation software (DIYABC v2.1.0) was used (Cornuet et al.  
2014) to analyse the population history. This program combines large scale simulations and 
evaluates the summaries of simulated datasets and observed datasets. Seven different 
evolutionary scenarios were simultaneously tested and the final data compared. The scenario 
with the highest likelihood was selected and rerun on its own with the same parameters. In 
this scenario population B was the oldest and original source population, from which derived 
first the population R2 and later population G. Population R1 was separated independently 
from the population R2 and has no direct link with population B or G (Figure 3.7). Wood 
mice reach sexual maturity after two months and they start to produce new offspring after 
two-four months. Based on this, data can also be used to estimate the time when the 
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divergence of the populations happened. DIYABC calculated that the population R2 
separated from the population B approximately 40.6-80.1 years ago. When a new population 
is created from its ancestral population, there is an initial size reduction for population since 
the invasive population generally starts with a few immigrants. Based on the allele 
frequencies, NeEstimator software (Nomura, 2008) estimated contemporary effective 
population size (Table 3.6). Population B was the largest, followed by R2, while G 
population had only 55 individuals. These data correspond with the data obtained from 
BOTTLENECK and DIYABC. Population B is the oldest, ancestral population and later R2 
and G were separated. A significant association of mouse genetic group with trapping 
location was found (χ2 = 46.6; D.F. = 9; P = 0.000). When we look at the Malham Tarn 
sampling sites (Figure 3.5), the ancestral B population is located in the north and the mice 
from this population were not found in Spiggot Hill. From all collected mice, 24 belonged to 
this population and the highest number (26.67%) was found in Ha Mire (Table 3.7). This 
sample size is too small to make any final conclusions. With 40 sampled individuals 
population G was the largest and mice were found in all four sampling sites (Tarn Fen 
26.09%, Tarn Woods 55.36% and Ha Mire 10%). Interestingly, Spiggot Hill was inhabited 
only by two populations, R1 and R2. When we know, that population B is the ancestral one 
from which separated R2, and from R2 derived R1, we can conclude that no population 
originated in this sampling site and the mice sampled mice migrated here, possibly from Ha 
Mire or Tarn Fen.  
The COLONY program was used to infer full- and half-sib relationships, assign parentage, 
infer mating system (polygamous/monogamous) and reproductive skew in both diploid and 
haplo-diploid species. This program implements a maximum likelihood method to assign 
sibship and parentage jointly, using individual multilocus genotypes at a number of 
codominant or dominant marker loci. Twenty two families of wood mice were identified in 
this sample collection from the study site. These comprised 4 families of full-sibs and 18 
families of half-sibs. Nine families were assigned to the population B, 12 to the population G, 
11 to R1 and 10 genetically belonged to R2. Most of the identified families comprised only a 
few mice (n=2), the highest number of detected siblings was 9 with an average of 4.05 mice 
per family (the table with detected families and T. gondii prevalences is presented in Chapter 
4). The likelihood probability values for some siblings were smaller, which suggest they were 
possible second generation siblings or they shared only one of the parents.  
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Table 3.6 Effective population size estimated with NeEstimator software (Nomura et al. 
2008) based on linkage disequilibrium random mating model for four different allele 
frequencies. N= number of sampled mice, Ne = estimated population size 
Population          N Ne  estimate for   different allele frequency 
0.05 0.02 0.01 0+ 
R1 37 134.6 168.0 319.2 319.2 
R2 25 136.2 375.0 180.1 180.1 
G 40 55.0 156.9 187.8 187.8 
B 24 227.2 infinite infinite infinite 
  
 
Figure 3.5 The population structure of Apodemus sylvaticus in four sampling areas (Spiggot 
Hill, Tarn Fen, Tarn Woods and Ha Mire) at the study site (Malham Tarn, Yorkshire, UK). 
The pie charts represent the percentage of each population at each location.  
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Table 3.7 The population structure of wood mice from the study site (Malham Tarn, 
Yorkshire, UK) in relation to sampling sites.  R, G and B represent the genetic populations as 
defined by STRUCTURE. Ha Mire, Spiggot Hill, Tarn Fen and Tarn Woods represent the 
four geographical locations from which the mice were collected (see Figure 3.5).  
 
 
Site/Population 
R1 R2 G B  
Total No. % No. % No. % No. % 
Ha Mire 9 30.00 10 33.33 3 10.00 8 26.67 30 
Spiggot Hill 13 76.47 4 23.53 0 0 0 0 17 
Tarn Fen 7 30.43 5 21.74 6 26.09 5 21.74 23 
Tarn Woods 8 14.29 6 10.71 31 55.36 11 19.64 56 
Total 37  25  40  24  126 
 
 
 
 
Figure 3.6 Principal Component Analysis (PCA) of four A. sylvaticus populations for the 
final selected scenario in DIYABC (Cornuet, 2014).   
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Data obtained from the GenA1Ex about the population richness and diversity showed very 
significant (P< 0.001) diversity among the populations (D'=0.43, sH= 0.233 O’=0.594) but 
very small within individual populations (D’=0.818, sH=1.922, O’=0.182) (Table 3.8). Total 
Shannon Informational Diversity Index, sH(GT) for the wood mouse population from 
Malham Tarn Nature Reserve was 1.919. This value was within the normal range 1.5-3.5. 
The value of Simpon’s Index of Diversity (O’=1-D) ranges between 0 and 1 and the greater 
the value is, the greater the diversity is. This index represents the probability that individuals 
randomly selected from a sample will belong to different species (category). D stands for 
Simpon’s Index and it measures the probability that two individuals randomly selected from a 
sample will belong to the same species or some category other than species (Simpson, 1949). 
With this index, 0 represents infinite diversity and 1, no diversity. The greater the value is, 
the lower the diversity is. The value for the Simpson’s Index of Diversity between R1 and R2 
was significantly higher than between other populations. It was unexpected to see the highest 
diversity between these two populations, especially when R1 separated from R2 only 
recently. For some unknown reasons, the gene flow between these two populations is low and 
the genetic distance is growing.  
 
 
 
 
Figure 3.7 Historical scenario supported by highest posterior 
probabilities in analyses using Approximate Bayesian 
Computation (DIYABC) and its schematic representation 
shows population B as an ancestral population from which 
derived populations R2 and G. Population R1 derived from 
the population R2. 
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Table 3.8 Table of Shannon Pairwise Analysis [0, 1] Scaled Diversity, D' and [0, 1], Scaled 
Overlap, O'=1-D'    
 
Pop1 
 
Pop2 
D' 
Among 
populations 
 
      O'=1-D' 
Among 
populations 
Average 
Within Pops 
sH 
Among 
Pops 
sH 
R1 R2 0.276 0.724 1.784 0.145 
R1 B 0.552 0.448 1.910 0.301 
R2 B 0.500 0.500 1.846 0.285 
R1 G 0.412 0.588 1.964 0.230 
R2 G 0.387 0.613 1.930 0.211 
B G 0.428 0.572 2.063 0.227 
Overall  0.432 0.574 1.922 0.233 
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3.4. Discussion  
    This study was designed to provide baseline information on the genetic population 
structure of the wood mouse (Apodemus sylvaticus) using microsatellite analysis. The genetic 
structure of populations reflects many aspects of their ecology, including past and present 
demography, interactions with habitat and landscapes, social structure and migration. The 
results from multiple analytical approaches have shown that the chosen ten microsatellite loci 
were sufficient for this analysis and the level of genetic variation was very high. The A. 
sylvaticus population in Malham Tarn Nature Reserve showed a high gene flow among 
different sampling sites and populations. The results indicate that the wood mice from all 
areas are genetically related but fragmentation of the population is observed and the gene 
flow might be higher than observed in other studies. All our loci were highly polymorphic 
(except 8S), with an average number of 23.6 alleles per locus. Mean of the expected 
heterozygotes was high, averaging from 0.359 to 0.927. Significant departures from Hardy-
Weinberg equilibrium were observed on all ten loci. Traditional F-statistics, Bayesian 
clustering analysis and assignment tests indicated the four well defined populations (R1, R2, 
B and G) are present at four sampling sites. Three localities, Ha Mire, Tarn Fen and Tarn 
Woods were inhabited by all four populations, only Spiggot Hill consisted of two 
populations, R1 and R2. The analyses of the population history identified population B as the 
ancestral population, from which approximately 40-80 years ago (assuming that wood mice 
start to breed 2-4 months after the birth) separated into R2 and G. There is no evidence, that 
the divergence of both daughter populations occurred at the same time, but this possibility 
cannot be excluded. Population R2 subsequently diverged to R1. The B population had the 
highest number (3.7) of private alleles when compared to other populations. It is surprising 
that these populations have become genetically differentiated so quickly. FST values ranged 
from 0.003 to 0.154 and were significant for all populations except the population R1. 
Reliability of estimates of genetic summary statistics (FST, heterozygosity) is more dependent 
on the number of loci than on the number of sampled individuals. As indicated by a 
Wilcoxon signed rank test, there was no evidence of an excess of He in tested populations. 
The mode shift test indicated that the distribution of allele frequencies fitted the normal L-
shaped distribution expected from a population in mutation-drift equilibrium.  
BOTTLENECK data confirmed that all four populations are expanding. Population G had 
only 55 individuals predicted at the 0.05 allele frequency. This could mean that the expansion 
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is over and the population is now entering a bottleneck, which is characteristic of a sharp 
reduction in population size. Interestingly, population R2 had a very high population size 
estimated for allele frequency 0.02 when compared with R1, but not for other frequencies. 
This can possibly mean that R2 expansion is slowing down, in contrast with R1 where faster 
expansion can be expected. Infinite values for the ancestral B population suggest that this 
population is still large enough and probably will continue to grow and expand further.  
 After a bottleneck, there is often a shift in allele frequency distribution towards more allele 
present at an intermediate frequency than at a low frequency (Luikart et al. 19998).  It can be 
difficult to detect bottleneck in populations of rodents because the methods used in bottleneck 
detection techniques lack statistical power for the studied population sizes.  
In total, 12 migrants were detected, belonging to three populations G, R1 and R2. There was 
no detected migration from the B population. Migrating mice originated from all four 
sampling sites and there were no sex differences. The majority of the migrants were adults or 
young adults. It is possible that a single mating pair may establish a successful population 
upon entering a new habitat. A small number of effective migrants per generation is sufficient 
to prevent strong genetic differentiation among populations (Whitlock and McCauley, 1999). 
Migration can be different between the sexes as there is usually a strong sex bias in dispersal 
potential in rodents.  At the same time, the coexistence of subpopulations connected by a 
limited amount of gene flow can maintain much more genetic variation across the entire 
population than a randomly mating population of the same size (Lacy et al.1987). The 
location of the first ancestral B population is a pure speculation but the genetic distribution 
points at Tarn Woods. The source population must be located close to Ha Mire and Tarn Fen 
but it must be distant from Spiggot Hill as this site has no individuals from B and G 
populations. Tarn Woods, a larger forested and compact area is more suitable habitat for 
different species and can sustain larger populations. The results from NeEstimator showed 
that  population B is the largest one and is not going to reach a bottleneck anytime soon in 
contrast with population G, for which  can be predicted a rapid decrease in population size. In 
the year 1947 Malham Tarn Field Study Centre was opened. The Centre occupies a large 
Georgian country house, leased from the National Trust, in 1946 underwent massive 
reconstruction, two stable blocks in the wood were converted into accommodation and 
derelict buildings were repaired. The reconstruction of the stables could have forced the wood 
mice living there before to leave their habitat and migrate to surrounding areas. This time 
correlates with the divergence time obtained from DIYABC. It is possible that a few mice 
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migrated south (in single or several migrations) and set up population R2, while other mice 
spread into surrounding woods. Around 1970 experimental blocking of the grip drains on the 
main bog was begun and this has been pursued systematically since 1987. This change has 
significantly raised the water table and could have caused the divergence of the R2 
population in Spiggot Hill.  The Spiggot Hill area is able to sustain a very large population; 
but is very often flooded during the spring, so probably the mice migrate to surrounding 
areas. The landscape structure allows easy migration between Ha Mire, Tarn Woods and Tarn 
Fen area. Gene flow across the landscape additionally suggests that small to medium size 
roads and grasslands may not be strict barriers to movement of mice. It is possible that the 
mice migrate (or stay in the original areas) due to high-quality habitats during the low phase, 
perhaps with source and sink populations  and then expand back out into areas of lower 
quality during the increase and peak phases. A larger forested area and more connected 
fragments represent a more suitable habitat for different species than smaller, isolated forest 
fragments.  Neighbouring sampling sites Tarn Woods, Ha Mire and Tarn Fen are located 
within short distance of each other with no obvious barriers and so no isolation by distance is 
expected in here localized populations. Pairwise Population Matrix of Nei genetic distance 
(Nei D), identity (Nei I) and   FST values suggest that all four populations are closely related. 
The fact that gene diversity estimates for the northern (located in Tarn Fen, Tarn Woods and 
Ha Mire) and southern (Spiggot Hill) populations were relatively high suggests current or 
relatively recent connectivity. Indeed, pairwise FST analysis showed that the northern and 
southern populations are not completely isolated from each other. It is possible that the 
populations from Spiggot Hill (R1 and R2) effectively act as one large population, but they 
may have experienced significant fluctuations in size. BOTTLENECK data has shown a 
faster expansion in R1 population and slower in R2. Although there is clear evidence of 
ongoing gene flow between neighbouring populations, genetic distance between the 
populations B (ancestral, source population) and R1 (derived from R2) is growing. The main 
reason for this is probably the geographical location and spatial dispersion of individual 
populations. Demographic factors, such as population substructure and social structure can be 
responsible for significant FST values. The presence of undetected null alleles can inflate the 
proportion of homozygotes. It is unlikely that they caused heterozygote deficiency in this 
study as no null alleles were detected with MICROCHECKER. The significant heterozygote 
deficiency could be the result of inbreeding or identity by descent. It is possible that mild 
inbreeding is present in wood mice populations. Genetic drift in small populations can also 
decrease observed heterozygote frequencies and compound any potential effects of mating 
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among relatives. In contrast, a high degree of polygyny and male-biased dispersal will cause 
heterozygote excess (Storz et al. 2001). The differences in frequencies of heterozygotes 
between males and females were not significant. Males had a higher number of alleles and 
lower number of deficient heterozygotes when compared to females. There are only few data 
on the genetic structure of wood mice populations in natural habitats. Most of the research 
done on small rodents used different species or the population was located in urban or 
agricultural areas.  This study of wood mice from Malham Tarn Nature Reserve indicates that 
the level of genetic structure is unusually complex for such a small geographic area, where 
the distance between individual sampling sites is approximately one mile. For future studies 
of the wood mice population, a larger sample size is necessary, as a small number of mice 
can influence the results (i.e. number of siblings in individual families). Ten microsatellites 
were sufficient enough to determine the population structure, but for the future study more 
polymorphic marker are recommended. Microsatellite DNA variation reflects the impact of 
evolutionary forces (mutation, migration, genetic drift and inbreeding) that affect overall 
genetic variation and the high rates of change at microsatellite loci make them suitable to 
reconstruct recent changes in population structure (Goldstein and Schlotterer, 1999). On the 
other hand, microsatellites are neutral and so they don’t provide direct measure of the genetic 
diversity relevant to natural selection and adaption (Frankham et al. 2002). As the wood mice 
have a short life span, more frequent sampling is recommended and it should not exceed the 
period of two years, as this can affect the population structure. It is important to include 
ecological and geographical factors into the analysis, as they play an important part as they 
may drive patterns of genetic diversity. Many of the software programs used in population 
genetics studies now investigate how ecological factors interact with genetic diversity. Highly 
variable microsatellite loci are useful genetic markers especially when conducting a pilot 
study on species, when only a little background information is available.  
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Chapter 4:  
An investigation into the prevalence of Toxoplasma gondii infection 
in wood mice (Apodemus sylvaticus) in Malham Tarn Nature Reserve 
  
65 
4.1. Introduction  
 
  Toxoplasma gondii is an apicomplexan parasite with a global distribution. The members of 
the family Felidae are the only known definitive host (Dubey and Frenkel, 1972; Hutchinson, 
1965). It infects a whole range of warm-blooded vertebrates, including domestic and game 
animals, birds and humans (Dubey and Beattie, 1988). There are three main routes of 
transmission: via oocysts shed in faeces of the definitive hosts, ingestion of tissue cysts and 
congenital transmission. However, the elucidation of these routes during the past three 
decades has not elucidated which of these routes is more important epidemiologically. The 
effect of vertical transmission on the overall spread of the parasite is not clear as its 
magnitude may depend on the host species, as well as on the parasite strain. The most general 
mode of spread of toxoplasmosis depends on the presence of the oocysts, which are produced 
only by the intestinal stages in the cat and the other members of the family Felidae. 
Experimental studies demonstrate the ability of T. gondii to be transmitted congenitally, but 
few studies have investigated the frequency of this transmission route in natural populations. 
Murine models are of particular interest when studying the epidemiology of Toxoplasma as 
the cat often predates on small rodents. Experimental infection of both house mouse and the 
wood mouse with infective oocysts demonstrated a high frequency of vertical transmission 
(Thierman et al. 1957, Beverley et al. 1959, Remington et al. 1961, Owen and Trees, 1998; 
Marshall et al. 2004, Murphy et al. 2008). The results indicated that vertical transmission in 
A. sylvaticus and M. musculus is extremely efficient and probably endures for the life of the 
breeding female. This mechanism favours parasite transmission and dispersion by providing a 
potential reservoir of infection in hosts predated by the cat. In a natural population of house 
mice, vertical transmission occurred in 75% of pregnancies , but on the contrary, in BALB/c 
laboratory mice, and in other species such as rats Rattus sp. and hamsters Mesocricetus 
auratus, vertical transmission occurs essentially when infection is acquired during pregnancy, 
but is less likely in chronically infected individuals (Freyre et al. 2006). Calomys callosus, a 
rodent of the family Cricetidae widely distributed in Central Brazil, has been used in previous 
studies, demonstrating its high susceptibility to T. gondii infection (Favoreto et al. 1998). 
Also, this rodent was shown to be a suitable experimental model to study the dynamics of 
congenital toxoplasmosis, due to the ability of a highly virulent strain of T. gondii (RH strain) 
to infect trophoblast cells during the early blastocyst-endometrial relationship. The 
seroprevalence of T. gondii in rats (Rattus norvegicus and R. flavipectus) was investigated in 
66 
Guangzhou, southern China, between November 2009 and January 2010. In total, 217 rat 
serum samples were collected; antibodies to T. gondii were detected by the modified 
agglutination test (MAT), and 7 (3.2%) were found positive (Yin et al. 2010). Antibodies to 
Toxoplasma gondii were investigated in serum samples of field mice, Microtus fortis, from 
Yuanjiang, Hunan Province, People's Republic of China. The modified agglutination test 
(MAT) incorporating formalin-fixed whole tachyzoites and mercaptoethanol was used to 
determine antibodies. Antibodies to T. gondii (MAT > or = 1:20) were found in 36 (29%) of 
124 trapped mice (Zhang et al. 2004).  
Toxoplasma was also maintained within the captive rat population in the absence of cats at a 
prevalence, intensity, and age and sex distribution similar to that of the farmstead rat 
populations. These results suggest, firstly, that Toxoplasma can be perpetuated within wild rat 
populations without the sympatric presence of cats and secondly, that the congenital route is 
the predominant route of transmission in wild rats. This study concludes that wild rats 
represent a significant and persistent wildlife intermediate host reservoir for toxoplasmosis. 
The prevalence of congenital transmission is low in humans ranging between 0.01 and 1% of 
live births (Tenter et al. 2000), but is much higher in other mammalian species such as sheep 
(Hide et al. 2009; Innes et al. 2009). However, this route could explain possible high 
prevalence of T. gondii in some areas with very low cat densities or in marine mammals. In 
rodents this route of transmission may be more important. Little is known of T. gondii 
genotypes and prevalence in wild populations. The majority of epidemiological studies in 
wild animals have been based on serological diagnostic methods (Franti et al. 1976; Jackson, 
1986; Webster, 1994; Dubey et al. 1995; Smith and Frenkel, 1995; Hejlicek et al. 1997; Jeon 
and Yong, 2000; Jakubek et al. 2001; Yin, 2010). PCR–based studies have shown higher 
prevalence in some wild mice populations with prevalences ranging from 10.4% (Vujanic et 
al. 2011), 13.6% (Kijlstra et al. 2008), 29% (Zhang et al. 2004) up to 40.78% (Thomasson et 
al. 2011) and 59% (Marshall et al. 2004). The aims of this study were to investigate the 
detailed distribution of T. gondii infection in a series of localised populations of A. sylvaticus 
collected in a systematic manner (Boyce et al. 2012; Boyce et al. 2013). These populations 
reside in an area relatively free of cats with density lower than 2.5 cats per km
2 
(Hughes et al. 
2008) but where previous studies have demonstrated a high prevalence of T. gondii infection 
(Thomasson et al. 2011). The objectives were to investigate host genotype and spatial 
location in relation to T. gondii infection and genotypes. In this study we investigated the 
prevalence of T. gondii in a wild population of Apodemus sylvaticus and combined 
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commonly used T. gondii markers and novel tools used in population genetics to investigate 
the rodent population structure at the family level.  
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4.2. Materials and Methods 
   A total of 126 wood mice (A. sylvaticus) were captured, using Longworth Traps, from the 
surrounding area of Malham Tarn Field Centre (Tarn Woods, Tarn Fen, Ha Mire and Spiggot 
Hill), North Yorkshire between the periods October 2009 - October 2011 (full protocol is 
described in Chapter 2). The brains were dissected out, using sterile technique, and 
transferred into sterile tubes containing 400 μl of lysis buffer and stored at −20 °C. Protein 
was digested and DNA extracted using proteinase K followed by a phenol/chloroform 
extraction (Duncanson et al. 2001). Extracted DNA was tested for mammalian tubulin to 
ensure viability for PCR (Terry et al. 2001). This confirmed the quality of DNA as suitable to 
undergo PCR, and eliminated the chance of obtaining false negatives due to PCR inhibition.   
    Detection of T. gondii was carried out using nested PCR amplification of the Surface 
Antigen Genes 1 (Savva et al. 1990) as modified by Morley et al. (2005).  DNA samples 
were also tested for T. gondii by nested PCR amplification of the repetitive and conserved 
gene B1 (Jones et al. 1999). PCR positive brain tissues were used for genotyping using three 
RFLP markers (SAG2, SAG3 and GRA6) as described by Su et al. (2006). All PCR reactions 
were performed using published primer sequences. All samples were tested a minimum of 
three times with each marker. Samples that were confirmed to be positive three times were 
further used for RFLP genotyping with SAG2, SAG3 and GRA6 markers. DNA from sheep 
known to be infected with T. gondii was used as a positive control, sterile water as negative 
control. All PCR reactions were performed using a Stratagene ROBOCYCLER 
TM
. PCR 
products were run on 1.5% agarose gel containing GELRED and visualized on an Alpha 
imager 
TM 
1220. The risk of contamination was minimized by the use of different locations in 
each phase of the methodology. For the majority of genotyping reactions, the Type II strain 
was used as the positive control (as this is the most predominant type in Europe) so that the 
occurrence of unusual Type I and Type III strains being derived from contamination by the 
control could be ruled out. To avoid confusion in type calling caused by partial digestion, 
careful analysis of band sizes, from all markers, was carried out in relation to published 
marker DNA sequences and other studies. 
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Microsatellite analysis 
  DNA extracted from 126 A. sylvaticus brain samples was prepared for microsatellite 
genotyping. All 9 A. sylvaticus loci have been amplified and genotyped (Makova, 1998). One 
Mus domesticus microsatellite (MS19) was used (full protocol described in Chapter 3). PCR 
products were then mixed with formamide and LIZ
TM 
standard size marker and genotyped 
using a GENOTYPER (Applied Biosystems 3130 Genetic Analyser) to gain allele sizes 
relative to the internal size standard. Samples for each locus were scored with PEAK 
SCANNER 
TM
 v1.0, that identifies peaks and fragment sizes for application-specific capillary 
electrophoresis assays. The program STRUCTURE 2.3.3 (Pritchard, et al. 2000) was used for 
using multi-locus genotype data to investigate population structure. The program MICRO-
CHECKER 2.2.3 (Van Oosterhout et al. 2004) was used to check for the absence of 
microsatellite null alleles and scoring errors.   Program COLONY v2.0.5.0 (Wang, 2004) was 
used to estimate the full- and half-sib relationships of mice.  
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4.3 Results 
To examine the prevalence of T. gondii in this population of A. sylvaticus, a series of PCR 
reactions were conducted using T. gondii specific PCR primers. DNA was successfully 
isolated from 126 mice brains and tested for the absence of PCR inhibition using 
amplification of the α-tubulin gene.  
Mammalian α- tubulin PCR 
All 126 samples showed a high amplification of the α-tubulin gene (Figure 4.1.). This 
confirmed the quality of DNA to undergo PCR and eliminated the chance of obtaining a false 
negative due to PCR inhibition. Sheep DNA was used as a positive control for tubulin PCR, 
sterile water as the negative control.   
 
Figure 4.1 Example of mammalian α-tubulin PCR of mice individuals (1-4) on a 1% (w/v) 
agarose gel. M = Hyperladdder I (Bioline), +ve denotes positive control, Lanes 3 – 6 = 
successful PCR amplification in mouse samples, -ve denotes water negative control. 
 
Amplification of B1 Gene  
B1 gene was successfully amplified in 12 out of 126 samples (Prevalence of 9.52%, 95% CI: 
5.40% - 16.04%). Field samples were considered positive by B1-PCR when second round 
PCR produced the predicted 96 bp band. The nested reaction did not yield product from 
either the first or the second-round negative controls. The B1 gene is a 35-fold repetitive gene 
sequence with unknown function. It is highly conserved which makes it an ideal target for 
PCR amplification, but this was not confirmed in our case. Other markers were more reliable 
and showed better amplification of parasite DNA.  
      M    +ve   1       2       3       4      -ve 
1200 bp 
200 bp 
400 bp 
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Figure 4.2 An example of B1 PCR 2.5% agarose gel electrophoresis of Malham mice 69-78, 
M=Hyperladder V Bioline marker, Lane 2 = positive control, Lanes 3-12 = tested samples, 
Lane 20 = negative control. Sample 75 shows positive amplification of the B1 gene. 
 
SAG1 PCR Amplification 
126 brains were available for testing from wood mice. The T. gondii SAG1 PCR assay was 
positive in 44 animals which gave an infection rate of 34.92% (95% CI: 27.1% - 43.6%). An 
example of successful detection of T. gondii can be seen from Figure 4.3. Following the 
initial first round PCR using the external primers a product of 914 bp is amplified. This 
product was then used in the second round of the PCR assay to give a highly specific product 
of 522 bp. 
 
 
Figure 4.3 SAG1 PCR of wood mice on 1.5% agarose gel. Lane 1, Hyperladder 100 bp 
(Bioline), Lane 2, positive control, Lanes 4, 5, 6, 7,8,10,12, 15 are T. gondii positive samples, 
Lane 16, negative control.  
 
M   +ve    69     70      71     72      73   74    75     76      77   78                                 -ve          
 
    100 bp 
96 bp 
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SAG2 PCR Amplification 
A total of 126 samples were collected and tested for amplification of the SAG2 gene. The 
SAG2 locus has two polymorphic sites at the 3
/
 and 5
/
 ends for type II and type III 
identification (Howe et al. 1997). Primers were selected to separately amplify 5
/
 and 3
/
 ends 
of the T. gondii SAG2 locus as 242 bp and 222 bp products. Any sample found to be positive 
for only one fragment was re-amplified in order to confirm status, and only samples found 
positive for both fragments were later genotyped. Amplification of both ends of the SAG2 
gene was successful in all 44 positive samples (Prevalence of 34.92%, 95% CI: 27.1% - 
43.6%). Negative controls remained free of amplified products.  
 
 
 
Figure 4.3 Nested-PCR amplification of SAG2 5
/
 end locus, Lane 1 = Hyperladder II 
(Bioline), Lane 2 - positive control, Lane 3 - negative control. Lanes 6, 9, 11, 12, 13 and 14 
are positive samples.  
 
Howe et al. (1997) previously described a method for the typing of T. gondii by restriction 
analysis of two PCR fragments derived from 5
/
 and 3
/
 regions of the SAG2 gene, using the 
enzymes MboI and HhaI, respectively. In this way, T. gondii can be classified as type I (not 
cut by either MboI or HhaI), type II (cut by HhaI but not by MboI) or type III (cut by MboI 
but not by HhaI). Nested PCR for 3
/
and 5
/
 ends of SAG2 gene demonstrated that after 
digestion of the amplicons with enzymes MboI and HhaI 16 samples had Type II alleles, 3 
had Type III and 18 were mixtures of SAG2 Type II and Type III (Table 4.2). No Type I was 
present at the SAG2 locus. In four mice we were not able to identify the genotype. 
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Figure 4.4 Agarose gel electrophoresis analysis of SAG2 PCR amplification products and 
restriction digests from T. gondii infected samples. Image A shows PCR-RFLP analysis of 
the 5
/
end flanking region, Lane 1 is Hyperladder II (Bioline), Lane 2 is undigested control. 
Sample in Lane 5 was digested with MboI what indicates Type III. Undigested samples in 
Lanes 3, 4 and 6 are possible type I or II. Image B shows PCR-RFLP analysis of the 3
/
end 
flanking region, Lane 1 is Hyperladder II (Bioline), and Lane 2 is undigested control. 
Samples in Lanes 4, 6, 7 and 8 were digested with HhaI so that means they are Type II. 
Samples in Lanes 3 and 5 were uncut and are possible type I or III.  
 
SAG3 PCR Amplification 
Genetic analysis of the SAG3 locus was performed to determine the prevalence of the 
different genotypes of T. gondii (strain types I, II, and III) in wood mice from Malham Tarn 
area. 226 bp products at the end of second round of amplification were considered PCR 
positive (Figure 4.5). Genetic analysis was performed by PCR-RFLP at the SAG3 locus of T. 
gondii. The amplified SAG3 products were digested with AlwNI and NciI (full protocol is 
available in Chapter 2). Unique RFLP patterns generated by these enzymes can be used to 
identify SAG3 alleles previously associated with Type I, II or III genotypes (examples are 
presented in Figure 4.6).  NciI cuts Type I twice (99bp, 65bp and 62bp), Type II stays uncut, 
Type III cuts once (161 bp, 65bp), AlwnI cuts Type II only (128, 98bp); Types I and III stay 
uncut. Complete characterization of the SAG3 gene was successful in 44 samples (34.92%, 
95% CI: 27.1%-43.6%).  The digestion of the SAG3 PCR products with AlwNI and NciI 
revealed Type III genotype in 4 mice, Type II in 13 mice, 8 mice had the mixture of Type II 
and Type III, 1 mouse had the combination of Type I and Type III and 16 mice had all three 
types present at SAG3 locus. Results are summarized in Table 4.2.   
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Figure 4.5 PCR amplification of SAG3 locus. Lane 1= Hyperladdder II (Bioline), Lane 2 = 
negative control, Lane 3 = positive control, Lanes 4-13 =positive samples.  
 
 
 
 
 
Figure 4.6 Agarose gel (2.5%) electrophoresis analysis of SAG3 PCR amplification products 
and restriction digests from T. gondii infected samples. Lane 1- Hyperladder 50bp (Bioline),  
Lane 3-  mixed Type I and Type III positive controls + NciI - mixed patterns, Lane 6 – 
Undigested SAG3 control (no enzymes added), Lane 7- Type II control  + AlwnI, Lane 9 – 
Type I andIII,  Lane 11 – Sample 106 + NciI – shows mixed Type I and III, Lane 12 – 
Sample 97 + NciI – bands disappeared, Lane 13- Sample 75 + NciI – shows mixed Type I and 
III, Lane 15- Sample 106 + AlwnI – Type II present, Lane 16 – Sample 97 + AlwnI- cut Type 
II present, Lane 17- sample 75 + AlwnI – uncut- type II not present 
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GRA6 PCR Amplification 
GRA6 nested PCR was performed using published sequences: F1: 
ATTTGTGTTTCCGAGCAGG, R1: GCACCTTCGCTTGTGGT and F2: 
TTCCGAGCAGGTGACC, R2: GCCGAAGAGTTGACATAG (Khan et al. 2005).  A 344 bp 
product at the end of the second round was considered to be positive (Figure 4.7A). For 
RFLP typing, 5 µl of nested PCR products were treated with MseI in total volume of 20 µl at 
37˚C for 1 h and then digested samples were resolved on a 2.5% agarose gel to reveal 
banding patterns. Complete characterization of the GRA6 gene was successful in 44 samples. 
Genotyping of the GRA6 locus with MseI revealed that 15 mice had Type II patterns, 14 had 
Type III and 15 mice contained the mixture of Type II and Type III patterns. No Type I allele 
was observed at the GRA6 locus (Image 4.7B). A summary of results is presented in Table 
4.2. 
 
              
 
Figure 4.7 Image A: PCR amplification of GRA6 locus. Lane 1 is the negative control, Lane 
2 –positive control, Lanes 3-6 are T. gondii positive samples. Lane 7 is the 50 bp Hyperladder 
(Bioline). Image B shows PCR-RFLP analysis of GRA6 PCR products. Lane 1 is the 50 bp 
Hyperladder (Bioline), Lane 2 represents undigested control,  Lanes 3, 4 and 9 (very weak 
bottom bands) show mixed infections of Type II and III (with some partial digests, indicating 
that  possibly Type I is present too), Lanes 5, 6, 7 and 8 show digest patterns typical for Type 
II (Khan et al. 2005).   
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Overall prevalence of T. gondii prevalence by multilocus PCR 
In total forty four samples gave positive reactions with four T. gondii specific markers SAG1, 
SAG2, SAG3 and GRA6. Thus an infection rate of 34.92% (95% CI: 27.1%-43.6%) was 
found.  In total, out of 44 positive mice from Malham Tarn, 5 had Type II alleles at all three 
tested loci, 23 had the combination of Type II and Type III alleles and 16 had all three 
genotypes present. Table 4.2 presents the RFLP results for all 44 positive mice using genetic 
markers GRA6, SAG2, and SAG3 used as described elsewhere (Khan et al. 2005; Su et al. 
2006). Detailed analysis of the RFLP patterns for the three loci showed that for many samples 
a mixture was the only possible interpretation. A total of 17 juveniles, 65 young adults and 44 
adults were present in this cohort of 126 of which 7 (41.18%), 27 (41.54%) and 10 (22.72%) 
were PCR positive for T. gondii (Table 4.1, Figure 4.9).  
 
Table 4.1 The PCR analysis of the brain tissue from A. sylvaticus from Malham Tarn. PCR 
analysis was conducted with 4 T. gondii specific markers, SAG1, SAG2, SAG3 and GRA6 
(Su et al. 2006). 
 
Age 
Group 
Juveniles Young adults Adults Total 
Gender No. 
tested 
No. 
positives 
(%) 
No. 
tested 
No. 
positives 
(%) 
No. 
tested 
No. 
positives 
(%) 
No. 
tested 
No. positives 
(%) 
Males 7 4   
(57.14) 
35 12 
(34.86) 
34 8  
(23.53) 
76  24 (31.58) 
Females 10 3   
(30.00) 
30 15 
(50.00) 
10 2  
(20.00) 
50 20  (40.0) 
Total 17 7  
(41.18) 
65 27 
(41.54) 
44 10 
(22.72) 
126   44 (34.92) 
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Table 4.2 Genotypes of T. gondii in wood mice from the study site (NA – marker was not 
able to be amplified). Genotypes defined as listed previously (Su et al. 2006) 
 
Mouse No.           GRA6 
PCR-RFLP Markers 
SAG2 (Combined 5/ and 3/) SAG3 
6 II II  II 
7 III III  I, II &III 
23 III II &III  II 
28 II II &III  II 
31 III II &III  II 
32 III II &III  II 
43 II &III II II &III 
44 II NA NA 
52 II II  II 
53 II II II 
54 II &III II &III II 
59 III NA NA 
60 II II II 
71 III III I, II &III 
72 III II &III II &III 
75 II II &III I &III 
78 II &III II &III II &III 
84 III II &III I, II &III 
85 II &III II &III II &III 
86 II &III II &III II&III 
87 II  &III II &III I, II &III 
88 II II I, II &III 
89 II &III II  II&III 
97 II II &III  II &III 
99 II &III II &III I, II &III 
78 
102 II &III II &III III 
103 II &III II &III III 
106 III II &III I, II &III 
108 II &III III II 
110 III III I, II &III 
111 II &III Not II or III II &III 
112 II &III III III 
113 II  &III III I, II &III 
114 II III I, II &III 
115 II II I, II &III 
116 II II I, II &III 
117 II II II 
118 III II II 
119 II II II 
120 III II I, II &III 
121 II II III 
123 III II I, II &III 
124 III II I, II &III 
125 II  &III II I, II &III 
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Mice collected in autumn showed higher infection rates when compared with mice from the 
spring and summer samplings (Figure 4.8). Interestingly, the mice collected in autumn 2011 
had almost two time higher prevalences than the mice collected in the same period the year 
before (Figure 4.8). 
 
 Figure 4.8 Seasonal changes in prevalence of T. gondii in wood mice  
 
No significant age prevalence effect was detected in sampled mice, P = 0.23 (Figure 4.9). 
 
Figure 4.9 The prevalence of T. gondii in different age groups of wood mice 
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A total of 24/76 (31.58%, 95% CI: 22.19%-42.74%) of male and 20/50 (40%, 95% CI: 
27.59%-53.84%) of female mice were found to be positive for T. gondii. No significant 
difference was found in prevalence in males and females with χ2 =0.863, D.F. = 1, P = 0.353 
(Figure 4.10). 
 
Figure 4.10 The prevalence of T. gondii by locality and sex 
 
To understand the distribution of T. gondii in mice from different collection sites, the 
prevalence was calculated for each site (Table 4.3). The null hypothesis of no significant 
association between prevalence of T. gondii infection and location capture was tested. While 
variation in prevalence was seen at each site, this was not significant (χ2 = 5.75, D.F = 3, P= 
0.125). At some sites (e.g. Ha Mire) prevalence that appeared to differ from others, individual 
pairwise relationships between sites and prevalence were also tested. Only the relationship 
between Ha Mire and Tarn Fen showed a weak significant association of prevalence with site 
(Fisher Exact Test, P = 0.048) while all other combinations did not.  
 
Table 4.3 Prevalence of T. gondii infected A. sylvaticus at sites of collection. 
Location 
 
No. tested 
 
No. T. gondii 
positives 
Prevalence (%) 
 
Ha Mire 30 15 50.00 
Tarn Fen 23 5 21.74 
Tarn Woods 56 20 35.71 
Spiggot Hill 17 4 23.53 
Total  126  44 34.92 
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To understand the distribution of T. gondii in mice from different genetic populations, as 
inferred from STRUCTURE (see Chapter 3), the prevalence was calculated for each 
population (Table 4.4). Bayesian clustering analysis and assignment tests indicated the four 
well defined populations (R1, R2, B and G) are present at four sampling sites. Three 
localities, Ha Mire, Tarn Fen and Tarn Woods were inhabited by all four populations, only 
Spiggot Hill consisted of two populations, R1 and R2. There was a significant difference 
across all genetic populations for T. gondii prevalence (χ2 =7.950, D.F. = 2, P = 0.018). The 
differences in prevalences for some groups were greater than others, so we tested individual 
for individual pair – wise relationship.  Group R1 had a prevalence that showed a highly 
significant association between each genetic group and prevalence when compared with 
Group G (Fisher Exact Test (FET), P = 0.003) and Group B (FET, P = 0.0012) but other 
combinations were not significant (R1 vs R2, FET, P = 0.11; R2 vs G, FET, P = 0.44; R2 vs 
B, FET, P = 0.15; G vs B, FET, P = 0.6) 
 
Population No. tested No. positive 
for T.gondii 
Prevalence 
(%) 
R1 37 5 13.51 
R2 25 8 32.00 
G 40 18 45.00 
B 24 13 54.17 
 
Table 4.4 Prevalence of T. gondii infected A. sylvaticus with respect to genetic population. 
R1 R2, G and B represent the populations as designated using STRUCTURE. These data 
suggest that infection status of A. sylvaticus is more closely related to genetic population 
structure than to location of capture. 
 
Some previous studies have suggested that vertical transmission of T. gondii might be 
important in natural populations of mice (Owen and Trees, 1998; Hide et al. 2009; 
Thomasson et al. 2011) in which case a relationship should be detectable between infection 
and family line (Morley et al. 2005). To address this question, families were assigned to the 
mice using the program COLONY and the relationship with T. gondii infection examined 
(Table 4.5). The COLONY program can be used to infer full- and half-sib relationships, 
assign parentage, infer mating system (polygamous/monogamous) and reproductive skew in 
both diploid and haplo-diploid species. Twenty two families of wood mice were identified in 
this collection in the study site. These comprised 4 families of full-sibs and 18 families of 
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half-sibs based, as advised in the program literature, on mice being considered to be siblings 
if the likelihood probability was more than 0.85. Each identified family was quite small 
comprising only a few mice (n=2 to n=10).  A range of prevalences were found in each of the 
families, for example, six families had 0% prevalence and one family had 85.7%. The 
average prevalence in families was 32.55%.  This suggests differences in prevalence of T. 
gondii between families and could support the notion of a mechanism that maintains 
transmission within families. However, this hypothesis was not significant (χ2 = 0.284, D.F. 
= 1, P = 0.5943). However this result could be confounded by the very small number of mice 
in each family. Positive siblings had one, two or all three genotypes present; in some cases 
the same T. gondii genotype was present in all members of the same family.  
 
Table 4.5 Prevalence of T. gondii and genotypes present in 22 individual A. sylvaticus 
families assigned by COLONY. Only four families (19-22) are fullsib siblings, where 
likehood probability was 1.   
Family Number 
of 
siblings 
Males Females T. gondii 
positive 
T. gondii 
prevalence 
(%) 
Genotypes 
Present 
1 6 0 6 3 50 II, III 
2 4 0 4 2 50 I,II,III 
3 7 7 0 4 57.14 II,III 
4 3 3 0 2 66.66 II,III 
5 5 5 0 2 40 II,III 
6 3 3 0 1 33.33 II,III 
7 5 0 5 2 40 II 
8 3 3 0 1 33.33 II 
9 5 1 4 1 20 II 
10 7 1 6 6 85.71 I,II,III 
11 4 4 0 1 25 II 
12 3 0 3 1 33.33 III 
13 10 10 0 4 40 I,II,III 
14 6 6 0 1 16.67 II,III 
15 6 4 2 3 50 I,II,III 
16 4 4 0 0 0 0 
17 3 3 0 0 0 0 
18 3 3 0 0 0 0 
19 2 1 1 1 50 II,III 
20 2 1 1 0 0 0 
21 2 1 1 0 0 0 
22 2 1 1 0 0 0 
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4.4 Discussion  
   The results of this study demonstrate that T. gondii has well-established population in wood 
mice in Malham Tarn Nature Reserve. We detected a relatively high prevalence of the 
parasite, with 34.92% (95% CI: 27.14% - 43.59%) of all mice infected in an area with a small 
number of cats (Hughes et al. 2008). This prevalence was lower than the one observed by 
Thomasson et al. (2011) in her earlier study from the same locality, when 40.78% of mice 
were T. gondii  positive, but this is not significantly different (P = 0.51). Most reports of T. 
gondii infections in wildlife are from serosurveys. One of the main limitations of 
serosurveillance is inadequate test sensitivity and so many infections could be undetected. 
Our results are in contrast with some previously reported data on wild rodents from Germany, 
when they found 0% prevalence in field mice, shrews and voles (Hermann et al. 2012). The 
prevalences in small mammals in Europe vary, depending upon the species and country 
where the research was done. In a similar PCR based recent study, 0.7% of Microtus arvalis 
in Austria (Fuehrer, 2010) were positive. High seroprevalences were detected in rodents in 
Europe in Ardennes (France), the prevalence in shrews (Sorex sp.) was 60%, in moles (Talpa 
europaea) 39% and in water voles (Arvicola terrestris) 39% (Alfonso et al. 2007), in North 
America in the Peromyscus spp., (between 23 – 31 %) while the species Mus musculus and 
M. californicus were negative (Dabritz et al. 2008). Similar seroprevalence has been detected 
in wild carnivores, 33% prevalence in polecats (Mustela putorius), 18% in stone martens 
(Martes foina) and 17% in pine martens (Martes martes), Hejlicek et al. (1997), 56% in red 
foxes (Murphy et al. 2007),  43% in artic foxes (Vulpes lagopus, Prestrud et al. 2008) and 
84.7% of foxes (Vulpes vulpes) from Saxony-Anhalt and 74.5% of foxes from Brandenburg  
were seropositive (Hermann et al. 2012). These carnivores often prey on rodents, so the 
prevalence is expected to be higher due to the cumulative effect of consuming infected prey. 
  Little is known of genotypes of T. gondii circulating in wild animal populations. As T. 
gondii genotyping extends to samples from unstudied geographic regions, researchers report 
an increasing number of atypical strains with newly identiﬁed alleles (Dubey et al. 2007, 
Parmeswaran et al. 2010).  In our study, only five mice had a Type II genotype on all three 
studied loci, the other mice had two or all three genotypes present. In previous study from 
this area (Thomasson et al. 2011) all three genotypes were detected, only with one difference, 
that always only one genotype was present in each mouse at the same time. Detailed analysis 
of the RFLP patterns showed that a mixture was the only possible interpretation. This 
indicates that mixed infections are more common in natural populations than previously 
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thought. A high rate of mixed infection in intermediate hosts can lead to increased numbers 
of recombinant genotypes if the final host is present. The mice probably get infected by 
ingesting oocysts with water or food (insects, grains), by oocyst- contaminated soil or by 
vertical transmission, either transplacentally or through ingestion of milk.  
   Numerous studies have demonstrated that T. gondii is capable of vertical transmission in a 
variety of hosts, including humans (Eichenwald, 1948; Thiermannn, 1957; Beverley, 1959; 
Remington et al. 1961; De Roever- Bonnet, 1969; Owen and Trees, 1998; Duncanson et al. 
2001). Vertical transmission could possibly explain high prevalence in arctic foxes (Prestrud 
et. al., 2007) where the definitive host is not present and the most important intermediate 
hosts in this ecosystem, Svalbard reindeers and voles have 0% prevalence and so the presence 
of oocysts are probably not the main route of transmission. If the infection in Malham Tarn 
area was caused by oocysts in the environment, we would expect higher prevalence in older 
individuals, because they had greater opportunity to contract the infection. But in our study 
there was no significant age prevalence effect and no increased prevalence with age was 
observed. In contrast adults had lower prevalence when compared with young adults and 
juveniles.  Considering that mice have a relatively short life span, this might seem obvious, 
unlike in larger animals, where age prevalence can be established. No significant difference 
was found in prevalence in males and females (χ2 = 0.863, D.F. = 1, P = 0.353), as higher 
prevalence would be expected in males if the infection was contracted from the environment, 
as the males tend to have larger territories and explore the environment more than females.   
No differences in sex specific prevalence are expected if T. gondii infection is transmitted 
congenitally. Interestingly Tarn Fen was the only site with 0% prevalence in males. Our data 
suggest that infection status of A. sylvaticus is more closely related to genetic population 
structure. There was a significant difference between each genetic population (χ2 =7.950, 
D.F. = 2, P= 0.018). For example, population R1 has the lowest prevalence and has only one 
individual mouse with a Type I genotype, while the populations B and G have all three 
genotypes present. Most of the individuals from the R1 population occupy Spiggot Hill and 
Ha Mire. Spiggot Hill has a much more restricted diversity of genetic groups suggesting that 
there is less migration to that site. This area lacks trees and is not very suitable to sustain a 
very large population, indicating that the habitat structure of the landscape allows a slow 
migration of mice from one population to another, serving as a source population. B and G 
populations are areas covered with woodlands and tree canopies with high humidity and both 
have very suitable conditions to sustain large population of rodents. There are several 
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possible interpretations for this. Firstly, different populations have some genetic differences 
in susceptibility of infection. Population B had the highest prevalence of T. gondii (54.17%). 
This population is the ancestral source population from which about 40-80 ago years 
diverged R2 and subsequently from it R1 was formed (see chapter 3). Probably, at the same 
time or later, population G separated from B. Two populations that originated directly from 
the ancestral one have much higher prevalences than R1. In total 12 migrants were identified 
in the wood mouse population structures. From these migrants five were T. gondii positive, 
one from population R1 and four originated in R2. It is known that the parasite is capable of 
altering the natural behaviour of the host to favour its transmission in the environment 
(Webster, 2001). It is possible that the infected mice from the population B were migrants too 
which explored more distant habitats and started a new population.  As far as we can 
ascertain, there are no examples of this migration scenario reported, although laboratory 
studies have shown that inbred lines of rodents differ in their susceptibility to T. gondii (Li et 
al. 2012; Gao et al. 2015). Previous studies on sheep (Morley et al. 2005, 2008) have shown 
that when pedigree analysis is carried out on family lineages, there is evidence that the 
parasite is unevenly distributed amongst families even when they are exposed to the same 
environment. We tried to further analyse these population on family levels but there was no 
significant difference in prevalence of T. gondii between families and the very large 95% 
confidence intervals suggested that this was almost certainly due to small sample sizes of 
mice in each family. Most of the families were represented by only two members, the largest 
was seven. We did see uneven distribution of infection in different families and in some 
families the same genotypes were present across siblings, but this was not statistically 
significant. To conduct future work on such a very detailed family based analysis like this, on 
natural populations of Apodemus, will involve sampling on a considerably greater scale.  
Nested PCR is more sensitive than conventional PCR but is not preferred for routine 
diagnosis because it requires two PCR amplification steps. This makes the work more 
intensive and expensive, with a higher risk of contamination, while it is also more time-
consuming. The total amount of DNA from the pathogen will vary among samples in routine 
practice. One of the major difficulties in the detection of T. gondi in animal tissues is the 
limitation of sample size, as the parasite may be present in the unexamined tissues.    
The majority of the previously reported studies analysed only strains from a small fraction 
(i.e. humans and domestic animals). A sample set that is highly biased towards a certain host 
species, towards cases of disease or both increases the likelihood of oversampling particular 
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genotypes. It is also possible that limitations in the discriminatory power of the markers used 
in these early studies missed much of the genetic diversity present.  A more diverse 
population structure was later confirmed as typing techniques with increased resolutions were 
applied to isolates more representative of T. gondii’s geographic distribution. A few wildlife 
samples that were included in Howe and Sibley study (1995) were genetically distinct from 
the three major clones, with some of them potentially representing recombinants of the three 
clonotypes. This suggested that a productive sexual stage for this parasite exists in nature and 
the wider sampling, more representative of T. gondii’s broad host range, would reveal much 
greater genetic diversity. However, without sequencing, definitive classification as 
archetypical strain is not possible in regions where generic diversity is substantial. The 
dominance of a limited number of genotypes in certain sample sets and from widely 
geographically dispersed locations is remarkable, but it does not lead to classification as a 
clonal population (Ajzenberg et al. 2002).  In some cases the population is highly clonal, in 
others appears to be epidemic and overall, should be classified as intermediate. To what 
degree either clonal or sexual propagation can be detected in a sample set is dependent on 
several factors including the number and genomic location, of genetic markers used, the 
polymorphism present in the markers, the resolution of the techniques used to detect 
polymorphism and the host and geographic location of origin of the isolates. It is possible that 
wildlife samples are perceived to be more genetically diverse than domestic samples because 
more extensive and sensitive sampling has been applied to the more recently acquired 
wildlife isolates or a highly clinically biased sample set has been used repeatedly in multiple 
studies to represent strains in domestic animals and humans.  
 The role of the cats in transmission is questionable as the infective state occurs for around 2 
weeks and therefore all infective oocysts must be released during this period. In this study 
mixed infections were detected which would mean that a higher number of cats was present 
in this area or a single cat was infected with multiple strains or a sexual recombination in the 
cat could generate new combinations of genotypes.  There is little evidence to link infection 
in wood mice to cats, especially when the density of cats is very low. Rodents are unable to 
acquire the disease by carnivory so the congenital transmission if one of the possible 
explanation although is generally considered to be relatively rare (Tenter et al. 
2000).  Consequently, T. gondii infection levels could theoretically persist within a mouse 
population in the absence of felid-derived oocysts. The only study to date, to have 
investigated this route of transmission in a natural mammalian population showed that high 
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levels (61%) of congenital transmission in sheep (Duncanson et al. 2001) and urban mice 
(Marshall et al. 2004) occurs. It is clear from the highly clonal structure of T. gondii 
genotypes that the parasite must have succeeded in generating asexual transmission cycles 
which frequently bypass the definitive host, and this points at transmission in food (Aspinall 
et al. 2001) or vertical transmission (Marshall et al. 2004). 
Williams et al. (2004) detected higher infection rates in Charollais sheep when compared to 
other pedigrees raising the possibility that pathogenesis varies with host breed or families. 
Laboratory studies have shown that inbred lines differ in their susceptibility to T. gondii (Li 
et al. 2012, Zhao et al. 2013). Another explanation is that T. gondii is being selectively 
transmitted through related lineages. Despite the detailed analysis conducted here, it is clear 
that it will remain difficult to investigate the importance of the different transmission routes 
of T. gondii infection in natural population of wild animals.  
Populations R1 and R2 which were found only in Spiggot Hill do not seem to appear 
separately in any of the geographic regions and it is difficult to estimate how genetically 
distant is R1 from R2. Spiggot Hill has a much more restricted diversity of genetic groups 
suggesting that there is less migration to and from that site.  Family analysis using COLONY 
also showed a small number of examples of members of the same family that were trapped in 
different locations. What is surprising is that there are genetic groups and there must be some 
mating barriers in this area and they are not based on geographical location as can be seen by 
the geographical spread of mice from different groups. There might be behavioural barriers to 
mating (e.g. clans, families) or there might be more complex ecological processes occurring 
such as annual over winter population bottlenecks followed by spring/summer mice 
migration. This is a complex ecosystem and there is not enough data to look at such a 
question. One of the weaknesses is the limitation of the STRUCTURE program when it 
comes to population number calculations, it is computationally difficult to obtain accurate 
estimates of Pr(X/K) and the method merely provides an ad hoc approximation and the 
biological interpretation of K may not be straightforward. This is a particular problem for 
geographically closely related locations where there can be exchange of genetic material. 
This will result in an overestimate of population numbers. A further complication for the 
programme is inbreeding within a population which will also affect population numbers 
predicted by the programme.  
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Some scientists have recently presented a hypothesis suggesting that toxoplasmosis is 
transmitted from infected men to non-infected women during unprotected intercourse (Flegr 
et al. 2014). Arguments for the hypothesis were that tachyzoites are present in seminal fluid 
and tissue of the testes of various animals, including humans. In some species infection of 
females by artificial insemination with semen from infected males has been observed. Up to 
two thirds of T. gondii infections in pregnant women cannot be explained by the known risk 
factors. There is no direct evidence to confirm this hypothesis of sexual transmission but 
interestingly this hypothesis offers the best explanation for the high number of mixed 
infections in tested mice. 
The prevalence of 34.92 % has been confirmed at Malham Tarn area, with all three genotypes 
present. The absence of cats in the environment reduces the chances of contracting T. gondii 
via the oocyst route, but still the parasite is perpetuated. One of the possible explanations is 
congenital transmission. In our study we used a PCR-based diagnostic, which is one of the 
most specific methods and determines the presence of parasite DNA. Our data showed that 
the prevalence of T. gondii in natural mammal populations is high and the parasite can be 
perpetuated in the absence of felids possibly via the congenital route.  
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Chapter 5 
Prevalence of infection and genotypic diversity of Toxoplasma gondii 
in patients with lung cancer 
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5.1 Introduction 
 
   Toxoplasma gondii is a protozoan intracellular parasite which can be found in all warm-
blooded animals and around 30% of the human population is estimated to be infected 
(Remington, 1993; Dubey, 2001), with the prevalence reaching 80% in some areas (Tenter et 
al. 2000; Pappas et al. 2009). Humans usually get infected from water contaminated with cat 
faeces, food (ingestion of cysts from undercooked meat), during blood transfusion, organ 
transplantation or congenitally. In humans, primary infection is usually asymptomatic or does 
not require medical treatment. If the symptoms occur, they are usually mild influenza like 
symptoms, rarely hepatosplenomegaly and lymphadenopathy can occur, and are often self-
limiting (Krick and Remington, 1978). Latent infections are thought to induce morphological 
and behavioural changes in infected persons (Webster, 2001). In immunosuppressed and 
immunodeficient patients, T. gondii infection can have fatal consequences. Toxoplasma 
gondii can invade every type of nucleated cell in the body, but target organs such as the 
lymph nodes, brain, heart and lungs are preferred sites. Proliferation of tachyzoites results in 
the infection of neighbouring cells and necrosis (Evans et al. 1991). Common presentations 
include encephalitis, pneumonia and myocarditis.  
Pulmonary pneumonia is very rare in immunocompetent patients, but has been recognized 
with increased frequency in patients with AIDS (Caterral et al. 1986) and its general 
frequency is estimated to be between 0.2 and 3.7% but is probably underestimated (Knani et 
al. 1990). In cases from Brazil the mortality amongst AIDS patients due to the pulmonary 
toxoplasmosis was estimated at 55% (Pomeroy et al. 1992) while, for example, the mortality 
rates of T. gondii induced encephalitis in AIDS patients were between 10-40% (Vidal et. al 
2004). The main problem was that the recognition of T. gondii infection in these patients is 
often delayed. The problem is that the clinical findings often mimic those of other atypical 
pneumonias. In patients with disseminated toxoplasmosis, 33% had evidence of subclinical 
pulmonary involvement, even if pneumonia had not been diagnosed clinically. The patients 
with pulmonary toxoplasmosis could be divided into two groups, patients which present 
clinically apparent pneumonia as the main clinical feature and patients, where no evidence of 
pneumonia was observed but other organs were involved (Pomeroy et al. 1992). The clinical 
and radiological features are nonspecific (Cohen et al. 1985). Serological studies lack 
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sensitivity and specificity and are of limited value (Montoya, 2002). Definitive diagnosis of 
toxoplasmosis requires either histological demonstration of the organism or isolation by 
culture. Toxoplasma gondii can be detected by haematoxylin and eosin staining, but, for 
example, in one study of cerebral toxoplasmosis, the organism was not seen in 50% of 
positive cases (Luft et al. 1984). 
Patients with cancer may have deficient cellular immunity and are potentially more 
susceptible to T. gondii infections. Not much attention has been paid to this group of patients 
and only a few reports are available. These are mostly based on serological studies and not 
much is known about the genotypes that are present. In a study done by Yuan and colleagues 
(2007), the seropositivity rates of T. gondii IgG in nasopharyngeal carcinoma (46.15%) and 
rectal cancer (63.64%) groups were significantly higher than the other cancer groups, 
pulmonary carcinoma (4.55%), breast cancer (9.53%), gastric carcinoma (10.00%), 
hepatocellular carcinoma (14.29%) and uterine cervix carcinoma (12.50%). They proposed 
that this demonstrated that there is a likely association between T. gondii infection and some 
kinds of cancer. Interestingly, the IgM rates were not statistically significantly higher. 
Immunoglobulin M (IgM) is the first immunoglobulin to appear in the immune response. 
Immunoglobulin G (IgG) is the predominant antibody in the secondary immune response 
which is most commonly seen with recurrent exposure to specific antigen. If IgG and IgM are 
both negative, this indicates the absence of infection or extremely acute recent infection. If 
testing reveals a positive IgG and negative IgM, this indicates an old infection (older than one 
year). If both IgG and IgM are positive, this indicates either a recent infection or false 
positive test results (Liesenfeld et al. 1997). The rates in Liesenfelds’ study were lower than 
those described in other reports (Yazar et al. 2004). Thomas and Lafferty (2011) compared 
national figures from 37 countries and found that brain cancers are more common in 
countries where T.gondii infections are more common. Brain cancer was 1.8 times more 
common in countries where T.gondii was most common, than in those where it was virtually 
absent. To take the two extremes, in South Korea, where 4 % of people are infected, 3.4 
people out of every 100 000 develop brain cancer each year. In Brazil, 67 % of people are 
infected, and 5.5 out of every 100 000 develop brain cancer each year. Previous 
investigations have revealed that T. gondii could cause gliomas in experimental animals 
(Wrensch et al. 1993). Studies carried out by Ryan et al. (1993) showed that antibody 
positivity to Toxoplasma is associated with meningioma. However, molecular events 
involved in Toxoplasma induced brain cancers are not well understood. The team of Dr. 
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Gnanasekar (Thirugnanam et al. 2013) are testing the hypothesis that micro RNAs (miRNAs) 
are specifically associated with brain cancers. They think that T. gondii is capable of 
manipulating host miRNAs, which play a central role in post-transcriptional regulation of 
gene expression (work still in progress).  
Traditional studies have concluded that majority of T. gondii strains comprises three distinct 
clonal lineages designed I, II and III (Howe et al. 1995; Grigg et al. 2001). The parasite 
appears to reproduce largely clonally in nature, with sexual recombination occurring only 
rarely.  Several reports show that type II is the most prevalent genotype in Europe and North 
America (Darde et al. 1997, Sibley et al. 1992). Type II has been also frequently associated 
with human diseases (Howe and Sibley, 1995), when more than 70% of human cases of 
toxoplasmosis were found to be caused by this genotype. It is well known that the virulence 
of the parasite differs in laboratory animals, depending on the T. gondii strain (Johnson et al. 
1997). Type I strains are highly virulent in mice and generate higher levels of parasitaemia 
than types II and III (Howe and Sibley, 1995). The type I strain in humans has been linked to 
a high frequency of ocular toxoplasmosis and congenital toxoplasmosis, while SAG2 Type I 
predominated (75%) among other cases of congenital infection (Fuentes et al. 2001). Type II 
has been often associated with toxoplasmosis in AIDS patients with some fatal consequences 
(Fuentes et al. 2001). Type I and atypical strains have never been reported in asymptomatic 
or benign congenital toxoplasmosis (Ajzenberg et al. 2002). Type III is not very common in 
the human population, but Grigg (2001) observed atypical recombinant I and III genotypes in 
patients with ocular toxoplasmosis and AIDS. Aspinall (2002) in her study on patients from 
England and Wales discovered type III in only one case out of 32 and neither of the 
genotypes seemed to be associated with particular disease. She also found no correlation 
between the SAG2 type and clinical presentation, but detected an unusually high number of 
mixed SAG2 I and II genotypes in the PCR products. In study performed on amniotic fluid, 
only one case  of mixed infection (Type I and II) was detected by direct typing but 
interestingly murine inoculation of the sample led to only one Type II strain isolation (Villena 
et al. 2004). It is possible that atypical/recombinant genotypes are associated with severe 
toxoplasmosis at least in immunocompetent patients (Carme et al. 2002). Reactivation of 
unusual I/III  genotype in HIV positive patients  in France (originating from Ghana) led to 
severe encephalitis and chorioretinitis, followed later by septic shock, organ failure and death 
(Genot et al. 2007). All these studies were based mostly on SAG2 PCR-RFLP (Howe et al. 
1997) and used old T. gondii nomenclature using only a few markers. The main problem with 
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this system is that a single allele does not necessarily imply that all alleles are of the same 
type and it makes it very difficult to identify atypical strains. Multilocus genotyping is 
necessary to reveal atypical or recombinant genotypes. New multilocus nested PCR designed 
by Su et al. (2006) and reported in  Swab et al. (2013) uses 10 T. gondii markers able to 
detect a much greater variety of genotypes  (SAG1, SAG2, SAG3, BTUB, GRA6, L358, 
APICO, PK1, c22-8 and C29-2) and all known RFLP genotypes are collected in the T. gondii 
database (www.toxodb.org). Analysis with these new markers can provide more data on T. 
gondii population structure and reveal possible link between some unusual genotypes and 
diseases in humans and animals.  
The aims of this study were to determine the prevalence and genotypes of T. gondii in 
humans with lung cancer and a variety of lung diseases (asthma and COPD). Parasite 
prevalence will be determined by parasite specific PCR, histological and immunochemical 
methods. Due to the nature of the available human tissue samples, identification of parasite 
genotypes will be conducted using PCR and genotyping directly from the samples.  
Objectives  
 To extract DNA from lung tissue obtained from cancer patients 
 To confirm the quality of DNA extracted using mammalian tubulin PCR 
 To detect the presence of T. gondii using nested PCR amplification of T. gondii 
specific genes (B1, SAG1, SAG2, SAG3) 
 To detect the presence of T. gondii using haematoxylin and eosin staining 
 To detect the presence of T. gondii with T. gondii specific Immunohistochemical 
staining (using commercial antibodies) 
 Identify T. gondii genotypes in positive samples using RFLP on T. gondii specific 
genes (SAG1, SAG2, SAG3, GRA6, Apico, L358, alt.SAG2, BTUB, c22-8, c29-2, 
PK1 (Su et al. 2006, Shwab et al. 2013) 
 To analyse infection data in relation to biological range of known clinical parameters 
(age, sex, disease etc.) 
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5.2 Materials and Methods 
 In total, 88 DNA and 76 tissue samples from lung cancer patients from Wythenshawe 
Hospital were tested for the presence of T. gondii using molecular, histological and 
immunohistochemical methods as described in Chapter 2. The tissue was collected form non-
cancerous tissue taken as a part of lung resection for removal of cancerous tissue.  From all 
88 patient samples, 12 had some missing data or tissue was not available for 
immunohistochemistry so these samples were excluded from the final analysis. The presence 
of the parasite was tested with nested PCR with five different markers, SAG1, SAG2 (3
/
 and 
5
/
 were tested separately), SAG3 and B1 (as described in Chapter 2).  Each DNA sample was 
tested three times at its original concentration. Samples were accepted as positive if the 
presence of the parasite DNA was confirmed in all three reactions. Ten additional T. gondii 
genes SAG1 (Su revised method), SAG2, SAG3, GRA6, Apico, L358, alt.SAG2, BTUB, 
c22-8, c29-2, PK1 (Su et al. 2006, Swab et al. 2013) were used as RFLP markers for direct 
genotyping of parasite DNA from PCR positive lung tissues. With these markers, samples 
were also tested three times and were accepted as positive if at least one reaction gave 
positive results. If samples were negative in all three reactions they were considered to be 
negative with that marker. Two negative controls were used, sterile water and DNA from a 
wood mouse negative for T. gondii. A Type II strain from Slovakia and RH strain (Type I) 
were used as positive controls. Each marker was tested on T. gondii negative human genomic 
DNA (Promega, Madison, WI, USA, product code G304A) to check for false positive results.  
Immunohistochemistry was performed in paraffin embedded tissue using commercial 
polyclonal antibodies produced in rabbits (Thermo Fisher Scientific, Catalogue number PA1-
38789, Rockford, IL, USA). The tissue sections were cut in 5 µm sections and mounted on 
positively charged glass slides. Three negative controls were used, lung sections from T. 
gondii negative wood mouse (Apodemus sylvaticus), human lung sections with primary 
antibodies omitted and cells derived from a C2C12 culture (mouse myoblast cell line, free of 
T. gondii). Cell culture derived T. gondii RH strain tachyzoites and lung tissue from a T. 
gondii infected wood mouse were used as positive controls. Immunostained slides were 
assessed using quantitative criteria (ImageJ) to provide a percentage score which described 
the degree of infection (as described in Chapter 2). Finally, Haematoxylin and Eosin staining 
was used to confirm that structures compatible with T. gondii stages can be observed within 
sections. Data was analysed by logistic regression. All analyses were undertaken using R (R 
Core Team, 2013).  
95 
5.3 Results  
5.3.1 Molecular analysis of the human lung tissue samples 
The tissue samples were collected from 88 patients with lung cancer at the Wythenshawe 
Hospital, Northwest Lung Centre in Manchester as a part of long term study on lung disease. 
For each sample, data was available on age, gender, lung conditions (COPD, asthma) if 
present and on smoking status of individuals. For 12 patients, not all data or tissue of suitable 
quality was available, so they were excluded from the final analysis but we included them in 
genotype studies and using the molecular diagnostic markers. DNA was successfully isolated 
from 88 frozen lung tissues blocks and tested for the absence of PCR inhibition using PCR 
amplification of the α-tubulin gene. All 88 samples showed good amplification of the α-
tubulin gene and were used for further testing (Figure 5.1). PCR products from B1, SAG1, 
SAG2 3’, SAG2 5’ and SAG3 were sequenced to confirm the correct identity of PCR 
amplified bands (Figure 5.20, 5.21, Appendix).  
 
                                        1      2      3    4      5     6     7      8            9 
 
Figure 5.1 PCR amplification of the α-mammalian tubulin gene to check for PCR inhibition 
Lane 1 = Hyperladder 100kb (Bioline), Lanes 2-7 = tested samples, Lane 8 = positive control 
(woodmouse DNA), Lane 9= negative control. Expected product size was 1600bp. 
We used highly sensitive nested PCR protocols to detect T. gondii in the group of lung cancer 
patients. DNA extracted from 88 frozen lung tissue blocks was tested for the presence of the 
parasite with four markers B1, SAG1, SA2 (3
/
 and 5
/
 end were tested separately) and SAG3. 
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Each sample was tested three times at the original DNA concentration. The samples were 
considered to be positive if they successfully amplified in all three reactions. Negative 
controls (water and T. gondii negative woodmouse DNA) were interspersed throughout the 
PCR reactions to detect any false amplification. Different stages of the PCR assay were 
conducted in separate rooms to minimize the risk of contamination. PCR products were 
visualized by agarose gel electrophoresis. All 88 tested samples (36 females and 52 males) 
were confirmed to be positive for T. gondii with markers B1, SAG1, SAG2 3
/
, SAG2 5
/
 and 
SAG3, giving a prevalence of 100% (95% CI: 95.19% - 100%). Examples of the gel images 
for tested markers can be seen in Figures 5.2-5.5. 
 
 
 
Figure 5.2 An example of B1 PCR gel electrophoresis on human lung cancer patients. Lane 1 
is the Hyperladder 100bp (Bioline), Lanes 2-5 are T. gondii positive patients, Lane 6 is the 
positive control (expected 96bp product), Lanes 7 and 8 are the negative controls (sterile 
water and T. gondii negative wood mouse). 
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Figure 5.3 Example of SAG1 PCR of lung tissue from human lung cancer patients on 1.5% 
agarose gel. Lane 1, Hyperladder 100 bp (Bioline), Lane 2 = positive control (522bp product 
size), Lanes 3, 4,5,6,7, and 8 are T. gondii positive patients, Lanes 9 and 10 are negative 
controls. 
 
SAG2 locus has two polymorphic sites at the 3
/
 and 5
/
 ends for type II and type III (Howe et 
al. 1997), so amplification of this locus was performed separately. Two nested PCRs, one 
targeting the 3
/
 end of the SAG2 gene and the other targeting the 5
/
 end of SAG2 gene were 
optimized as per the method of Fuentes et al. (2001).  
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Figure 5.4 An example of  nested-PCR amplification of SAG2 3
/
 Lane 1 = Hyperladder 
100bp (Bioline), Lane 5 is the negative control, Lanes 1,2,3,4,6,7,8,9 and 10 are positive 
patients (some very weak bands are present), Lane 11 is the positive control (expected 
product size 242 bp). The results were clearer on original gels by adjusting exposures and on 
computer version but on printed images it is difficult to see the bands. 
 
 
Figure 5.5 An example of nested-PCR amplification of T. gondii SAG2 5
/
 end locus from 
lung cancer patients.  Lane 1 = Hyperladder 100bp, Lanes 2 and 10 = negative controls, 
Lane3 = positive control, Lane 4, 5, 6, 7, 8 and 9 = positive patients. The results were clearer 
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on original gels by adjusting exposures and on computer version but on printed images it is 
difficult to see the bands. 
 
 
Figure 5.6 An example of PCR amplification of SAG3 locus from lung cancer patients on 
1.5% agarose gel. Lane 1 = Hyperladdder 100bp (Bioline), Lane 2 = positive  control 
(expected 226 bp product), Lanes 4 and 6 are the negative controls, Lanes 3, 5, 7, 8, 9 and 10 
are positive samples. The results were clearer on original gels by adjusting exposures and on 
computer version but on printed images it is difficult to see the bands. 
 
After detecting such a high prevalence with five molecular markers we decided to use further 
immunohistochemical and histological methods to confirm the presence of the parasite.  
 
5.3.2 Immunohistochemistry (IHC) detection of T. gondii 
Immunohistochemistry was performed on 76 of the 88 tissue sections using commercial 
polyclonal antibodies produced in rabbits. Unfortunately we were not able to obtain the tissue 
section from the remaining 12 patients. All 76 sections were confirmed to be positive for T. 
gondii (Figure 5.7). 
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 Overall the IHC showed the following results. Various numbers of cysts were detected, but 
surprisingly a very high number of alveolar macrophages were infected with the parasite. 
ICH also revealed focal groups of tachyzoites. Immunostained slides were assessed using 
quantitative criteria (ImageJ) to provide a percentage score which described the degree of 
coverage of infected tissue. For each patient (slide) three randomly selected x 400 
magnification microscope fields were photographed. After the calculation of the proportional 
staining area to whole fields with ImageJ (as a percentage of stained pixels), the mean 
percentage of pixels in the stained areas was calculated for each slide. According to the final 
mean (intensity score) the patients were divided into three grades. Grade 1 had an intensity 
score below 10%, grade 2 between 10-20% and grade 3 contained all the patients with an  
intensity score greater than 20%. The slides were also scored for tachyzoites, infected 
macrophages, cysts and infected other cell types. The presence of tachyzoites, infected 
macrophages and other cell types represents active infection while the presence of cysts is the 
sign of latent infection. Example of the results for the samples and for the controls is 
presented in Figure 5.7.  Figure 5.7A shows the positive control, RH strain tachyzoites 
stained with antibodies. A second positive control was lung tissue from infected wood mouse 
(5.7D). Two negative controls used in testing can be seen on Figures 5.5B and C. Alveolar 
macrophages infected with T. gondii can be seen in Figure 5.7F, infected other cell types in 
Figure 5.7G and stained cyst is visible in Figure 5.7E. In Figure 5.7H represents visible 
ruptured T. gondii cyst with free bradyzoites. Frequencies of different stages of T. gondii 
detected with IHC in the lung tissue of cancer patients are presented in Table 5.1. 
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Figure 5.7: Anti-Toxoplasma gondii antigen immunostaining of human lung and control 
tissues. (A) Cell culture derived T. gondii RH strain tachyzoites stained with polyclonal anti 
–T. gondii antibodies. Brown staining indicates detection of T. gondii.  (Positive control). 
(x400 magnification). (B) Human lung section stained with polyclonal anti –T. gondii 
antibodies with primary antibodies omitted (negative control). (x400 magnification). (C) 
Cells derived from a C2C12 culture (mouse myoblast cell line) which is T. gondii free 
A B C 
D E 
F G H 
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(negative control) and stained with polyclonal anti –T. gondii antibodies (x400 
magnification). (D) Lung tissue from a T. gondii infected wood mouse (Apodemus sylvaticus) 
stained with polyclonal anti –T. gondii antibodies. Brown staining indicates detection of T. 
gondii.  (Positive control). (x400 magnification). (E) Human lung section, from subject 1045, 
stained with polyclonal anti –T. gondii antibodies.  T. gondii cysts can be seen. (x400 
magnification). (F) Human lung section, from subject 1040, stained with polyclonal anti –T. 
gondii antibodies. Alveolar macrophages infected with T. gondii can be seen. (x400 
magnification). (G) Human lung section, from subject 1028, stained with polyclonal anti –T. 
gondii antibodies. Fibroblasts infected with T. gondii can be seen. (x400 magnification). (H) 
Human lung section, from subject 975, stained with polyclonal anti –T. gondii antibodies. 
Ruptured T. gondii cysts and free T. gondii  tachyzoites can be seen. (x400 magnification). 
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Table 5.1 Frequencies (%) of different stages of T. gondii detected with IHC in the lung tissue of cancer patients 
Sample Age Sex Grade Infection  stage Cysts Macrophages Other infected cells types Tachyzoites Prevalence Sample type 
603 67 M 1 Tachyzoites 0 0 0 8.9 8.9 HEX 
629 70 M 2 cyst tach macro 0.83 14.65 0 3.2 18.68 HEX 
637 74 M 1 macro, tach 0 6.37 0 2.41 8.78 asthma 
664 75 M 2 tach, macro, cells 0 0.77 0.46 12.1 13.33 COPD S 
674 68 M 1 cyst, macro 0.38 2.5 0 0 2.88 COPD EX 
757 75 M 3  macro, cells 0 20 23.5 0 43.5 COPD S 
812 78 F 3 cysts, tach, cells 4.3 0 8.2 19.22 31.72 HS 
813 79 M 1 other cells 0 0 1.02 0 1.02 HEX 
817 74 F 3 macro, tach 0 20.45 0 7.69 28.14 HS 
818 78 M 2 macro, tach 0 14.67 0 0 14.67 COPD S 
819 79 M 2  macro, cells 0 16.99 2.27 0 19.26 COPD EX 
821 72 M 2 cyst, tach, macro, cells 2.2 6.1 4.47 4.66 17.43 COPD S 
822 67 M 2  macro, cells 0 10.71 2.1 0 12.81 COPD EX 
823 84 M 1 tach, macro, cells 0 5.7 2.14 1.8 9.64 HEX 
825 64 M 1 cysts, tach, cells 1.21 0 2.13 1.1 4.44 HEX 
827 68 M 1 Macro 0 8.18 0 0 8.18 COPD EX 
828 50 F 2 Macro 0 10.34 0 0 10.34 HS 
829 79 F 3 Macro 0 34.24 0 0 34.24 HEX 
832 76 M 1  tach, cells 0 0 2.98 0.33 3.31 HEX 
833 69 F 3 cysts, tach, cells 0.5 0 2.78 40.69 43.97 HEX 
834 69 F 1 Cyst 0.2 0 0 0 0.2 HS 
835 80 F 2 Macro 0 10.39 0 0 10.39 COPD S 
836 76 M 1 Tachyzoites 0 0 0 8.37 8.37 HEX 
837 69 F 1 Tachyzoites 0 0 0 9.72 9.72 HNS 
840 57 F 1 Cyst 2.9 0 0 0 2.9 HS 
965 82 F 1 Macro 0 1.21 0 0 1.21 COPD S 
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968 82 F 1  tach, cells 0 0 1.43 5.61 7.04 HEX 
972 75 F 1  tach, cells 0 0 1.5 6.48 7.98 HEX 
973 66 F 3 cysts, tach, cells 0.8 0 0.3 25.87 26.97 HS (COPD border) 
975 71 F 2 cysts, tach 1.6 0 0 12.03 13.63 HS 
976 69 F 1 Cyst 1.6 0 0 0 1.6 COPD S 
979 75 F 3 cysts, tach 1.1 0 0 22.81 23.91 COPD S 
985 67 M 1 cysts, tach, cells 0 0 0.3 4.81 5.11 HEX 
988 73 F 2 cysts, tach, cells 0.27 0 1.9 13.14 15.31 HEX 
989 71 M 3 cysts, tach, cells 1.2 0 0.4 25.1 26.7 COPD EX 
997 80 M 2 cyst, macro, cells 1.2 5.07 4.3 0 10.57 COPD EX 
999 60 M 3 macro, tach 0 35.07 0 8.62 43.69 COPD S 
1004 67 M 3 tach, macro, cells 0 13.77 1.14 26.86 41.77 COPD S 
1005 78 M 1 Macro 0 1.1 0 0 1.1 COPD EX 
1006 72 M 1 Macro 0 6.45 0 0 6.45 COPD EX 
1008 76 M 1 other cells 0 0 1.4 0 1.4 HEX 
1010 78 M 1 macro, tach 0 4.04 0 1.11 5.15 COPD S 
1013 60 M 1 other cells 0 0 1.74 0 1.74 COPD EX 
1014 62 F 1 tach, macro, cells 0 2.08 0.95 0.52 3.55 COPD EX 
1015 65 F 1 macro, tach 0 3.5 0 0.3 3.8 HNS 
1017 70 M 1 cyst, macro 1.1 2.6 0 0 3.7 COPD EX 
1018 44 F 1  macro, cells 0 5.87 0.89 0 6.76 HS 
1021 66 F 1 Macro 0 8.8 0 0 8.8 HS 
1025 68 F 2 macro, tach 0 10.44 0 1.08 11.52 HS 
1026 77 M 1 Tachyzoites 0 0 0 0.81 0.81 COPD EX 
1028 58 F 3  macro, cells 0 28.57 9.1 0 37.67 HEX 
1029 66 M 2 Macro 0 11.88 0 0 11.88 COPD S 
1030 61 M 2 cysts, tach 11.3 0 0 7.37 18.67 COPD EX 
1032 59 M 2 tach, macro, cells 0 14.16 1.97 1.4 17.53 HS 
1033 62 F 1 Macro 0 7.14 0 0 7.14 HEX 
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Patients’ health status data presented in the last column was provided by Helen Carlin as a part of her PhD research.  
1035 63 M 2 macro, tach 0 12.43 0 0.51 12.94 HS 
1036 71 F 2 Macro 0 12.37 0 0 12.37 HNS 
1037 72 M 3 macro, tach 0 31.94 0 5.79 37.73 COPD S 
1040 71 M 3 Macro 0 31.91 0 0 31.91 HS 
1043 75 F 3  macro, cells 0 18.1 6.6 0 24.7 COPD S 
1045 59 M 2 cyst, tach, macro, cells 0.59 11.78 0.9 1.69 14.96 HEX 
1047 65 M 2 tach, macro, cells 0 13.53 1.57 2.32 17.42 COPD S 
1049 61 F 3 macro, tach 0 34.52 0 6.12 40.64 asthma 
1051 70 M 3 cysts, tach, cells 0.4 0 15.8 9.34 25.54 asthma 
1052 79 M 1 cysts, tach, cells 4.2 0 0.9 1.02 6.12 COPD EX 
1053 75 F 2 tach, macro, cells 0 16.63 1.88 1.34 19.85 HS 
1054 67 F 3 Macro 0 20.51 0 0 20.51 HS 
1060 76 F 1 other cells 0 0 0.61 0 0.61 COPD EX 
1064 75 M 1 Macro 0 6.08 0 0 6.08 COPD EX 
1067 52 M 2 macro, tach 0 10.91 0 1.2 12.11 HS 
1068 66 M 2 macro, tach 0 15.02 0 1.75 16.77 COPD S 
1069 57 F 3 tach, macro, cells 0 21.68 2.4 4.66 28.74 HEX 
1070 79 M 1  macro, cells 0 0.8 0.27 0 1.07 HEX 
1071 64 F 2 macro, tach 0 16.5 0 2.35 18.85 HS 
1072 74 M 2 macro, tach 0 10.63 0 4.12 14.75 HEX 
1101 65 F 1 cyst, tach, macro, cells 0.6 2.63 0.7 3.53 7.46 HNS 
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5.3.3 Haematoxylin and eosin staining 
All 76 tissue sections were successfully stained with haematoxylin and eosin and observed 
under the light microscope. The presence of structures consistent with infection by the 
parasite was confirmed in 67 samples. In all cases tissue cysts (Figure 5.8B, D, E, F and G) of 
different sizes, infected macrophages (Figure 5.7A) and other infected cell types (5.7C) were 
observed but no free tachyzoites could be detected. The remaining 9 samples could not be 
reliably confirmed as potentially infected by this method but could have possessed less 
visible structures such as tachyzoites.  
 
                       
                       
A B 
C D 
107 
             
Figure 5.8: Haematoxylin and Eosin staining of human lung sections (A) Infected 
alveolar macrophage with four visible tachyzoites (red arrow) in subject 1040.  (x400).   (B) 
Tissue cyst from subject 1070 (x400) and (C) young tissue cyst in subject 1028. (x400). (D) 
Probable free bradyzoites (red arrow) observed in subject 684 possibly come from the 
ruptured cyst (orange arrow). Images E, F, G show different stages of tissue cysts from 
subbjects 821, 827 and 968 (x400). 
 
5.3.4 Summary of prevalence 
In this study we have detected 100% prevalence of T. gondii in a cohort of lung cancer 
patients using molecular and immune-histological techniques. In order to determine factors 
associated with increased probability of COPD/obstruction and any relationship with T. 
gondii infection, logistic regression was used. Patients were placed into 2 categories – healthy 
(no obstruction) or unhealthy (COPD/Asthma) and considered against factors that predicted 
individuals in each category. Factors included age and gender of the individual and a number 
of measures of smoking and Toxoplasma status. Average age of tested subjects was 64.64 
years. Toxoplasma associated variables: acute infection (when infected macrophages, other 
infected cell types and tachyzoites were observed), latent (when only the cyst stage was 
detected), grade of infection, i.e. free tachyzoites (only the free tachyzoite stage was present) 
and Toxoplasma intensity (mean percentage of stained pixels for each sample). A surprisingly 
high number of patients (96.05%) showed evidence of an active form of infection, as defined 
by the presence of tachyzoites or infected alveolar macrophages (or other cell types). Only 
three subjects (3.95%) had the dormant cyst stage as the only stage present (Table 5.1). None 
of the measures (e.g. smoker status Toxoplasma status, gender, age etc.) were significantly 
associated with the probability of being healthy (i.e. no obstruction). 
 
G F E 
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5.3.5 Molecular analysis and RFLP genotyping 
After confirming the presence of T. gondii in tested tissue samples with B1, SAG1, SAG2 (5’ 
and 3’), SAG3, haematoxylin and eosin staining and final confirmation with T. gondii 
specific antibody staining, positive samples were RFLP-genotyped with 11 markers. The 
genotypes were compared, identified and matched to those listed in T. gondii database at 
www.toxodb.org. Examples of successful genotyping with selected markers and RFLP-
pattern diagrams from which we derived T. gondii genotypes (Type I, II, III or unusual types) 
are listed in Figure 5.9 - 5.19. From 88 tested samples all 88 were confirmed to be positive 
with both, 3
/
 and 5
/
 markers and all were successfully RFLP genotyped. Strain typing 
revealed Type I in 3 patients, Type II in 58 patients and Type III in 10 patients. Seventeen 
tissue samples had mixed infection of Types II and III at SAG2 loci.  
 
                                                      
Figure 5.9 A) PCR-RFLP analysis of the SAG2 5
/
 end flanking region on 2.5% agarose gel. 
Lane 1 is Hyperladder II (Bioline), Lane 2 is undigested control (242bp). Lanes 3-6 contain 
samples which were incubated with MboI. This enzyme cuts Type III only while Types I and 
II stay undigested. The sample in Lane 3 was fully digested which indicates Type III is 
present. B) PCR-RFLP analysis of the SAG2 3
/
 end flanking region on a 2.5% agarose gel. 
Lane 1 is Hyperladder II (Bioline), Lane 2 is undigested control (222bp).  Lanes 3-5 were 
incubated with HhaI which digests Type II only (present in Lane 4) while Types I and III stay 
undigested. All here presented bands were detected on original gels but not on reproduced 
prints.  
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All 88 tested samples were positive with SAG3 marker and all were successfully genotyped 
in two independent restriction digests. Type II was the most prevalent genotype and was 
detected in 78 cases. Type III only was found in one patient. Type I was present only as part 
of mixed infection with Type II in two cases and together with Types II and III in four cases. 
Two patients had both genotypes II and III. 
   
Figure 5.10 An example of agarose gel electrophoresis analysis of SAG3 PCR amplification products and 
restriction with AlwNI (cuts only type II) digests from T. gondii infected lung tissue samples. Lane 2 is the 
undigested control, Lane 20 contains Hyperladder 50bp (Bioline). All samples were fully digested with AlwNI 
and that means they are all Type II. The diagram shows patterns of digestion of Type II with AlwnI and specific 
restriction product sizes.  
         
Figure 5.11 An example of agarose gel electrophoresis RFLP analysis (diagram) of SAG3 PCR 
amplification products and restriction NciI (cuts only type I and III) digests from T. gondii infected samples on 
2.5% agarose gel with Hyperladder 50bp (Bioline) in lane 1. Lane 4 contains undigested control. Lanes 2, 3, 15 
and 20 contain partially digested products which indicates that mixed genotypes (products from two types) are 
present. The samples in remaining lanes stayed undigested and that means they are all type II.  
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Out of 88 tested tissues samples only 43 (48.86%) were amplified and successfully genotyped 
with alternative SAG2 marker. RFLP detection revealed Type II in 30 samples, one sample 
had only Type I and no sample had only Type III. One case was a mixed infection of Types I 
and II and seven patients had mixed infection of Types II and III. An unusual Type I was 
found in four patients.  
 
            
Figure 5.12 A) Agarose gel electrophoresis of alt.SAG2 marker on a 1.5% gel with 1kb 
Hyperladder (Bioline) in Lane 1. Lane 2 is the positive control; Lane 4 negative control and 
Lanes 3, 5 and 7 are positive samples. B) RFLP double digests of alt.SAG2 PCR products 
with enzymes HinfI and TaqI on 2.5% agarose gel. Lane 2 is the undigested control, digest 
patterns in Lanes 3 and 4 represent type I. Lane 5 is type II but the top bands are missing.  
Partial digest in Lane 6 suggests that mixed infection is present (I+II). The results were 
clearer on original gels by adjusting exposures and on computer version but on printed 
images it is difficult to see the bands (yellow arrows) 
After testing tissue samples with Apico marker we found only 27 to be amplified, giving a 
prevalence of 30.68 %. Strain typing revealed Type I in 11 cases, followed by Type III in 9 
cases and only 3 patients had Type II at this locus. In four patients we found mixed infection 
of genotypes II and III.  
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Figure 5.13 A) Apico PCR electrophoresis on a 1.5% agarose gel with Hyperladder I 
(Bioline) in Lane 1. Lane 2 is the positive control (640bp product), Lane 3 and 9 are negative 
controls. Only one positive sample is in Lane 10. B) Double digest of the PCR products with 
AflII and DdeI on 3% agarose gel using Bioline Hyperladder V (Lane 1) Lane 2 shows the 
undigested control, Lane 3 represents mixed infection (partial digestion) of types II and III ,  
in Lanes 5 and 6 samples are both types I.  
BTUB and c22-8 were the most successful RFLP markers (after SAG2 and SAG3). BTUB 
amplified parasite DNA in 54 out of 88 tested samples (61.36%). Interestingly with this 
marker Type I was the most dominant and was found in 32 cases as a single type infection, 
followed by Type III with 9 cases and Type II with 8 cases. Two patients had mixed infection 
of Type I and II and 3 patients were of mixed types II and III. With the c22-8 marker 56 out 
of 88 tested samples were found to be positive (63.64%). With this marker Type I one was 
also the most prevalent one and was found in 39 patients. Four patients had Type II infection 
and only one had Type III present. Mixed infections of Type I and II were found in four 
cases, five had mixed genotypes I and III and all three types were found in 2 patients. One 
unusual Type I was also detected.  
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Figure 5.14 A) BTUB PCR agarose gel electrophoresis (1.5% gel). Lane 1 is Hyperladder I 
(Bioline), Lane 2 is the positive control, Lanes 9 and 10 negative controls, Lanes 3, 5,6 and 8 
are positive samples ( weak bands present). B) Double digest of the BTUB PCR products 
with enzymes BsiEI and TaqI on a 2.5% agarose gel. Lane 1 is Hyperladder V (Bioline), 
Lanes 2 and 3 are undigested controls, Lane 4 contains mixed infection of Types III and II, 
Lanes 5, 6,7,8,9 and 10 are all Type I.  
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Figure 5.15 A) Nested PCR of the c22-8 marker on 1.5% agarose gel. Lane 1 = Hyperladder 
I (Bioline), Lane 2 = positive control (521bp), Lanes 3 and 4 = negative controls, Lanes 8 and 
10 = positive samples. B) Double digest of the c22-8 PCR products with enzymes BsmAI and 
MboII on a 2.5% agarose gel. Lane 1= Hyperladder V (Bioline), Lane 2 = undigested control, 
Lane 3= mixed infection (Type I and II), Lane 4= mixed infection (type I and III), Lanes 5, 6, 
7 = Type I, Lanes 8 and 9 = mixed infections (Type I and III).  
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Figure 5.16 A) Gel electrophoresis of the c29-2 marker (1.5% agarose gel). Lane 1= 
Hyperladder 100bp (Bioline), Lane 2 = positive control (446bp), Lanes 3 and 4 = T. gondii 
positive samples, Lane 5 = negative control. B) Double digest of the c29-2 PCR products 
with enzymes HpyCH4IV and RsaI on a 2.5% agarose gel. Lane 1= Hyperladder 50bp 
(Bioline), Lane 2 = undigested control, Lane 3 = Type I, Lane 4 = Type II, Lane 5 = Type III.  
 
Markers L358 and c29-2 showed similar amplification rates, with 41 (46.59%) and 42 
(47.72%) samples amplified. With L358 Type I was found in 3 cases, Type II in 16 and Type 
III in 3. Two mixed infections of Type I and II, two of Type I and III and four of Type II and 
III were also found. RFLP with c29-2 revealed Type I in 12 patients, Type II in 10 and Type 
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III in nine patients. From ten detected mixed infections, two had Type I and II present, three 
had I and III and four had II and III genotypes present. Two unusual cases of Type I were 
also found.  
 
                    
 
Figure 5.17 A) GRA6 PCR products gel electrophoresis on a 1.5% agarose gel. Lane 1 = Hyperladder I 
(Bioline), Lane 2 = positive control (344bp), Lanes 5, 6, 7 and 9 = positive samples, Lane 8 = negative control. 
B) Restriction digests of the GRA6 PCR products with MseI on 2.5% agarose gel. Lane 1 = Hyperladder 50bp 
(Bioline), Lane 2 = undigested control, Lanes 3, 4, 5 and 6 = Types II. 
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Figure 5.18 A) Gel electrophoresis of L358 marker products on a 1.5% TBE agarose gel.  
Lane 1 = Hyperladder I (Bioline), Lane 2 = positive control, Lanes 3 and 6 = positive 
samples, Lane 5 = negative control. B) Double digest of the L358 PCR products with 
enzymes HaeIII and NlaIII on a 2.5% agarose gel. Lane 1 = Hyperladder V (Bioline), Lane 2 
= undigested control, Lanes 3 and 5 = mixed infection (Type I, II and III), Lane 4 = mixed 
infection (Type I and III). The results were clearer on original gels by adjusting exposures 
and on computer version but on printed images it is difficult to see the bands. 
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From all used markers PK1 had the poorest ability to amplify, when form all 88 tested 
samples only 9 were found to be positive (10.23%). From these, Type I was found in one 
case, Type II in three patients, two cases had mixed infection of Type I and III and one had 
genotypes II and III present. We found two unusual Types I.  
 
               
. 
Figure 5.19 A) Gel electrophoresis of PK1 marker on 1.5% agarose gel.  Lane 1 = 
Hyperladder I (Bioline), Lane 2 = positive control (903bp), Lane 3 = negative control, Lanes 
5, 7 and 8 = positive samples. B) Double digests of the PK1 PCR products with enzymes 
AvaI and RsaI on 2.5% agarose gel. Lane 1 = Hyperladder I (Bioline), Lane 2 = undigested 
control, Lane 3 = mixed infection (Type I and III), Lane 4 = Type II, Lanes 8 and 9 = are 
unusual Type I   
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The results of successful replication for each of the individual markers are listed in Table 5.2. 
When comparing two markers, the one with lower detected prevalence and recorded it in the 
table. Using this method we created a matrix table where we compared the successful 
replications for all used markers. In the future this pairwise combination of two markers 
allows us to select combinations with the highest sensitivities (e.g. B1-SAG1, SAG2-SAG3) 
for fast detection of T. gondii, and avoid markers with low detection rates as PK1-SAG1-Su. 
Strain typing was performed using 11 PCR-restriction fragment length polymorphism (PCR-
RFLP) markers: SAG1, SAG2, alt. SAG2, SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1, 
and Apico. Even though the markers used in the multilocus PCR-RFLP were developed 
based on sequence polymorphisms in the clonal Type I, II and III lineages (Su et al. 2006), 
non-clonal alleles (unique alleles) have already been revealed for SAG1, alt. SAG2, c22-8, 
c29-2, PK1 in different studies. The profiles found after digestion with restriction 
endonucleases were compared with the profiles of the reference strains in a virtual database, 
the ToxoDB database (www.toxodb.org). Recent multilocus PCR-RFLP genotyping of more 
than 1500 samples worldwide has revealed 221 different genotypes (www.toxodb.org). To 
identify the T. gondii strain and match it with strains listed in the database it is important to 
successfully genotype tested samples on all loci. If one or more loci are missing, it is not 
possible to match the genotype with those presented in the database. Genotyping with a 
single marker does not allow identification of nonclonal strains, and to determine more 
precisely the presence of polymorphisms in the population. It was not possible to carry out 
the complete genotyping in majority tested samples due to the nonamplification of some 
markers and the occurrence of extremely polymorphic digestion patterns. PCR-RFLP of 
genetic markers has been shown to be effective in the identification of T. gondii genotypes. 
However, there have been some technical problems, such as incomplete PCR amplification 
and restriction enzyme digestion. PCR-RFLP relies on single-copy polymorphic DNA 
sequences and requires a large amount of parasite DNA. The genotypes detected in lung 
tissue samples are described in Table 5.3 and Table 5.4. Only two samples were fully 
genotyped at all 10 loci. One sample (case 813) contained a single genotype only and 
according to the Toxodb database could be identified as a new strain. From 86 partially 
genotyped samples, 41 had single genotypes present and 55 were mixed infections. From the 
41 single genotypes, four could be assigned or are closely matching to known T. gondii 
isolates: TgCkBr168 (database ID- 129), PRU (ID-3), isolate B73 (ID-127) and 30 could be 
possible new isolates. From the 55 mixed genotypes only two directly match known isolates 
TgCatEg57, B73 and PRU. The value of multilocus enzyme electrophoresis as a tool for 
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genetic analysis has largely been demonstrated, but its main handicap is the need of a large 
quantity of purified Toxoplasma DNA.  
Table 5.2 The matrix of successful PCR reproduction with T. gondii markers. Five markers 
(B1, SAG1, SAG2 3
/
 and 5
/
 and SAG3 had a success rate 100% (red). Markers BTUB (green) 
and c22-8(orange) also showed high rates of successful replications. 
Successful PCR (%) B1 SAG1 SAG2 5' SAG2 3' SAG2 SAG3 L358 Apico C29-2 SAG1(Su) GRA6 PK1 BTUB alt.SAG2 c22-8
B1 100 100 100 100 100 100 46.59 30.68 47.72 23.86 57.95 10.23 61.36 48.86 63.63
SAG1 100 100 100 100 100 100 46.59 30.68 47.72 23.86 57.95 10.23 61.36 48.86 63.63
SAG2 5' 100 100 100 100 100 100 46.59 30.68 47.72 23.86 57.95 10.23 61.36 48.86 63.63
SAG2 3' 100 100 100 100 100 100 46.59 30.68 47.72 23.86 57.95 10.23 61.36 48.86 63.63
SAG2 100 100 100 100 100 100 46.59 30.68 47.72 23.86 57.95 10.23 61.36 48.86 63.63
SAG3 100 100 100 100 100 100 46.59 30.68 47.72 23.86 57.95 10.23 61.36 48.86 63.63
L358 46.59 46.59 46.59 46.59 46.59 46.59 46.59 30.68 47.72 23.86 46.59 10.23 46.59 46.59 46.59
Apico 30.68 30.68 30.68 30.68 30.68 30.68 30.68 30.68 30.68 23.86 30.68 10.23 30.68 30.68 30.68
C29-2 46.59 46.59 46.59 46.59 46.59 46.59 46.59 30.68 47.72 23.86 46.59 10.23 46.59 46.59 46.59
SAG1(Su) 23.86 23.86 23.86 23.86 23.86 23.86 23.86 23.86 23.86 23.86 23.86 10.23 23.86 23.86 23.86
GRA6 57.95 57.95 57.95 57.95 57.95 57.95 46.59 30.68 47.72 23.86 57.95 10.23 57.95 48.86 57.95
PK1 10.23 10.23 10.23 10.23 10.23 10.23 10.23 10.23 10.23 10.23 10.23 10.23 10.23 10.23 10.23
BTUB 61.36 61.36 61.36 61.36 61.36 61.36 46.59 30.68 47.72 23.86 57.95 10.23 61.36 48.86 61.36
alt.SAG2 48.86 48.86 48.86 48.86 48.86 48.86 46.59 30.68 47.72 23.86 48.86 10.23 48.86 48.86 48.86
c22-8 63.63 63.63 63.63 63.63 63.63 63.63 46.59 30.68 47.72 23.86 57.95 10.23 61.36 48.86 63.63
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Table 5.3 Distribution of T. gondii genotypes determined in lung cancer patients by PCR-RFLP. U-atypical alleles, * - SAG2 RFLP in mixed 
infection cannot exclude possible Type I, ** - SAG1-(Su) RFLP does not differentiate between the Types II and III 
 Marker 
Genotype B1 SAG1 SAG2 SAG3 c22-8 alt SAG2 L358 Apico C29-2 SAG1(Su) GRA6 PK1 BTUB 
I NA NA 3 0 39 1 3 11 12 3 5 1 32 
II NA NA 58 78 4 30 16 3 10 15** 23 3 8 
III NA NA 10 1 1 0 13 9 9 15** 10 0 9 
I+II NA NA 0 3 4 1 3 0 2 1 1 0 2 
I+III NA NA 0 0 5 0 2 0 3 0 5 2 3 
II+III NA NA 17* 2 0 7 4 4 4 0 7 1 0 
I,II,III NA NA 0 4 2 0 0 0 0 0 1 0 0 
U NA NA 0 0 1 4 0 0 2 2 0 2 0 
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Selected samples were sent for sequencing (Source Bioscience, Rochdale) to confirm the mixed infections and resolve the strain type. The 
fragments were sequenced with both internal primers. Samples showing mixture of two or three alleles revealed possible double peaks at known 
polymorphic sites indicating the presence of more alleles in the same sample (Figure 5.20-5.21). Due to the presence of strong background noise 
we cannot definitely confirm or exclude the presence of mixed strains.  
 
Figure 5.20 Sequence analysis of the SAG3 marker using forward primers, which reveals possible double peaks (yellow arrows) at know 
polymorphic sites (sample 833, contains mixed genotypes I and III).                 
Blast identified this sample as possible Type II strains PTG (99%), Me49 (99%), PRU (99%) and SAG3 Type I, GenBank: KT310097.1 (97%).  
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Figure 5.21 Sequence analysis of the SAG3 marker using forward primers, which reveals possible double peaks (yellow arrows) at known 
polymorphic sites (sample 1049, contains mixed genotypes I, II and III). 
This sample was identified by BLAST as strain AF10/08U and SAG3 Type I, GenBank: KT310097.1 .Strain AF10/08U was detected in Tunisia (Boughattas 
et al. 2010) and was associated with congenital toxoplasmosis. In this study this strain had mixed alleles II and III on SAG3 loci.  
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Table 5.4 T. gondii genotypes determined in 88 human patients with lung cancer  
Sample SAG2 5' SAG2 3' SAG2 SAG3 L358 Apico C29-2 SAG1(Su) GRA6 PK1 BTUB alt.SAG2 c22-8 Sample type 
603 I or II II  II  II  N I N N N N II N N P 
625 I or II II  II  II  N II N N N N N N N P 
629 I or II II  II  II  N III N N N N I N II p 
637 I or II II  II  II  N I N N N N I N N asthma 
663 I or II II  II  II  N I N N N N N N N COPD S 
664 I or II II  II  II  N N N N N N I+II N N COPD S 
674 I or II II  II  II  N III N N II N II N N COPD EX 
684 I or II II  II  II  N I N N N N N N N HS 
757 I or II II  II  II  N N N N N N N N N COPD S 
812 I or II II  II  II N II III N II N N II I HS 
813 I or II II  II  II III I III II or III II I I u1 I HEX 
817  III + mix II + mix II+III III III N N N I,II,III  N III N I HS 
818 I or II II  II  II II+III I III N II+III N I II I COPD S 
819 I or II II  II  II III N N N N N I II I COPD EX 
821  III + mix II + mix II+III II N N N N III N N N I + III  COPD S 
822 I or II II  II  II III N III N III N N II+III I COPD EX 
823 I or II II  II  II N N II N II N III II I HEX 
824 I or II II II  II II+III N II N II N II N N COPD S 
825 I or II II II II N I II+III N II+III N I I+II I p 
827 I or II II II II N N u1 N II N III N I COPD EX 
828  III + mix II + mix II+III II II III II+III N II+III N N II+III I HS 
829 I or II II II II I+II I III N III N N N I HEX 
832  III + mix II + mix II+III I,II,III  II N I N II+III N I II I HEX 
833  III + mix II + mix II+III I+II N I II N N N N N I HEX 
834 I or II II II  I,II,III  III N II I II+III N N I I HS 
835 I or II II II  II N N I N III N I u1 I COPD S 
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836 I or II II II  II I + III  N III N III N N II I HEX 
837 I or II II II  II N III II II or III II N N II I HNS 
839 I or II II II  I,II,III  I+II N II+III N I + III  N N II+III I HEX 
840 I or II II II  II N III I N I N N II I HS 
918 I or II II II  II II I I N III N II II II COPD S 
963 I or II II  II  II  N N N N I + III  N II N N HS 
965  III + mix II + mix II+III II I N II N I + III  N N N N COPD S 
968 III I or III  III II II N III N II N III II III HEX 
972 I or II II II II III N I+II N I+II N III N I HEX 
973 I or II II II II N N II N III II I II I p 
975 I or II II II II N N I N I N N II I HS 
976 I or II II II II N N I I II N I II I COPD S 
979  III + mix II + mix II+III I+II N N I+II II or III II N I+II II I+II COPD S 
985  III + mix II + mix II+III II N N II+III N II+III N I II+III I+II HEX 
988 I or II II II II N N N II or III I N I N I HEX 
989 I or II II II II N N N I +( II or III) II I + III  I + III  II I+II COPD EX 
997 I or II II II  II II N II II or III II N I II I COPD EX 
999 I or II II II  II N N I N I N N N N COPD S 
1004 I or II II II II I N u1 N III N III II I p 
1005  III + mix II + mix II+III II II N I I I + III  I + III  III II I + III  COPD EX 
1006 I or II II  II  II II+III N III N II N N N I COPD EX 
1008  III + mix II + mix II+III II III I I II or III II II+III II II+III I+II HEX 
1010 II II II II N N I + III  N N N I + III  N N p 
1013 I or II II II II+III II III I N II N III N I COPD EX 
1014  III + mix II + mix II+III II I N I + III  N N N I + III  N II COPD EX 
1015  III + mix II + mix II+III II N N N N N N I N N p 
1016 I or II II II II+III II N N N II N N N N HEX 
1017 III I or III  III II N N I + III  N N u1 II II I + III  COPD EX 
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1018 I or II II II II N II+III I N N N N N N HS 
1020 I or II II II II N II+III N u1 II+III N I II I p 
1021 I or II II  II  II I+II II N N N N I N N HS 
1023 I or II II  II  II I + III  N N N N N N N N HNS 
1025 III I or III  III II N II+III N II or III N N N N N HS 
1026 I or II II II II N N N N III N I N I COPD EX 
1027 I or II II II II N N N N II N I N I HNS 
1028 I or II II II II II N N N N N III N N HEX 
1029 I or II II II II N N N N I + III  N I N I COPD S 
1030 I or II II II II N N N N II N N u1 N COPD EX 
1032  III + mix II + mix II+III II II+III N N N N N N N u2 HS 
1033  III + mix II + mix II+III II N N N N I N N II I,II,III  HEX 
1035 I or II II II II II N I N N N I II+III I HS 
1036  III + mix II + mix II+III II N II+III N II or III N N N N N HNS 
1037 I or II II II II N   N II or III N N N N II COPD S 
1040 I or II II II II N III N N N N I u1 I HS 
1043 I or II II II II II N III N N N I N N COPD S 
1045 I or II II II II N N II N II N I II N p 
1047 III I or III  III II N N N II or III II N N II I COPD S 
1049 I or II II II I,II,III  II N N N N N N N I asthma 
1051 I or II II II II II N N N N II N N I + III  asthma 
1052 I or II II II II N N N II or III N N N II N COPD EX 
1053 I or II I or III  I II N III N II or III II N I II I + III  HS 
1054 I or II I or III  I II II N N N N N I N N HS 
1056 III I or III  III II II N N II or III II II I II N HS 
1060 I or II I or III  I I+II II N N N N N I II I COPD EX 
1064 III I or III  III II III N N N N N N N N COPD EX 
1067  III + mix II + mix II+III II III N N II or III N N I II I HS 
1068 III I or III  III II III N N N N N N N N COPD S 
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1069 III I or III  III II N N N N N N I N N HEX 
1070 III I or III  III II III III N u1 N u1 I II I p 
1071  III + mix II + mix II+III II III N N II or III II N II II+III N HS 
1072 III I or III  III II N N II N III N I II I,II,III  p 
1101 I or II II II II III N N N N N I N N HNS 
 
N= negative sample (yellow), HS = Healthy smoker, HEX = Healthy ex-smoker, HNS = Healthy non-smoker, COPDS = patient with Chronic Obstructive 
Pulmonary Disease), COPD EX= Ex COPD patient, p= pilot study, no data on health status are available. T. gondii genotype Type I-pink colour, Type II –
blue, Type III-green, Type  II or III type- brown, Type I or II-dark orange, Type I or III-purple, all three  Types present –red.  
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 5.3.5 Scanning Electron Microscopy and Transmission Electron Microscopy 
Selected tissue samples were sent to Salford Analytical Services (SAS) at the University of 
Salford for the analysis by Scanning electron microscopy (SEM) and Transmission electron 
microscopy (TEM). Structures similar to T. gondii stages (Figure 5.22) were observed using 
both types of microscopy. 
 
             
Figure 5.22 A) SEM of the lung tissue sample from case 979. A tachyzoite like structure 
(yellow arrow) can be observed. B) TEM of the macrophage from the patient 1040. A 
tachyzoite like structure can be observed in the red circle. 
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5.4 Discussion 
   In this study we investigated the prevalence of T. gondii in clinical samples from patients 
with lung cancer. We used four commonly used PCR markers (SAG1, SAG2, SAG3 and B1), 
histological and immunohistochemical staining to confirm the presence of the parasite. The 
prevalence ranged from 23.86% (SAG1Su) up to 100% (SAG1, SAG2, SAG3 and B1). 
Haematoxylin and eosin staining confirmed parasite like structures in all tested tissue sections 
and the staining with polyclonal T. gondii antibodies detected the parasite in all 76 stained 
sections. This study has revealed 100% prevalence in this cohort of lung cancer patients.  
These observed prevalences are unusually high but correspond with others studies, as the 
prevalence is estimated to be between 15 % up to 85% depending on geographical location 
(Dubey and Beattie, 1988).  Around 50% of the adult population in Germany is infected and 
as many as 90% of adults in Paris are seropositive (Hökelek et al. 2013). The most recent 
studies in the UK show infection in the range of 7 to 34% (Joynson et al. 1992; Pappas et al. 
2009; Flatt et al 2013; Public Health Wales 2014). Recent reports show that latent 
toxoplasmosis can possibly play an important role in manifestation of many psychiatric and 
neurological disorders such as bipolar disorder, personality disorder, Parkinson disease 
(Miman et al. 2010), Alzheimer disease (Kusbeci et al. 2011), OCD, epilepsy (Yazar et al. 
2003), schizophrenia (Torrey and Yolken, 2005; Niebuhr et al. 2007), autism and brain 
tumours (Thomas et al. 2012; Vittecoq et al. 2012) but not much is known about the 
prevalences in cancer patients.  In the study performed by Yuan (Yuan et al. 2007), the 
positivity rates of T. gondii IgG in nasopharyngeal carcinoma (46.15%) and rectal cancer 
(63.64%) groups were significantly higher than the other cancer groups, pulmonary 
carcinoma (4.55%), breast cancer (9.53%), gastric carcinoma (10.00%), hepatocellular 
carcinoma (14.29%) and uterine cervix carcinoma (12.50%)., demonstrating that there is a 
likely to be a stronger association between T. gondii infections and some kinds of cancer. 
Thomas and Lafferty (2011) in their study compared national figures from 37 countries and 
found that brain cancers are more common in countries where T.gondii infections are more 
common. Brain cancer was 1.8 times more common in countries where T.gondii was most 
common, than in those where it was virtually absent. The high percentage in the here 
presented study might be due to the fact that all patients have cancer and are 
immunocompromised which increases their susceptibility to T. gondii. Cancer is associated 
with defects in cell-mediated immunity and chemotherapy predisposes to the development of 
toxoplasmosis.  
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Selected samples were sequenced to resolve strain type whenever there were unclear enzyme 
digestion results or possible mixed genotypes present. In these cases, sequence analysis 
revealed possible double peaks at known polymorphic sites, indicating the presence of 
multiple alleles but due to the presence of background noise this cannot be fully confirmed. 
However, even sequence analysis has a limited capacity to detect mixtures where one 
component is in significant excess over another. As both, restriction analysis and sequencing 
independently confirmed the presence mixed strains in the PCR products, we are confident 
that this was not an artefact. 
In this study a combination of different independent markers was used. Most of these markers 
had good sensitivity and were able to detect T. gondii DNA in a small amount of tissue. This 
technique was suitable for direct genotyping but it was not possible to genotype all tested 
samples on all loci. A high number of mixed infections were detected, with some samples 
having all three genotypes present. Mixed infections have been previously reported in 
England and Wales (Aspinall et al. 2003). This was explained by possible ingestion of more 
than one type of parasite in food products containing meat originating from multiple animals 
(Aspinall et al. 2002). This also suggests that intermediate hosts are more often infected with 
more than one strain as previously thought.  The majority of tested subjects were of higher 
age so that congenital transmission is unlikely to be the main source of infection, but it 
cannot be fully excluded.  Congenital transmission is the result of primary infection acquired 
by an immunologically naïve patient during pregnancy (Ajzenberg et al. 2002) and so this 
route of transmission does not explain the high number of mixed infections. Congenital 
infection acquired during the early stages of pregnancy also often results in severe foetal 
deformation or death. Infection acquired later may result in milder symptoms or neonate may 
be asymptomatic at birth.  It is possible that the patients were infected with mixed oocysts or 
tissue cysts from contaminated food during their life, or with combination of all three routes. 
The information on whether these patients ever had blood transfusion or underwent organ 
transplantation is not available, as this could be another possible source of infection. Only 
three patients had SAG2 Type I infection. This genotype has been linked to congenital 
transmission in humans (Howe et al. 1995) and ocular toxoplasmosis (Grigg et al. 2001). 
Type I was unexpectedly predominant with markers c22-8 and BTUB. However the majority 
of tested patients had SAG2 Type II genotype present which has been reported as most 
prevalent genotype within both humans and animal populations (Owen et al. 1999). This 
genotype produces a high cyst burden in mice and is prone to reactivation in experimentally 
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immunocompromised mice (Howe at al. 1995). This corresponds with the high number of 
cysts detected in tested cohort of present study. Only ten patients had SAG2 Type III 
infection. These strains have been found to be common in animals, but are reported to be 
associated with human cases of toxoplasmosis significantly less often (Howe et al. 1995). 
Overall, 55 mixed infections were detected. In general, there is no clear correlation between 
strain genotype and symptomatology. In immunocompromised patients, the three SAG2 
genotypes are related to neurological diseases, with pneumonia or other related lung diseases 
(Fuentes et al. 2001). There is no data available on other markers, and possible links to 
particular diseases, as all original genotyping was based on the SAG2 marker only. The 
results presented here demonstrate that is possible to use direct genotyping with standard T. 
gondii RFLP markers on clinical tissue samples, and if full characterization is not always 
obtained, at least partial characterization is available. The nested PCR is fast and highly 
sensitive and the use of direct genotyping also avoids misleading results due to artificial 
selection in relation to the culture process. The use of cell culture or mice to isolate and grow 
the parasite from the clinical samples might produce sensitive variation in the observed 
genotyping frequencies due to an effect of differential selection of the strains (Frenkel et al. 
1997). Extreme caution needs to be applied when claiming a correlation between T. gondii 
genotypes and toxoplasmosis clinical presentation until there is a more complete knowledge 
regarding the parasite genotypes circulating in the human population.  
Pathological diagnosis of acute toxoplasmosis is most reliably established by demonstration 
of tachyzoites. With haematoxylin and eosin staining, tachyzoites can be seen in alveolar 
lining cells, filling macrophages, or free in the alveolar space. The surrounding inflammation 
is usually mononuclear, but mixed inflammation, vasculitis, necrotizing granulomas, 
abscesses and giant cells can be observed. Immunohistochemical staining with avidin-biotin 
peroxidase increases the sensitivity of routine staining. The usefulness of PCR for the 
diagnosis of the pulmonary toxoplasmosis remains unestablished. PCR would detect the 
tissue cyst present in dormant infection as well as the tachyzoites in acute infection. The 
diagnosis is established by the observation of tachyzoites in broncho-alveolar lavage fluid or 
transbronchial biopsy specimens. Reports have shown that the lung is frequently involved in 
fatal cases of pulmonary toxoplasmosis, where 55% of the patients died, even when 
pneumonia was not diagnosed on clinical grounds (Pomeroy et al. 1992). Therapy for acute 
toxoplasmosis is indicated in immunocompetent patients with significant organ dysfunction 
and in all immunocompromised patients. 
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Many bacterial and protozoan pathogens have clonal population structures and specific 
clones are often associated with particular disease (Tibayrenc et al. 1990).  Araujo in his 
study observed that different strains of T. gondii induced different cytokine responses in 
CBA/Ca mice (Araujo et al. 2003). In previous reports the majority of human toxoplasmosis 
cases were associated with infection by the Type II genotype, often associated with 
toxoplasmosis in AIDS patients with some fatal consequences (Fuentes et al. 2001).  The 
Type I strain in humans has been linked to a high frequency of ocular toxoplasmosis and 
congenital toxoplasmosis (Fuentes et al. 2001). Type I and atypical strains have never been 
reported in asymptomatic or benign congenital toxoplasmosis (Ajzenberg et al. 2002). Type 
III is not very common in human population, but Grigg (2001) observed atypical recombinant 
I and III genotypes in patients with ocular toxoplasmosis and AIDS. Carme suggested that is 
possible that atypical/recombinant genotypes are associated with severe toxoplasmosis at 
least in immunocompetent patients (Carme et al. 2002). Type III has been often associated 
with African countries, but as we do not know the background and the origin of the patients, 
we cannot exclude they are come from this area.  
All our patients have been diagnosed with lung cancer and subsequently underwent treatment 
and probably chemotherapy. Many of them had high number of infected alveolar 
macrophages, which is a characteristic of Type II infections. Some of the patients suffer from 
asthma and COPD and are on medication, which supresses the immune system. All these 
patients are at risk of reactivation of latent infection, leading to toxoplasmic encephalitis or 
pulmonary toxoplasmosis; which can complicate and delay their treatment or lead to death. 
We suggest that all cancer patients should be monitored for T. gondii to prevent 
complications during their treatment.  
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CHAPTER 6: 
 
General Discussion 
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  The protozoan intracellular pathogen Toxoplasma gondii has a worldwide distribution and 
can infect all warm-blooded vertebrates, causing severe disease in immunocompromised 
humans. Felids are the definitive hosts and other mammals can serve as intermediate hosts 
that can be infected by ingested oocysts, tissue cysts or congenitally (Dubey et al. 2001). It is 
estimated that about 30% of the human population is infected but some areas can exceed 40% 
(Pappas et al. 2009). Little is known of T. gondii genotypes and prevalence in wild natural 
populations of rodents and humans in the UK. In this study we developed methodologies that 
can be used to investigate these questions. We have investigated the prevalence and 
genotypes of T. gondii in a wild rodent population of Apodemus sylvaticus in an area 
relatively free of cats and in a cohort of human cancer patients. We have used T. gondii 
standard markers and novel molecular tools used in population genetics to investigate the 
rodent population, and human samples were also tested with histological and 
immunohistochemical methods to verify the reliability of PCR approaches.  
 
6.1. Prevalence of T. gondii in natural populations of wood mouse 
In recent years there has been an increased interaction between humans, domestic and wild 
animals that could result in a greater exchange of pathogens. There is a close relationship 
between domestic and sylvatic life cycles, therefore contact between herds and wild animals 
can give rise to economic losses relating to reproductive problems caused by T. gondii. 
Rodents are often considered as relevant marker species to assess environmental 
contamination by T. gondii, as felids prey on them and so the prevalence in carnivores is 
expected to be higher. It has been experimentally confirmed that rodents infected with T. 
gondii lose their innate fear of cat odours (Vyas et al. 2013) and this can increase the chance 
of the transmission to the definitive host. In total, brains from 126 wood mice from Malham 
Tarn Nature Reserve were tested with five T. gondii markers (B1, SAG1, SAG2, SAG3 and 
GRA6) and 34.92% (95% CI: 27.14% - 43.59%)   of all mice were infected.  A total of 24/76 
(31.58%, 95% CI: 22.19%-42.74%) of male and 20/50 (40%, 95% CI: 27.59%-53.84%) of 
female mice were found to be positive for T. gondii. No significant difference was found in 
prevalence in males and females (χ2 =0.863, D.F. = 1, P = 0.353). A total of 17 juveniles, 65 
young adults and 44 adults were present in this cohort of 126 of which 7 (41.18%), 27 
(41.54%) and 10 (22.72%) were PCR positive for T. gondii. There was no significant age 
prevalence effect detected (P = 0.23). However prevalence of infection is known to 
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accumulate with age in some species and so larger species with longer life expectancy are 
more likely to show this trend than smaller species, such as mice. Additionally small rodents 
can be more susceptible to infection and die soon after contracting the infection and this may 
explain the lack of an age prevalence effect usually seen. Four different genetic clusters of 
mice were detected in this population and interestingly there was a significant difference 
between each genetic population in T. gondii infection prevalence (χ2 =7.950, D.F. = 2, P = 
0.018). Twenty two families of wood mice were identified in this collection in the study site 
with an average T. gondii prevalence in families of 32.55% but with no significant 
differences  in individual families (χ2 = 0.284, D.F. = 1, P = 0.5943). Our data showed that 
the prevalence of T. gondii in natural mammal populations is high and the parasite can be 
perpetuated in the absence of felids possibly via the congenital route. High levels of vertical 
transmission have been documented in Mus musculus, M. domesticus and A. sylvaticus 
(Owen and Trees, 1998; Marshall et al. 2004). The majority of epidemiological studies in 
wild animals have been based on serological diagnostic methods (Franti et al. 1976; Jackson, 
1986; Webster, 1994; Dubey et al. 1995; Smith and Frenkel, 1995; Hejlicek et al. 1997; Jeon 
and Yong, 2000; Jakubek et al. 2001; Morsy et al. 2001; Yin, 2010; Mercier, 2013; Elamin, 
2014;  in comparison the  PCR–based studies have shown higher prevalence when used  in 
wild mice populations with prevalences ranging from 10.4% (Vujanic et al. 2011), 13.6% 
(Kijlstra et al. 2008), 23.9% (Yan et al. 2014), 29% (Zhang et al. 2004) up to 40.78% 
(Thomasson et al. 2011) and 59% (Marshall et al. 2004). Unfortunately we were not able to 
obtain the blood and do serological tests on sampled mice and were therefore unable to 
directly evaluate the sensitivity of PCR over serology. The sensitivity of different assays can 
influence detection of infection and so makes it difficult to compare the prevalences among 
studies using different methods. For example Araujo et al. (2010) isolated T. gondii from a 
rat which was identified as seronegative using MAT. Direct methods (PCR) can also be 
negative in seropositive individuals (Iqbal et al. 2007). Due to a dormant infection the 
antibody prevalence can be also related to age of the host due to the accumulation of 
exposure to parasite with age.  
6.2.Toxoplasma genotypes circulating in wildlife 
 In Europe and North America three main clonal lineages (types I, II and III) are 
predominantly found (Howe and Sibley, 1995), with type II being more frequent in Europe. 
Recently a fourth clonal type (haplogroup 12) has been discovered in North America (Khan 
et al. 2011). A few isolates originating from remote area of South America have been 
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analyzed and showed different multilocus genotypes suggesting that other lineages could 
circulate in other parts of the world (Darde et al. 1998). Su et al. (2003) constructed a 
phylogenetic tree of the Apicomplexa using rRNA sequences and showed that these three 
clonal lines formed a single branch with two other apicomplexa (Hammondia, Neospora) 
which had a common ancestor around 12 million years ago. Limited genetic diversity 
between and within clonal lineages indicates that they have evolved recently from a common 
ancestor, 10 000 years ago at the most (Su et al. 2003). Separate co-existing domestic and 
sylvatic cycles of T. gondii transmission may explain the distribution of archetypal and 
atypical genotypes in different hosts. Strain genotype also influences host immune response. 
The strain virulence is not the same according to the host, for example type I strains are 
highly virulent in mice but are not pathogenic in rats (Zenner et al. 1999; Li et al. 2012).  
Information on T. gondii strains circulating within the UK is limited. To determine the strains 
from the Malham Tarn Nature Reserve all 44 positive mice were RFLP genotyped at SAG2, 
SAG3 and GRA6 loci. In our study, only five mice had only Type II genotype on all three 
loci and the remaining 39 positive mice had mixed infections (23 had the combination of 
Type II and Type III alleles and 16 had all three genotypes present). This corresponds with 
genotypes observed in a previous study (Thomasson et al. 2011), when all three clonal 
lineages were detected in this locality. Type II was the most prevalent, but type I was more 
frequent than expected as this type is rare in wild life in Europe. Our study using three RFLP 
markers did not identify any atypical strains, but possibly adding more markers at other loci 
could identify novel genotypes in this population. Mixed infections in intermediate hosts 
have been reported previously (Ajzenberg et al. 2002, Aspinall et al. 2003, Dubey et al. 
2003, Pena et al. 2006). Detection of mixed infections is of particular interest in 
epidemiological studies. Experimental studies showed that non-canonical genotypes can 
develop when a cat ingests prey infected with T. gondii of more than clonal type followed by 
a sexual cross but this is believed to be rare in nature (Sibley et al. 1992). Genotypes different 
from clonal type II were found in Spain, Poland, Portugal and Germany in chickens, pigs and 
pigeons (de Sousa et al. 2006; Waap et al. 2008; Berger-Schoch et al. 2011).  
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6.3. Material and methods improvements 
Another problem was the aspect of sampling. Most previous genotype data are based on 
studies from humans and domestic animals, but the few isolates originating from other 
animals (arctic foxes, sea otters and some others) revealed identification of atypical 
multilocus genotypes or some unusual alleles. Emerging new clonal types may show different 
levels of virulence in intermediate hosts. In summary our results show no distinctive 
genotype dispersion pattern for the study area, but indicate some differences in the prevalence 
of types among wild rodents. For future study it would be beneficial to work with a larger 
sample size, this would be especially useful for genetic studies and analyses of the rodent 
family structures and T. gondii infection prevalence. As the life span of mice is only a few 
months and they breed about three times per year, the sampling period over two years caused 
some complications when we tried to assign the individuals into populations and families. We 
observed higher infection frequencies from the autumn samplings and this can be possibly 
linked to the source of infection and transmission.  The mice should be sampled at least twice 
per month for the maximum period of two years. Ten microsatellite mice markers were 
suitable for the population studies but it would be useful to use some T. gondii microsatellites 
to analyse the circulating parasite strains. Maybe testing DNA extracted from the blood could 
be performed to detect early infection before the parasite has created tissue cysts. In a 
Brazilian study DNA was extracted from the buffy coat instead of the whole blood and the 
detected prevalence was 48.6% (Kompalic-Cristo et al. 2007). Some serological and 
histological studies on different tissue types (lungs, brain, and liver) should be compared with 
molecular results. Isolation and culturing of the parasite would be a big advantage for the 
parasite genetic analysis and should be employed if possible. This however is very 
cumbersome for large epidemiological studies.  
 
6.4. Human toxoplasmosis 
  Humans may acquire T. gondii infection by ingesting food or water containing sporulated 
oocysts, by consuming raw or undercooked meat or congenitally. Major outbreaks of 
toxoplasmosis in Canada and Brazil were food- and waterborne related (Bowie et al. 1997; de 
Moura et al. 2006). The high seroprevalence rates found among vegetarians (Hall et al. 1999) 
in India support the importance of environmental or water contamination. In humans, primary 
infection is usually asymptomatic or does not require medical treatment. If the symptoms 
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occur, they are usually mild influenza like symptoms, rarely hepatosplenomegaly and 
lymphadenopathy can occur, and are often self-limiting (Krick and Remington, 1978). Latent 
infections are known to induce morphological and behavioural changes in infected persons 
(Webster et al. 2001). In immunosuppressed and immunodeficient patients T. gondii infection 
can have fatal consequences. The lungs represent the second most common site of T. gondii 
infection in people with AIDS (Marche et al. 1989). Those individuals with defects in cell 
mediated immunity represent a large group of the population at risk of pulmonary 
toxoplasmosis.  
6.5. Toxoplasma gondii in cancer patients 
Most of the studies that investigate the link between cancer and T. gondii infection are based 
on serological prevalence detection of the parasite in cohorts of cancer patients rather than by 
direct investigation of tissue samples. In our study we tested 88 samples from patients with 
lung cancer and other lung diseases (COPD, asthma) for the presence of T. gondii using 
molecular and immune-histological and a prevalence of 100% (95% CI: 95.19%-100%) was 
detected. This is a surprisingly high prevalence when compared to some previous studies. 
Overall 8.38% of examined patients with malignant neoplasms in China were positive for 
antibodies against T. gondii. However, when nested PCR detection was used on the same 
sample, only 3.55 % of these patients were positive (Wang et al. 2015). In another study from 
China (Cong et al. 2015) much higher seroprevalence was detected, with 35.56% of the 
cancer patients overall being positive for anti-T.gondii IgG. The highest prevalence of 
infection (Table 6.1), in this study, was observed in lung cancer patients (60.94%) followed 
by cervical cancer patients (50%). Among 356 cancer patients, 21 (5.9%) cases were found to 
be IgG-positive and 8 (2.3%) were IgM-positive, and five of them were found to have both 
IgG and IgM antibodies (Shen et al. 2014). The total seroprevalence of Toxoplasma infection 
among these patients was 6.8%. A study in Iran concluded that 45.2% of cancer patients were 
seropositive for T. gondii (Ghasemian et al. 2007). High seropositivity rates were detected in 
women with breast cancer (86.4%).  
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Table 6.1 Seroprevalence of T. gondii detected among different cancer patients groups 
(Wang et al. 2015, Yuan et al. 2007). 
Cancer type T. gondii prevalence (%) 
Lung cancer 60.94 
Cervical cancer 50.00 
Breast cancer 60.94 
Nasopharyngeal carcinoma 46.15 
Rectal cancer 63.64 
Gastric carcinoma 10.00 
Hepatocellular carcinoma 14.29 
 
The problem is that serological studies lack both sensitivity and specificity. In few published 
studies IgM remained positive in patients with T. gondii infections for 12-18 months and the 
IgG avidity remained low for a maximum of 4 months. In the United States, less than 5% of 
people with AIDS and toxoplasmosis produce IgM antibody to T. gondii, and the rise in 
levels of IgG antibody is distinctly unusual (Mills et al. 1986). A variety of serological tests 
such as the dye test (DT), modified agglutination test (MAT), enzyme-linked 
Immunoabsorbent assays (ELISA), Immunoabsorbent agglutination assay (ISAGA), indirect 
fluorescent antibody test (IFAT) and indirect haemaglutination assays (IHA) are used to 
detect different antibody classes or antigens.  
 
6.6. Pulmonary toxoplasmosis 
Since pulmonary pneumonia in immunocompromised patients is most often due to 
reactivation of T. gondii infection, these patients generally have serological evidence of past 
infection (Caterall et al. 1986). Pomeroy and his team (1992) observed that pulmonary 
toxoplasmosis appeared in two basic settings, 33% of reported cases occurred in patients who 
had no underlying illness linked with immunosuppression and 67% of the patients were 
immunocompromised. Pulmonary toxoplasmosis only rarely develops in immunocompetent 
patients (Weller et al. 1988) with only 9 cases documented of T. gondii pneumonia. The 
symptoms are often nonspecific; cough is non-productive until there is coinfection with other 
microbes. The most common findings on chest X-Ray is the presence of diffuse interstitial 
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infiltrates but these feature are nonspecific.  How often pulmonary toxoplasmosis is clinically 
manifest is unknown, but the condition may be undiagnosed. Definitive diagnosis of 
toxoplasmosis requires either histological demonstration of the organism or isolation by 
culture.  
Toxoplasmosis has been frequently described to be associated with some specific 
malignancies such as acute and chronic leukaemia, lymphoma or multiple myeloma (Yazar et 
al. 2004). In addition, patients being treated with antineoplastic drugs for tumours such as 
breast, ovary and lungs have been associated with toxoplasmosis (Yazar et al. 2004). While 
the medical significance of a high prevalence of infection with T. gondii in lung cancer 
patients is clear, the biological relationships between parasite infection and lung cancer are 
not. In laboratory animal models, the mouse and rat, it has been shown that T. gondii 
infection is related to the balance between levels of inducible Nitric Oxide Synthase (iNOS) 
and Arginase-1 (Arg-1) expression (Li et al. 2012): high iNOS, low Arg-1 being associated 
with resistance and the reverse associated with sensitivity. Interestingly, peritoneal 
macrophages from inbred lines of rats are T. gondii resistant (high iNOS/low Arg1), while 
alveolar macrophages from the same lines are sensitive to infection and express low iNOS 
and high Arg-1 expression (Zhao et al. 2013). Thus it appears, at least in rats that epigenetic 
differences in gene expression define alveolar cells as having a different degree of 
susceptibility to T. gondii infection. In studies, in laboratory animal models, infection with T. 
gondii causes impaired anion secretion in airway tissues by inhibiting the P2Y2 receptor 
(Guo et al. 2015). This could interfere with lung function by affecting the correct 
maintenance of airway surface liquid as occurs in cystic fibrosis. Furthermore, studies in 
laboratory rodents have shown that glucocorticoids, drugs commonly used in cancer patients, 
stimulate T. gondii growth in cells both in vitro and in vivo (Wang et al. 2014). Little is 
known as to whether parallels exist in humans, but these studies on model systems raise 
questions about how we view the relationship between lung cancer and T. gondii infection. 
Recent reviews claim that human macrophages have iNOS activity, albeit induced by other 
stimuli rather than that inducing nitrite production in murine macrophages and so may be 
derived from other cellular sources (Fang et al. 2004; Schneemann et al. 1997). The high 
frequency of T. gondii infection in our lung cancer patients raises questions about whether the 
two conditions are linked. It is unlikely that there is a direct cause and effect linkage as there 
are no reported causative effects of T. gondii infection on producing cancers, as far as we are 
aware. However, many types of cancer can cause immunomodulatory effects on affected 
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tissues and individuals (Franklin et al. 2014; Zhao et al. 2015) and immunosuppression is a 
known risk factor associated with toxoplasmosis (Canessa et al. 1992, Montoya et al. 2004 
Ajzenberg et al. 2009; Ahmadpour et al.  2014). Thirugnanam et al. (2013) suggested that T. 
gondii infection can promote initiation and progression of cancer by modifying the 
miRNAome in brain cells. Interestingly there is some scientific evidence indicating that 
parasitic infections induce antitumor activity against certain types of cancers. It is possible 
that asymptomatic T. gondii infection stimulates the immune system and may have anti-
tumour activity. The inhibitory effect of T. gondii on cancer growth has also been shown in 
cell culture and a mouse model (Darani et al. 2012). Suppression of neoplastic growth has 
been detected for some bacteria, protozoa and helminths (Gambashidze et al. 2012) and that 
certain parasitic compounds have are able to inhibit cancer growth (Darani et al. 2009). In 
study conducted by Miyahara et al. (1992) injections of rats with T. gondii lysate antigen 
resulted in a significant reduction in tumour formation. In another study significant reduction 
in tumour size was observed in mice injected with T. gondii antigen absorbed in alum 
adjuvant (Darani et al. 2009). Also inhibition of Lewis lung carcinoma by T. gondii has been 
reported through induction of Th1 immune responses and IL-12 and interferon production 
(Kim et al. 2007). In a study conducted by Seyedeh et al. (2015) the frequency of low titer 
antibody against T. gondii in cancer patients was significantly higher than the frequency of 
low titer antibody against this parasite in healthy people and he concluded that exposure to 
this parasite may be related to resistance to cancer. In this study the age of the patients was 
below 70 years and all were in early stages of the different types of cancer. Toxoplasma 
tachyzoites fixed in formalin in’ study Suzuki et al. (1986) were shown to induce antitumor 
activity against EL4 lymphoma in C57B1/6 mice. Also it is possible that metabolic products 
of T. gondii have inhibitory effects on cancer cells (Choo et al. 2005).  
  In our study all tested cancer patients were T. gondii positive and some of them had mixed 
strain type infection. We do not know how different strains and genotypes interact with the 
immune system, for example whether they can protect against the cancer or infection could 
be associated with manifestation of the disease, and what their impact might be on the health 
of the tested subjects. Further studies with a wide range of tested animal species, cell cultures 
and different strains needs to be done to gain a deeper understanding of the mechanism of T. 
gondii infection and dissemination. We suggest performing serological, histological and 
molecular testing on a larger group of patients and to compare the data with a control group 
of healthy patients. Different types of tissue from patients with different types of cancer 
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should be tested and patients from the youngest age group available should be included to 
avoid the age prevalence effect. Molecular detection of parasite DNA in peripheral blood is 
of the greatest significance in immunocompromised patients (Costa et al. 2009, Daval et al. 
2010). Vujanic et al (2012) observed a decline in parasitaemia in a patient with reactivated 
toxoplasmosis during anti-parasite treatment using real-time PCR.  If possible, living 
parasites should be isolated and their biological characteristics (phenotype) defined using 
animal models and in vitro cell cultures. Ethnic background, travel history, dietary habits, 
medication and the presence of cats in the household should be added to the patients’ data.  
 In our study 96.05% of the patients had acute infection. For this reason it is important that 
patients with toxoplasmosis infection are diagnosed and referred for treatment for the 
possibility of severe toxoplasmosis, especially after chemo- and radiotherapy when their 
immune system is weakened.   
 
6.7. Molecular detection of T. gondii  
We used standard T. gondii PCR markers (B1, SAG1, SAG2, SAG3, GRA6, APICO, L358, 
PK1, SAG1-Su, BTUB, alt.SAG2, c22-8 and c29-2), histological and immunohistochemical 
staining to confirm the presence of the parasite. All 88 tested samples were confirmed to be 
positive for T. gondii with markers B1, SAG1, SAG2 3
/
, SAG2 5
/
 and SAG3, giving a 
prevalence of 100% (95% CI: 95.82%). The ability to detect T. gondii genomic DNA in 
clinical samples made it possible to directly type the parasite and compare the results with the 
T. gondii database (htttp://toxodb.org/toxo). Only two samples were fully genotyped on all 10 
loci and were identified as new strains. From all successfully genotyped samples, 34 had a 
single infection identified using all loci and 42 were identified as representing mixed 
infection at one or more loci with all three genotypes present. Type II genotype was the most 
predominant, followed by Type I and Type III. We detected 11 unusual genotypes. The 
presence of structures consistent with infection by the parasite was confirmed in 67 out of 76 
tested haematoxylin-eosin stained tissue samples. With haematoxylin and eosin staining we 
can detect tachyzoites in alveolar cell linings, filling macrophages or free on the alveolar 
space and surrounded by inflammatory cells usually mononuclear. The main problem of this 
method is the detection of the parasite, especially in the areas where many host cells are 
present as they have the same colour after staining. Immunohistochemistry was performed in 
76 tissue sections using polyclonal antibodies produced in rabbits. All 76 sections were 
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confirmed to be positive for T. gondii showing different stages of the parasite and a wide 
range of infected cell types. A surprisingly high number of patients (96.05%) showed 
evidence of an active infection. Given that the background levels of infection in the UK are 
considered to be low at 10% and the global infection rate is 30% (Pappas et al 2009), this 
represents an extremely high infection rate in these cancer patients. 
 
6.7. Genotypes of T. gondii detected in immunocompetent and immunocompromised patients 
   Human toxoplasmosis is mainly caused by Type II lineage, Type I and atypical strains are 
found in severe toxoplasmic retinochoroiditis and acute disseminated toxoplasmosis in 
immunocompromised patients. Moreover patients with ocular toxoplasmosis and animals are 
often infected by Type III strains (Howe et al. 1995). Genotypes in human asymptomatic 
population are largely unknown. In mice, type II (based on SAG2 PCR-RFLP) produce a 
high number of cysts and are more prone to reactivate in experimentally 
immunocompromised mice. It is possible that this type behaves the same in the human 
population but 15% of observed cysts in human patients belonged to type I, suggesting that 
type I can create cysts in human tissue (Howe et al. 1997). A few cases suggesting that the 
human immune system is less adapted to atypical genotypes than to genotypes usually 
circulating in domestic cycles (Darde et al. 1998). To date, no parasite strain has been shown 
to have specific pulmonary tropism, but there are some suggestions that South American 
strains could be more virulent, leading to disseminated toxoplasmosis. In our study Type II 
strains have been shown to be most prevalent and this corresponds to some previous studies 
on T. gondii in congenital infection and AIDS patients in North America and Europe 
(Ajzenberg et al. 2009). There is not enough data on T. gondii strains circulating in human 
populations in the UK to support or refuse our findings. Aspinall and her team (2002) 
analyzed 32 cases of human toxoplasmosis by PCR targeting the SAG2 gene. These consisted 
of toxoplasmic encephalitis in HIV/AIDS, 19 cases of congenital toxoplasmosis, three 
immunosuppressed patients and two immunocompetent patients. The majority of the clinical 
samples produced clear restriction patterns classifying them as type I, II and III, however 
some samples produced complex digestion patterns suggesting the samples were mix of 
SAG2 type I and II, and type I and III. The high frequency of type II strains may reflect the 
source of strains as latent infections of domestic and wild animals were often caused by types 
II and III (Howe et al. 1995).  Type I strains have been associated with high level virulence in 
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mice as they have the ability to cross epithelial barriers rapidly  (Sibley et al. 1992). The 
unusually severe encephalitis and chorioretinitis associated with the reactivation of T. gondii 
cyst of a genotype I/III strain was described in an immunocompromised patient (Genot et al. 
2007). In some other studies in France type II isolates showed a large predominance (>80%), 
with the occurrence of some type I and III isolates (Ajzenberg et al. 2002). In Poland, all 
genotyped samples were type II (Nowakowska et al. 2006). Also samples from Serbia and 
Romania among cerebral toxoplasmosis were type II (Djurkovic-Djakovic et al. 2006). In 
Europe, type III is more frequent in Mediterranean countries (Messaritakis et al. 2008) and it 
has been reported in Portugal (Waap et al. 2008), Spain (Fuentes et al. 2001) and Serbia 
(Djurkovic-Djakovic et al. 2014). Concurrent infections with parasites of different T.gondii 
types have been reported only in a few cases. Our finding that 47 out of 88 infections were 
mixed was unexpected. Only a small number (less than 5%) of isolates have mixtures of the 
two-allele patterns seen in the type strains, indicating that they are natural recombinants. It 
has recently been suggested that a wider range of genotypes might be found in geographically 
remote areas where transmission may rely more often on the sexual phase (Ajzenberg et al. 
2004) which only occurs in cats. It is hard to explain such a high frequency of mixed 
infections in our study as a consequence of exposure to mixed oocysts. One possible 
explanation is via food born infection on multiple occasions of more than one T. gondii type 
during their life. In previous work Aspinall et al. (2002) tested commercial meat products and 
38% of samples were T. gondii positive containing both SAG2 Type I and II mixtures. This 
scenario could account for the high number of mixed infections identified in our study. 
Toxoplasma gondii infection was considered to be acquired in the early stage and the 
prevalence is enhanced with age and declines in later stage (Nimir et al. 2010) and the 
average age of our patients was 69.65. Interestingly in a study from China (Zhang et al. 2015) 
a higher prevalence was in the younger population compared to the older age group. There 
was no significant difference in prevalence between males and females.  We do not have the 
data on ethnic background of the patients or their travel history. It is possible that they 
travelled abroad or moved from a different country and brought back rare strains with them. 
Selected samples for each marker were sent for sequencing to confirm the mixed infections 
and resolve the strain type. Samples showing mixture of two or three alleles revealed possible 
double peaks at known polymorphic sites indicating the presence of more alleles in the same 
sample. Due to the presence of strong background noise we cannot definitely confirm or 
exclude the presence of mixed strains. Sequence analysis has as well limited capacity to 
detect mixtures where one component is in significant excess over another.  
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6.8. Molecular epidemiological studies of T. gondii 
    Our study has shown that the analysis with only one or three markers is not sufficient and 
could easily misidentify the strains as representing a simple set of genotypes or single 
genotype. However most of the highly repetitive and sensitive markers (e.g. B1, SAG1) are 
not useful for genotyping the parasite due to a relative absence of polymorphism. Typing of a 
single allele (one locus) does not necessarily imply that all alleles are of the same type. The 
three clonal lineages T. gondii system is based on the results of SAG2 typing and only 
recently after new multilocus typing was used more unusual strains started to emerge. Mixed 
infections can be more common in some regions and these strains may present different 
clinical complications. In our study we used direct genotyping of clinical samples while all of 
the previously analyzed strains were isolated by repeated passage in mice and in vitro culture, 
and therefore the apparent frequencies of specific lineages may have been biased against 
strains that were more difficult to isolate. The study of Costa et al. (1997), the first to be 
performed directly on biological samples (37 amniotic fluid samples) reported no mixed 
infections by analysis of microsatellites in the gene encoding T. gondii β-tubulin. In another 
study (Vilenna et al. 2004), samples from tested amniotic fluids, only one had mixed 
infection (Type I and II) detected by direct typing but after the murine inoculation, only Type 
II strain was isolated. Direct microsatellite typing on brain tissue from infected pigeons 
without previous passage in mice appeared to be better and in agreement with genotypes 
determined by bioassay (Waap et al. 2008). The presence of mixed strains infections in 
primary samples could demonstrate a possible selection bias in following parasite inoculation 
into mice. Due to the limited sample amount and technical difficulties of direct genotyping 
we were not able successfully amplify and type all loci. A high number of samples were 
positive at the beginning of the project but were PCR-negative with other markers at the end 
of the study. Repeated freezing and thawing could lead to a DNA damage and deterioration 
of sample quality. It has been suggested to add 50% glycerol to the samples to prevent DNA 
shearing due to ice crustal formation (Roder et al. 2010). With the development of new 
molecular methods it will be possible to study correlation between the parasite genotype and 
disease patterns in infected patients. More detailed strain comparisons based on wider set of 
sequence based markers will be necessary the global population structure of T. gondii. There 
is an interest in determining how particular genotypes might differ in their capacity to induce 
pathology or occurrence in particular host species. Not all seropositive AIDS patients develop 
encephalitis and similarly seroconversion during pregnancy does not always lead to infection 
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of the foetus. Different migration capacities might contribute to strain specific differences in 
parasite dissemination. Dellacasa-Lindberg et al. (2007) demonstrated that a subpopulation of 
Type I parasite display enhanced migration in vitro compared with types II and III. One 
tachyzoite of Type I strain is sufficient to generate high parasite loads. Most T. gondii strains 
have been genotyped with only a small number of markers that are shared among many 
different strains. Understanding the genetic factors that influence the virulence and the 
mechanisms of genotype selection according to host species could contribute to the 
development of therapeutics designed to eliminate transmission or cure disease. The 
diagnosis of T. gondii infection is usually based on histopathological examination, serological 
assay and isolation of the parasite by mouse inoculation. Molecular assay such as PCR make 
it possible to detect small quantities of DNA and provide a sensitive diagnostic tool. In our 
study we performed different methods, molecular and histopathological for detecting T. 
gondii. We were not able obtain blood from mice and humans and conduct serological studies 
on our samples. No immunohistochemistry was performed on the mice samples so the nested 
PCR was the only method of detection.  The main purpose of this study was to design a 
specific and sensitive nested PCR assay to detect the parasite in human lung tissue sample 
and brain tissue from wood mice. The nested PCR followed by RFLP assay used in our study 
is a fast and highly sensitive method for detecting T. gondii and characterizing parasite 
directly on clinical samples. Although the isolation of the parasite in mice is considered the 
gold standard, the technique is time consuming and we worked on some old samples, stored 
in lysis buffer or at -20˚C. The demonstration of the parasite after the inoculation is often 
delayed since mice usually develop a latent rather than an acute infection (Derouin et al. 
1987). It could take one or two months of repeated passages to obtain a sufficient amount of 
tachyzoites and this could be difficult to achieve especially in slow dividing strains (Darde et 
al. 1996).  It would be interesting compare the seroprevalence for both tested species and as 
well as histopathological findings in brains and lung of mice and humans. In the work carried 
out by Hermann et al. (2012) the serological detection resulted in higher prevalence when 
compared with molecular methods. Our prevalences in wood mice correspond with some 
previously reported data, but our human lung tissue samples have the highest T. gondii 
prevalence ever reported. Lower values for the PCR detection in some study samples are 
possibly due to the irregular distribution of the parasite in the tissue. This was confirmed with 
immunostaining when different stages of the parasite and different intensities were observed. 
The DNA from whole mice brain was used for detection of T. gondii and the large amount of 
host DNA could inhibit the parasite specific PCR amplification. In contrast, from some lung 
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samples only a small amount of tissue was used for the DNA extraction, as the remaining part 
was used for histology. Maybe testing a greater number of tissue samples from each species 
by PCR could increase the overall detection rates. In some cases where multiple tissues were 
collected from individual animals, that more than one tissue could was positive for T. gondii. 
For example in study conducted by Burrells et al (2013), selections of badger tissues were 
positive for T. gondii, while the corresponding brain tissue was negative.  
 
6.9. Markers for individual characterization of T. gondii 
Another limitation of the markers used in our study is that they are not able to distinguish 
closely related genotypes derived from the same clonal lineage. Microsatellite typing is now 
considered one of the most powerful tools to study DNA polymorphism and is used often 
with combination with RFLP markers. A total of 15 microsatellite markers (TUB2, W35, 
TgM-A, B17, B18, M33, IV.1, XI.1, M48, M102, N60, N82, AA, N61 and N83) have been 
used to genotype T. gondii. Microsatellites are especially useful revealing recent mutations in 
closely related isolates within the lineage and can detect mixed infections. Since T. gondii is 
haploid, only one peak is expected for a given locus corresponding to one allele. More than 
one peak will be detected if mixed infections with different alleles are present in the sample 
(Ajzenberg et al. 2002). Microsatellite PCR typing requires only a small amount of DNA and 
allele sizing can be achieved with automatic sequencing by using fluorescent primers. The 
usefulness of microsatellite markers for isolate typing was demonstrated by Costa et al. 
(1997), Blacskton et al. (2001) and Ajzenberg et al. (2002). The limitation of this assay is the 
requirement of an automated sequencer and the presence of the host DNA can prevent 
detection of specific peaks or generate low peak intensity. As not sufficient amount of 
purified T. gondii DNA was obtained, this method was not performed on tested samples.  
Traditional detection of T. gondii from environmental and tissue samples relied on 
microscopic examination, which is often of low sensitivity and thus unreliable.  Different 
stages of the parasite can be stained with Haematoxylin and Eosin or Giemsa stain, which is 
cheap and time-effective. Its problem is the detection of tachyzoites which can be easily 
missed especially if many host cells are present. In one study of cerebral toxoplasmosis the 
organism was not seen in over 50% of positive cases (Luft et al. 1984). Periodic acid Schiff 
(PAS) is used to stain granules in bradyzoites (Dubey et al. 1998). This method is time 
consuming and the parasite can be easily missed if only the tachyzoite stage is present, 
147 
especially in the early stages of the infection. Electron microscopy is rarely used due its 
difficulty for routine use. 
 
6.10 Future work and recommendations 
   The research presented in this thesis has addressed many questions regarding the 
prevalence and genotypes of T. gondii in natural populations of rodents and human, but there 
are still several lines that should be pursued.  
 
6.10.1. Toxoplasma gondii in wood mouse 
   As discussed in Chapter 3, the selection of ten A. sylvaticus microsatellites was sufficient 
enough to successfully analyse the population structure of the wood mice. However two of 
the selected microsatellites showed very small variation and so replacing them with more 
polymorphic ones could achieve better results and more accurate analysis of the rodent 
population. Some improvements could be also done regarding the sample size. Our original 
sample size had 126 wood mice, which was enough to identify four populations but it was 
insufficient to analyse the mice on family levels. In our sampling site we have identified 22 
families with various numbers of siblings, ranging from two up to ten members in each 
family.  To increase the statistical power and to identify more siblings from individual family 
the minimum sample size needs to be increased. Using modelling this estimated that a sample 
size with minimum of 500 animals is required, if we need 22 families with 20 members in 
each family. This requires more regular sampling over the sampling period.  Ideally the 
sampling should be over a one year period, starting in January and finishing in December, as 
this will ensure better sample set for use in COLONY as mice are more likely to be same 
generation siblings rather than transgeneration. The mice should be collected preferably twice 
a month, from the same sampling sites. If this is done the population data from this study can 
be used to estimate the number of rodents in the individual sampling areas. Based on the 
allele frequencies (0.05), NeEstimator software estimated that 134.6 wood mice from the R1 
population, 136.2 from the R2, 55 from the G and 227.2 from the B population are present in 
this area. The software was not able to estimate the number of mice for the whole area. 
Possible replacement of two microsatellites could solve this problem and give us a more 
reliable overall estimate. Only 24 of the collected mice belonged to the population B. This is 
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a much smaller sample size, when compared for example population G, where 40 mice were 
assigned. To make the identification of the family units more accurate, it is necessary to have 
more balanced sample sizes. In Malham Tarn Nature Reserve there are a few more sites, 
which could possibly have large mouse populations, for example  local farms, other areas in 
the forest or by expanding further south and sampling mice around Malham Cove. As wood 
mice are quite prevalent in the UK and inhabit variety of habitats it would be interesting to 
include new sampling areas outside the Malham Tarn Nature Reserve. The aim of this 
expansion would be to be able to extend the outcomes of this work from a local to a national 
or international setting.  
   In Chapter 4 the prevalence and genotypes of T. gondii in natural populations of wood mice 
were analysed in relation to their population structure. The results showed an unusually high 
prevalence of the parasite in an area relatively free of cats. Surprisingly a high number of 
mice had mixed infections, harbouring two or all three main genotypes. This indicates that 
mixed infections are more frequent than previously thought. We do not know what the 
original source of the infection is and so can only speculate. The mice probably became 
infected by consuming oocyst together with infected food (e.g. carrion) or vertically 
transmitted from mother to offspring. Most likely it is the combination of all of these routes. 
T. gondii was detected in 44 out of 126 tested mice belonging to four different populations 
(Chapter 4). There was a significant difference between each genetic population. The direct 
genotyping method was used and it was possible to successfully genotype all positive 
samples on all tested loci (SAG2, SAG3 and GRA6). As not all standard T. gondii markers 
worked on these samples it was not possible to match our detected strains with those listed in 
the database (www. toxodb.org). In future studies it is recommended the full set of markers 
be used. One of the major issues was the presence of mixed infections in high number of 
mice. The identification of the strains from the RFLP gel images was very difficult to 
interpret due to the presence of partial digests or complex binding patterns and DNA smears. 
Using direct PCR RFLP it was not possible to obtain a sufficient volume of purified PCR to 
be sent for sequencing.  One of the possible solutions for the strain identification is the 
isolation of parasites directly from the tissue. The direct genotyping of cultured isolates can 
be also difficult if two or more strains are present in the culture. This is especially true if 
there is the different growth rate of individual strains in the medium. For example the RH 
(Type I) strain divides rapidly and can overgrown other strains in a very short time, what  can 
lead to their disappearance from the medium and so genotyping results may not reflect the 
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real strain structure of the isolate. It is also very difficult to grow some strains in cell culture. 
A possible solution might be a greater variety media to encourage better growth conditions 
for different strains. However, as yet there is no background data on this issue and with a 
current number of 231 T. gondii genotypes; this would be time consuming task. However 
better analysis of the isolates could help improve the way we address the challenging 
questions regarding the parasite transmission. An attempt was made to find any relationship 
between the infection and family structure to determine whether the same genotypes are 
present in the same families and populations. Due to the small number of siblings in each 
family and the presence of mixed infections, it was not possible to fully answer this question 
although we have found that some families shared the same genotypes. A larger sample size 
and better identification of the genotypes is necessary to improve this analysis. Another 
option on how to perform genotyping with a limited amount of sample or the parasite is 
uncultivable is to develop whole genome amplification to enrich for T. gondii DNA where 
the amplified DNA can be directly used in a range of genetic analyses (qPCR, sequencing, 
microsatellite analyses, etc.). One of the disadvantages of the whole genome typing approach 
is the risk of multiplying host or bacterial DNA and obtaining poor resolution if mixed 
genotypes are present. Based on all of the above mentioned techniques the isolation and 
cultivation of the parasite seems to be a crucial step. Before the parasite isolation it would be 
favourable to perform fast screening tests for the presence of T. gondii (e.g. IHC, 
Haematoxylin and eosin staining, LAMP, serological screening) as it would be time 
consuming and expensive to try to extract the parasite from few hundred samples from which 
would be possibly negative. After successful isolation and cultivation of different T. gondii 
strains it would be useful to set up a biobank where researchers from different areas could 
retrieve the data for their studies. Similar collections could be set up for parasites obtained 
from different tissue types and animals, including humans. 
 
 
 
6.10.2. T. gondii in lung cancer patients 
   Data presented in Chapter 5 show that T. gondii was present in cells of 88 lung cancer 
tissue using molecular, histological and immunohistological methods. This 100% prevalence 
150 
is in contrast to the average 30% worldwide infection rate. T. gondii markers B1, SAG1, 
SAG2 and SAG3 provided fast and reliable detection method and additionally can be used for 
strain typing. Future work would be aimed at gaining a full strain identification using a full 
set of markers as described in previous chapters. Immunohistochemistry and haematoxylin 
and eosin staining was used as a secondary confirmation method. During this research two 
main issues emerged. A similar problem was observed as found as with the wood mice 
samples using the direct genotyping method. From 88 tested samples, only two could be fully 
genotyped on all tested loci. We were not able to obtain enough of purified PCR product 
from the sample heavily biased towards   host DNA. Again, the solution for this problem 
could be the isolation and cultivation of the parasite. Genotyping performed on the isolates 
could solve the problem in identifying mixed infections present in tested patients. The second 
main issue was the lack of negative control samples from subjects without lung cancer. 
Although few negative controls were used for the PCRs and IHC (negative mouse tissue, cell 
culture) it was not possible able to test our methods on lung tissue from healthy individuals. 
Our modelling based on 100% infection rate showed that we need a minimum of 20 samples 
from healthy individuals (no cancer, COPD or other underlying conditions) to make it 
statistically robust. These control samples should have balanced by sex and age and 
preferably tested subjects should be free of any medication. Unfortunately it is very difficult 
to obtain lung tissue from healthy donors. In an ideal world a few different control groups 
could be obtained to control possible link between T. gondii and cancer or other diseases. In 
some studies they successfully decreased the size of the tumours using T. gondii lysate 
(Chapter 5) while in others they describe the parasite as the source of cancer. It is possible 
that different strains of T. gondii may evoke different responses depending on the health 
status of the human host while many others, presently unknown, factors could play crucial 
role. To investigate this problem it would be necessary to take a different and larger scale 
approach. In the first place is important to collect more data about the prevalence and strains 
circulating in the human population, from both healthy individuals and from patients with a 
range of diseases, including different types of cancer. Subjects should be tested using 
serological, molecular, histological and immunohistological methods in addition to live 
parasitic culture. For epidemiological studies is also important to know the amount of the 
parasite present in tested tissues, which could be measured using qPCR.  Samples need to be 
collected from different geographical locations across the country, from both, urban and rural 
area to obtain a full picture. A possible future development would be to set up biobanks with 
the collections of possibly all known strains and investigate their properties and virulence in 
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different hosts, starting with the cell cultures and moving to laboratory animals later. 
Attention needs to be paid to the development of more diagnostic methods and markers; 
especially those to able detect virulent strains much faster. In our study we tried to use 
Scanning electron microscopy (SEM) and Transmission electron microscopy (TEM) to detect 
the presence of the parasite. These methods are expensive; time consuming and not very 
practical for routine use but still can be used for final confirmation. If these methods are used 
on the tissue samples where not many host cells are present, they can provide another useful 
detection tool. They can be also used in the treatment analysis as they can show the effect of 
tested drugs on ultrastructural level.  
   Different types of tissue may have different susceptibility to parasites and this could explain 
the results in our study. Finally there were differences in status of tested subjects, where the 
human patients were already immunocompromised and so at risk contracting toxoplasmosis 
while the wild mice were at relatively good health as far as we are aware. What the two tested 
groups had in common was an unusually high number of mixed infections and the dominance 
of Type I. These results raise some new questions. What is the actual impact of individual 
strains on our tested subjects? We can estimate the effect of T. gondii on the cancer patients 
as there are some studies available, but there is little data on how the parasite affects wild 
animals. Only a few reports mention the negative impact of T. gondii on sea otters and 
dolphins, but most of the data is related to farm animals (e.g. pigs, sheep and chickens) and 
the possible risk to humans. As mentioned previously, we need to learn more about parasite 
genetics, host genetics and mechanisms of virulence. This will be only possible by detailed 
analysis of as many possible strains from many different intermediate hosts including humans 
from a variety of habits from all continents. Recently many parasites and bacteria have 
started showing increased resistance to treatment and medication. At the moment there are no 
reports of resistant T. gondii strains but we cannot exclude this possibility. This could have 
fatal consequences especially for the patients with impaired immune systems or if the disease 
is caused by some highly virulent strain. Many of the European countries run screening 
programmes for pregnant women but no automatic tests are available in the UK (until 
requested) and many of the pregnant women are not aware of the danger that T. gondii could 
cause to their unborn child. More education needs to be provided to larger communities and 
GP surgeries as T. gondii is often overlooked and ignored. In longer term, the founding of 
international networks of reference laboratories and information exchange between experts, 
doctors and ecologists could bring more answers to these outstanding questions. 
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Appendix 
 
181 
Apodemus sylvaticus genotyping and population data (-9 represents missing value) 
Expected    size (bp) 
                   
  
101-
110   
105-
124   
128-
154   
361-
622   
168-
209   
94-
118   
199-
296   
202-
216   
252-
268       
Primer  8S   TNF   4A   3A   1A   2A   7S   9A   12A   MS19   
Sample All 1  All 2 All 1 All 2 All 1 All 2 All 1 All 2 All 1 All 2 All1 All2 All1 All2 All1 All2 All1 All2 All1 All2 
1 120 120 109 109 -9 -9 363 382 217 234 99 99 208 243 203 203 441 441 82 89 
2 112 120 112 119 -9 -9 374 366 162 209 95 103 208 243 200 204 441 475 95 201 
3 120 120 115 120 130 144 374 382 170 217 99 99 202 202 200 203 441 441 118 201 
4 120 120 107 109 -9 -9 382 390 176 217 99 99 243 243 203 225 461 477 88 95 
5 112 120 119 122 130 144 375 385 158 176 99 99 208 237 203 225 441 441 118 201 
6 117 120 112 122 137 148 363 385 170 217 95 95 208 208 203 203 441 477 95 201 
7 120 120 107 109 128 134 363 382 162 217 99 99 202 243 203 203 445 461 93 95 
8 120 120 121 124 127 151 366 385 162 234 99 99 202 202 203 203 441 461 95 102 
9 120 120 112 114 128 134 366 375 176 217 99 99 208 208 225 225 445 481 95 201 
10 120 120 109 114 130 140 366 375 176 176 103 103 237 243 176 200 461 475 95 201 
11 120 120 109 115 130 140 375 382 217 217 95 99 210 243 96 96 445 461 95 201 
12 117 120 118 118 128 130 378 382 176 217 95 99 199 243 203 203 471 477 104 201 
13 128 141 109 122 -9 -9 -9 -9 158 217 -9 -9 205 207 225 225 -9 -9 95 95 
14 120 120 117 120 137 148 366 382 170 217 97 97 206 237 203 203 461 461 102 201 
15 120 120 120 122 137 148 363 378 217 217 99 99 206 243 203 225 461 467 95 95 
16 120 120 118 120 140 144 367 382 162 217 99 99 208 208 225 225 452 477 95 120 
17 120 120 118 122 130 133 367 382 176 176 97 97 210 210 176 225 441 445 97 104 
18 120 120 115 122 130 133 378 382 162 162 97 97 210 210 203 225 441 441 102 104 
19 117 120 120 122 133 154 382 390 162 217 99 99 210 210 203 225 461 467 95 97 
20 120 120 107 109 128 130 370 386 196 217 99 99 206 206 225 225 452 477 124 201 
21 112 120 108 122 137 148 365 378 176 211 99 99 206 238 176 225 -9 -9 104 201 
22 120 123 108 120 133 140 366 382 162 217 99 99 210 210 96 96 461 461 88 97 
23 112 120 118 122 140 148 375 378 176 217 99 99 210 210 176 200 441 467 95 104 
24 112 120 118 120 134 140 366 382 176 217 95 95 199 199 200 204 441 467 95 104 
25 117 117 117 122 128 144 375 382 217 217 95 95 198 209 203 203 477 477 95 118 
26 120 120 109 122 137 148 375 382 162 217 99 99 199 199 225 225 447 461 118 201 
27 120 120 107 109 133 152 363 386 162 234 99 99 208 208 203 203 445 461 95 201 
28 120 120 114 122 128 137 382 386 217 234 99 99 202 202 225 225 446 461 88 118 
182 
29 120 120 120 122 148 154 363 383 176 217 97 97 202 210 203 203 447 466 88 95 
30 120 120 106 124 134 137 378 390 162 217 95 103 210 210 225 225 461 461 88 95 
31 120 120 119 122 134 154 378 382 162 162 99 99 206 210 203 203 461 461 -9 -9 
32 112 120 115 119 130 154 367 374 158 162 99 99 208 243 203 203 437 461 92 95 
33 120 120 131 133 -9 -9 -9 -9 217 217 -9 -9 206 243 203 203 -9 -9 95 120 
34 120 120 118 133 -9 -9 -9 -9 -9 -9 -9 -9 -9 -9 203 203 437 437 96 96 
35 -9 -9 118 133 -9 -9 -9 -9 176 217 95 106 206 210 176 203 -9 -9 82 82 
36 131 134 122 133 -9 -9 -9 -9 158 176 -9 -9 204 206 -9 -9 -9 -9 82 96 
37 118 120 122 133 -9 -9 -9 -9 -9 -9 -9 -9 204 206 -9 -9 -9 -9 82 82 
38 120 120 119 128 133 148 374 394 176 217 99 99 206 206 203 203 -9 -9 97 201 
39 120 120 -9 -9 -9 -9 440 446 -9 -9 -9 -9 -9 -9 -9 -9 -9 -9 89 89 
40 118 120 109 133 134 141 436 460 -9 -9 82 95 210 237 -9 -9 -9 -9 82 96 
41 118 120 109 133 -9 -9 446 460 176 234 -9 -9 209 237 -9 -9 436 474 82 96 
42 120 120 128 135 133 140 374 390 162 217 99 99 210 210 203 203 437 481 118 120 
43 120 120 115 117 137 148 367 371 162 217 99 99 208 208 203 203 440 474 95 109 
44 117 120 115 122 137 152 367 371 176 217 -9 -9 206 243 225 225 441 441 95 201 
45 112 120 118 122 148 152 382 386 -9 -9 99 99 237 243 225 225 460 460 95 201 
46 120 120 109 122 127 134 382 386 155 168 99 99 237 242 203 203 446 454 93 95 
47 120 120 107 122 134 144 365 388 -9 -9 99 99 208 237 189 210 444 454 201 201 
48 120 120 107 122 128 130 367 370 182 211 95 99 206 238 203 203 474 474 102 104 
49 117 120 120 120 130 137 375 382 176 217 99 99 210 210 174 174 474 474 95 114 
50 120 120 120 122 128 130 378 386 162 217 99 99 206 208 203 203 438 440 102 104 
51 120 120 120 122 128 137 386 386 217 217 99 99 208 237 203 203 446 454 82 82 
52 120 120 118 120 128 148 376 386 162 217 99 99 199 242 203 203 440 454 85 92 
53 120 120 120 122 128 134 370 378 162 217 99 99 237 234 176 203 438 440 92 112 
54 120 120 122 135 128 130 367 386 162 217 99 99 206 237 203 203 470 470 92 120 
55 120 120 122 133 130 144 370 376 162 217 99 99 210 210 203 225 436 474 92 100 
56 120 120 110 122 130 144 376 386 162 217 99 99 208 237 203 232 461 461 82 99 
57 120 120 119 122 128 152 378 386 162 217 99 99 210 237 210 225 461 461 92 100 
58 120 120 117 119 134 134 363 378 162 217 99 99 206 206 203 203 440 476 -9 -9 
59 120 120 113 115 128 134 374 382 162 217 99 99 206 206 203 203 444 446 92 100 
60 120 120 118 120 128 148 374 390 162 217 99 99 206 237 119 126 446 454 92 100 
61 120 120 112 115 137 154 378 396 162 217 99 99 210 210 203 203 440 461 92 338 
62 117 120 115 120 134 134 378 390 162 217 99 99 199 208 225 225 -9 -9 92 100 
183 
63 120 120 115 122 128 148 374 382 162 217 99 99 210 210 203 203 -9 -9 92 100 
64 120 120 118 122 128 144 367 386 162 217 95 99 199 237 210 225 446 454 92 100 
65 120 120 120 120 127 127 378 390 162 217 95 99 225 243 203 203 440 461 92 100 
66 120 120 120 122 140 152 378 382 162 217 99 99 204 237 171 200 -9 -9 92 100 
67 109 120 109 132 133 140 375 382 162 217 99 99 199 206 96 96 -9 -9 92 100 
68 113 120 122 140 131 155 -9 -9 158 158 -9 -9 206 247 171 203 436 474 93 95 
69 120 120 120 120 133 152 378 382 217 217 85 88 206 210 -9 -9 444 470 92 134 
70 120 120 109 118 128 134 374 382 170 234 92 94 206 243 171 200 461 461 86 97 
71 120 120 109 118 128 145 382 386 217 217 92 94 208 210 -9 -9 444 474 92 92 
72 -9 -9 126 128 140 155 382 386 176 217 96 99 -9 -9 171 203 440 480 97 109 
73 120 120 115 124 128 134 371 382 158 158 113 94 206 247 203 203 461 461 201 201 
74 -9 -9 109 118 141 152 378 382 -9 -9 84 95 -9 -9 203 210 461 461 118 118 
75 120 120 115 118 134 141 371 386 170 234 96 99 -9 -9 204 204 444 478 104 252 
76 120 120 -9 -9 141 152 374 378 217 217 -9 -9 206 238 171 200 444 463 93 95 
77 120 120 -9 -9 140 140 371 386 158 176 96 99 206 210 171 203 -9 -9 100 324 
78 120 120 122 127 138 145 376 386 176 217 83 99 206 243 176 176 440 480 -9 -9 
79 -9 -9 119 119 133 141 -9 -9 204 217 81 99 -9 -9 203 203 -9 -9 102 104 
80 120 120 117 127 128 140 379 390 217 217 83 94 204 206 -9 -9 434 478 118 120 
81 120 120 109 127 128 134 374 382 217 234 83 83 208 243 171 224 -9 -9 88 110 
82 117 120 115 122 128 134 378 382 176 217 92 94 206 206 -9 -9 434 446 118 120 
83 120 120 115 122 134 141 371 382 176 217 92 94 206 206 -9 -9 461 461 118 118 
84 120 120 115 122 128 148 382 386 156 217 92 94 206 206 203 224 436 461 100 103 
85 120 120 110 133 128 131 367 382 217 217 80 94 204 206 -9 -9 444 478 89 89 
86 120 120 -9 -9 134 144 367 382 162 176 100 102 200 243 -9 -9 441 441 95 120 
87 120 120 92 92 134 134 371 382 162 217 86 98 206 208 203 203 -9 -9 95 95 
88 120 120 106 127 133 133 382 386 158 170 96 98 200 206 -9 -9 -9 -9 202 218 
89 120 120 109 115 128 128 374 382 217 217 84 94 196 243 203 225 441 441 -9 -9 
90 120 120 107 127 128 148 374 374 159 212 80 84 208 243 171 227 -9 -9 95 102 
91 120 120 115 115 144 144 371 371 162 217 96 98 208 208 203 203 441 461 88 95 
92 117 120 110 118 131 152 367 386 217 217 94 98 206 210 -9 -9 -9 -9 92 96 
93 120 120 122 128 131 144 367 367 178 217 84 86 208 243 210 225 438 440 104 120 
94 117 120 110 110 -9 -9 374 386 158 162 96 98 243 243 -9 -9 474 478 88 120 
95 117 120 122 126 134 140 382 390 217 217 84 86 206 238 171 171 461 478 95 95 
96 112 117 107 118 140 152 367 390 217 217 86 98 204 206 171 225 440 461 96 120 
184 
97 120 120 109 122 134 140 374 386 158 217 84 94 206 243 174 174 -9 -9 88 102 
98 120 120 115 133 128 134 371 374 158 217 84 84 196 208 171 203 444 454 95 104 
99 120 120 115 117 134 134 367 382 162 217 84 102 200 208 222 225 446 461 95 120 
100 120 120 118 127 131 152 378 386 158 162 80 84 200 204 200 203 454 461 98 104 
101 120 120 117 130 145 148 406 406 217 217 84 84 -9 -9 203 203 440 474 88 110 
102 120 120 115 133 -9 -9 -9 -9 217 217 84 84 209 243 203 203 440 444 95 104 
103 120 120 122 131 -9 -9 -9 -9 -9 -9 96 99 200 206 222 225 446 479 118 120 
104 120 120 122 131 127 148 -9 -9 162 217 96 99 -9 -9 200 203 440 446 82 88 
105 112 120 115 127 -9 -9 370 378 217 234 92 96 206 210 203 203 444 454 82 82 
106 118 120 112 115 117 127 370 378 162 176 92 96 202 206 203 203 416 444 96 96 
107 118 120 124 127 -9 -9 371 382 162 162 120 120 206 210 203 203 430 461 96 96 
108 118 120 124 139 -9 -9 -9 -9 217 217 120 120 206 210 203 224 440 461 96 104 
109 118 120 124 127 -9 -9 -9 -9 168 217 120 120 209 243 203 203 436 461 104 404 
110 118 120 106 127 147 154 -9 -9 162 217 120 120 202 206 169 169 -9 -9 96 96 
111 120 120 106 127 -9 -9 370 378 216 234 112 120 204 206 203 203 461 470 82 96 
112 101 120 122 126 128 133 367 378 162 176 118 120 198 200 203 224 436 461 82 82 
113 101 120 109 133 -9 -9 371 384 162 162 118 120 198 200 171 186 454 454 89 89 
114 101 120 115 127 128 133 -9 -9 162 162 118 120 200 206 171 186 -9 -9 96 120 
115 101 120 106 127 133 144 378 382 217 217 118 120 206 210 171 225 -9 -9 82 82 
116 113 120 116 119 81 81 370 370 158 176 118 120 202 206 169 203 -9 -9 82 82 
117 113 120 -9 -9 127 144 -9 -9 162 217 86 96 206 237 171 203 440 440 92 92 
118 101 120 -9 -9 81 81 -9 -9 -9 -9 101 120 235 237 169 203 -9 -9 85 97 
119 118 120 -9 -9 137 141 -9 -9 217 234 101 120 229 243 225 225 440 450 -9 -9 
120 100 120 122 127 81 81 371 386 162 217 101 120 208 243 171 225 436 461 93 95 
121 113 120 113 133 144 148 382 382 176 217 101 120 205 243 171 186 429 461 125 125 
122 120 120 113 119 140 144 363 367 176 196 113 120 206 243 171 186 429 461 108 110 
123 100 120 115 122 144 154 176 217 176 216 89 99 210 237 171 186 446 472 -9 -9 
124 120 120 115 139 127 133 374 382 -9 -9 101 120 -9 -9 171 203 446 446 82 120 
125 -9 -9 -9 -9 127 133 -9 -9 -9 -9 118 120 204 242 171 186 -9 -9 82 96 
126 100 120 126 127 -9 -9 370 382 176 217 100 120 202 243 169 183 -9 -9 82 110 
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T. gondii sequence data obtained from the lung cancer patients 
 
Sequence analysis of SAG1 marker (Savva et al. 1990) (subject 1051) was identified by BLAST as T. gondii VEG strain (95%). 
 
 
 
186 
Sequence analysis of the alt.SAG2 marker (subject 918) was identified by BLAST as T. gondii ME49 strain (93%). 
 
 
 
 
 
 
187 
 
Sequence analysis of the Apico marker (subject 829) was identified by BLAST as T. gondii   TgCatAu_9 strain (91%). 
 
 
188 
Sequence analysis of the BTUB marker (subject 1067) was identified by BLAST as T. gondii strain DEG or BEVERLEY (94%).   
 
 
 
189 
Sequence analysis of the C22-8 marker (subject 1032) was identified by BLAST as T. gondii strain  VEG or TgCatAu_7 (96%). 
 
 
 
190 
Sequence analysis of the GRA6 marker (subject 674) was identified by BLAST as T. gondii AF07/02U strain (99%). 
 
 
 
 
191 
Sequence analysis of the SAG2 3
/
 marker (subject 918) was identified by BLAST as T. gondii Me-49 strain 
 
 
 
 
 
 
192 
Sequence analysis of the SAG2 5
/
 marker (subject 918) was identified by BLAST as T. gondii Me-49 strain 
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